[
  {
    "indication_name": "1,3-Beta-Glucan Synthase Inhibitor",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "11 Beta-Hydroxysteroid Dehydrogenase (11 HSD) Inhibitor",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "11 Beta-Hydroxysteroid Dehydrogenase Type 1 (11 HSD1) Inhibitor",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "14-Alpha Demethylase Inhibitors",
    "therapeutic_area": "Infectious Diseases",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "177-LUTETIUM-PSMA-617",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "20s Proteasome Inhibitor",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "22q11.2 Deletion Syndrome",
    "therapeutic_area": "Genetic Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 4
  },
  {
    "indication_name": "2X-121 Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "30S Ribosomal Subunit (30S RNA) Inhibitor",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 2
  },
  {
    "indication_name": "3D Bioprinting",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "3D Cardiac Mapping System",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "3D Dental Scanners",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "4-1BB receptor Agonist",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "4D-310",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": "",
    "year_range": "",
    "total_reports": 1
  },
  {
    "indication_name": "5-Alpha Reductase Inhibitor",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "5-HT1A Antagonist",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 2
  },
  {
    "indication_name": "5-HT1B Agonist",
    "therapeutic_area": "Neurology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 2
  },
  {
    "indication_name": "5-HT1B Antagonist",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "5-HT1D Agonist",
    "therapeutic_area": "Neurology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "5-HT2A Agonist",
    "therapeutic_area": "Neurology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 2
  },
  {
    "indication_name": "5-HT2B Antagonist",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 2
  },
  {
    "indication_name": "5-HT2C Agonist",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "5-HT2C Antagonist",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "5-HT4 Agonist",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "5-HT4 Antagonist",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "5-HT4 Partial Agonist",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "5-HT6 Antagonist",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "5-HT7 Antagonist",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "5-Lipoxygenase Inhibitor (Arachidonate 5-Lipoxygenase Inhibitor)",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "A4250",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "AAV RPGR",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "AAV for the Hereditary Retinal Diseases - Competitive landscape",
    "therapeutic_area": "Ophthalmology",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "AAV2/8 LSPHGAA",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "AAV9 CLN3",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "ABECMA Market Size",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "ABILIFY MAINTENA Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "ABILIFY MYCITE Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "ABV-1504 Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "ABX464 Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 2
  },
  {
    "indication_name": "ACE-536 (Luspatercept)",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "ACP-01 Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "ACTEMRA Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "ACVR1 Protein Inhibitors",
    "therapeutic_area": "Genetic Disorders",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "AD109 Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "ADA-SCID - Competitive Landscape and",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2018,
    "year_range": "2018",
    "total_reports": 1
  },
  {
    "indication_name": "ADCETRIS Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "ADEMPAS Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "ADME Toxicology Testing",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "ADP101 Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "ADUHELM Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "ADVM-022",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "ADVM-022 Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "AFREZZA Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "AGB101 Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "AI in Oncology",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "AIDS Dementia",
    "therapeutic_area": "Infectious Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "AIDS Related Kaposi's Sarcoma Epidemiology Forecast",
    "therapeutic_area": "Oncology",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "AIDS Related Kaposi's Sarcoma Pipeline Insight",
    "therapeutic_area": "Oncology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "AIDS Related Kaposi\u2019s Sarcoma",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "AIMOVIG Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "AJM300 Market Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "AJOVY Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "AK002",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "AKL4 Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "AL Amyloidosis",
    "therapeutic_area": "Genetic Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2030-2034",
    "total_reports": 3
  },
  {
    "indication_name": "AL Amyloidosis \u2013 Epidemiology Forecast",
    "therapeutic_area": "Genetic Disorders",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "ALK-positive Non-Small Cell Lung Cancer (ALK+ NSCLC) Pipeline Insight",
    "therapeutic_area": "Oncology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "ALOFISEL Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "ALXN1840 Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "ALZ-801 Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "AMG0001 Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "AMPA Receptor Antagonist",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "AMT-130 Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "AMX0035 Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "AMZ-001 Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 3
  },
  {
    "indication_name": "ANAKINRA",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "ANAVEX2-73 Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "ANCA Associated Vasculitis \u2013 Epidemiology Forecast",
    "therapeutic_area": "Cardiovascular Diseases",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "ANCA Vasculitis",
    "therapeutic_area": "Cardiovascular Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "ANCA associated Vasculitis",
    "therapeutic_area": "Cardiovascular Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "ANCA-associated Vasculitis (AAV) Patient Pool Analysis",
    "therapeutic_area": "Cardiovascular Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "ANGPTL3 Protein Inhibitors",
    "therapeutic_area": "Cardiovascular Diseases",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "ANJESO Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "ANX005 Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 2
  },
  {
    "indication_name": "AP-101 Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "APL-2 Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "APP13007 Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 2
  },
  {
    "indication_name": "APPA Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "APT-1011 Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "APX3330 Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "AR1001 Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "ARALAST Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "AREXVY Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "ARGX-113 Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "ARISTADA and ARISTADA INITIO Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "ARO-APOC3 Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "ARO-C3 Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "ARO-ENAC",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "ARQ-151 Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "ASC22 Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "ASN002 (Gusacitinib) Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "AT-1501 Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "AT845",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "ATEZOLIZUMAB",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "ATH-1017 Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "ATI-450 Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "ATP Binding Cassette Sub Family B member 1 (ABCB1 or P-Glycoprotein or P-gp) Inhibitor",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "ATPase Inhibitor",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "ATR Protein Inhibitors",
    "therapeutic_area": "Oncology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "ATTR Amyloidosis",
    "therapeutic_area": "Genetic Disorders",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "AUSTEDO Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "AV-101 Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "AV-GBM-1 Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "AVASTIN Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "AVR RD 01",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "AX-8 Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "AXA1125 Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "AXL Kinase Inhibitor",
    "therapeutic_area": "Oncology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "AXL Receptor Tyrosine Kinase Inhibitors Market Size, Target Population, Competitive Landscape & Market Forecast",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "AXS-05 Market Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "AXS-05 Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "AXS-12 (Reboxetine) Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "AXS-14 Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "AZD-1775 Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Aarskog-Scott Syndrome",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Abdominal Aneurysms",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Abdominal Aortic Aneurysm",
    "therapeutic_area": "Cardiovascular Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 2
  },
  {
    "indication_name": "Abdominal Aortic Aneurysm Pipeline Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Abdominal Aortic Aneurysm Repair Devices",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Abdominal Stent Graft",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Abetalipoproteinemia",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Abilify - API Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Ablation Devices",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Abnormal Glucose Tolerance",
    "therapeutic_area": "Endocrinology and Metabolic Disorders",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Abrocitinib Market Market Size",
    "therapeutic_area": "Dermatology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Abscess",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Absorbable Hemostats",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Acanthamoeba Keratitis",
    "therapeutic_area": "Ophthalmology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Acetyl-CoA Carboxylase Inhibitors",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Acetylcholine Inhibitors",
    "therapeutic_area": "Other Diseases",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Acetylcholine Receptor (AChR) Antagonist",
    "therapeutic_area": "Neurology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Achondroplasia",
    "therapeutic_area": "Musculoskeletal",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 4
  },
  {
    "indication_name": "Achondroplasia Patient Pool Analysis",
    "therapeutic_area": "Rare Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Achromatopsia",
    "therapeutic_area": "Ophthalmology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2025-2032",
    "total_reports": 2
  },
  {
    "indication_name": "Acid Sphingomyelinase Deficiency (ASMD)",
    "therapeutic_area": "Endocrinology and Metabolic Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 5
  },
  {
    "indication_name": "Acinetobacter Infections",
    "therapeutic_area": "Infectious Diseases",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Aciphex - API Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Acne",
    "therapeutic_area": "Dermatology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 4
  },
  {
    "indication_name": "Acne Vulgaris",
    "therapeutic_area": "Dermatology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Acne Vulgaris Global API Manufacturers, Marketed and Phase III Drugs Landscape",
    "therapeutic_area": "Dermatology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Acne vulgaris Epidemiology Forecast",
    "therapeutic_area": "Dermatology",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Acoustic Neuroma",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Acquired Blepharoptosis",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Acquired Hemophilia A",
    "therapeutic_area": "Genetic Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Acquired Immunodeficiency Syndrome (AIDS)",
    "therapeutic_area": "Infectious Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Acquired Thrombotic Thrombocytopenic Purpura",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Acral lentiginous melanoma",
    "therapeutic_area": "Dermatology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2025-2032",
    "total_reports": 2
  },
  {
    "indication_name": "Acrocallosal Syndrome",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Acromegaly",
    "therapeutic_area": "Endocrinology and Metabolic Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Acromegaly - Global API Manufacturers, Marketed and Phase III Drugs Landscape",
    "therapeutic_area": "Endocrinology and Metabolic Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Acromegaly Patient Pool Analysis",
    "therapeutic_area": "Rare Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Acromegaly and Gigantism Therapeutics",
    "therapeutic_area": "Endocrinology and Metabolic Disorders",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Acthar Gel - API Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Actinic Keratosis",
    "therapeutic_area": "Dermatology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 4
  },
  {
    "indication_name": "Actinic Keratosis - Global API Manufacturers, Marketed and Phase III Drugs Landscape",
    "therapeutic_area": "Dermatology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Active Implantable Medical Devices",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Active Pharmaceutical Ingredient (API)",
    "therapeutic_area": "Other Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Acute Agitation And Aggression",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Acute Bacterial Prostatitis",
    "therapeutic_area": "Infectious Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Acute Bacterial Skin and Skin Structure Infections (ABSSSI)",
    "therapeutic_area": "Infectious Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Acute Cannabinoid Intoxication",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Acute Coronary Syndrome",
    "therapeutic_area": "Cardiovascular Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Acute Coronary Syndrome - Global API Manufacturers, Marketed and Phase III Drugs Landscape",
    "therapeutic_area": "Cardiovascular Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Acute Decompensated Heart Failure (ADHF)",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Acute Gout Flare",
    "therapeutic_area": "Musculoskeletal",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 2
  },
  {
    "indication_name": "Acute Graft-versus-Host Disease",
    "therapeutic_area": "Immunological and Autoimmune Disorders",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Acute Heart failure (AHF)",
    "therapeutic_area": "Cardiovascular Diseases",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Acute Hepatic Porphyria (AHP)",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Acute Intermittent Porphyria",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Acute Ischemic Stroke (AIS)",
    "therapeutic_area": "Neurology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2030-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Acute Ischemic Stroke Treatment and Diagnosis",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Acute Kidney Injury (AKI)",
    "therapeutic_area": "Genito Urinary System and Sex Hormones",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 2
  },
  {
    "indication_name": "Acute Liver Failure",
    "therapeutic_area": "Gastroenterology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Acute Lung Injury",
    "therapeutic_area": "Respiratory Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Acute Lymphoblastic Leukemia (ALL)",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2030,
    "year_range": "2025-2030",
    "total_reports": 2
  },
  {
    "indication_name": "Acute Lymphocytic Leukemia (ALL)",
    "therapeutic_area": "Oncology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Acute Muscle Injuries",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Acute Myelogenous Leukemia (AML)",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Acute Myeloid Leukemia (AML)",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2030-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Acute Myeloid Leukemia Pipeline Insight",
    "therapeutic_area": "Oncology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Acute Myocardial Infarction",
    "therapeutic_area": "Cardiovascular Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Acute Myocardial Infraction Epidemiology Forecast",
    "therapeutic_area": "Cardiovascular Diseases",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Acute Ocular Pain (AOP)",
    "therapeutic_area": "Ophthalmology",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 3
  },
  {
    "indication_name": "Acute Ocular Pain And Inflammation",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Acute On Chronic Liver Failure (ACLF)",
    "therapeutic_area": "Gastroenterology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 5
  },
  {
    "indication_name": "Acute Optic Neuritis",
    "therapeutic_area": "Ophthalmology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Acute Pain",
    "therapeutic_area": "Musculoskeletal",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Acute Pancreatitis (AP)",
    "therapeutic_area": "Endocrinology and Metabolic Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2028,
    "year_range": "2028",
    "total_reports": 1
  },
  {
    "indication_name": "Acute Pharyngitis",
    "therapeutic_area": "Infectious Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2032-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Acute Pulmonary Embolism",
    "therapeutic_area": "Respiratory Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Acute Pyelonephritis",
    "therapeutic_area": "Infectious Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Acute Radiation Syndrome",
    "therapeutic_area": "Other Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2025-2032",
    "total_reports": 2
  },
  {
    "indication_name": "Acute Renal Failure (ARF) (Acute Kidney Injury)",
    "therapeutic_area": "Genito Urinary System and Sex Hormones",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Acute Respiratory Distress Syndrome (ARDS)",
    "therapeutic_area": "Respiratory Diseases",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Acute Social Anxiety Disorder",
    "therapeutic_area": "Neurology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Acute Unilateral Vestibulopathy (AUV)\\n",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Adalimumab Biosimilars Insight",
    "therapeutic_area": "Immunological and Autoimmune Disorders",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2024,
    "year_range": "2024",
    "total_reports": 1
  },
  {
    "indication_name": "Adamantinoma",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2032-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Adderall - API Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Addison's Disease",
    "therapeutic_area": "Endocrinology and Metabolic Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Adempas - API Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Adeno-Associated Virus (AAV) Vectors in Gene Therapy",
    "therapeutic_area": "Genetic Disorders",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Adeno-associated virus (AAV) Vector Manufacturing",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Adenoid Cystic Carcinoma",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2025-2032",
    "total_reports": 3
  },
  {
    "indication_name": "Adenoid Cystic Carcinoma Epidemiology Forecast",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Adenosine A2A Receptor Agonist",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Adenosine A2A Receptor Antagonist",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 6
  },
  {
    "indication_name": "Adenosine A3 Receptor Agonist",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Adenosine Antagonist",
    "therapeutic_area": "Oncology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Adenosine Deaminase-Severe Combined Immunodeficiency",
    "therapeutic_area": "Genetic Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2032-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Adenosine receptor antagonists",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Adenovirus Infections",
    "therapeutic_area": "Infectious Diseases",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Adenovirus Nephritis",
    "therapeutic_area": "Hematological Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Adrenal Cortex Neoplasms",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Adrenal Crisis",
    "therapeutic_area": "Endocrinology and Metabolic Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Adrenal Crisis\u2013 Epidemiology Forecast",
    "therapeutic_area": "Endocrinology and Metabolic Disorders",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Adrenal Insufficiency",
    "therapeutic_area": "Endocrinology and Metabolic Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Adrenergic Antagonist",
    "therapeutic_area": "Ophthalmology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Adrenergic Uptake Inhibitor",
    "therapeutic_area": "Neurology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Adrenocortical Carcinoma",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Adrenogenital Syndrome",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Adrenoleukodystrophy (ALD)",
    "therapeutic_area": "Genetic Disorders",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Adrenomyeloneuropathy",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Adrenomyeloneuropathy (AMN) Epidemiology Report",
    "therapeutic_area": "Hematological Disorders",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Aducanumab Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Adult Growth Hormone Deficiency (AGHD)",
    "therapeutic_area": "Endocrinology and Metabolic Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Adult Intraventricular Haemorrhage",
    "therapeutic_area": "Neurology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Adult Myopia",
    "therapeutic_area": "Ophthalmology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2030-2034",
    "total_reports": 4
  },
  {
    "indication_name": "Adult R/R Raf-altered Solid Tumors",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Adult Spinal Deformity",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Adult T-Cell Leukemia-Lymphoma",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Adult-Onset Growth Hormone Deficiency",
    "therapeutic_area": "Endocrinology and Metabolic Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Adult-onset Still's Disease",
    "therapeutic_area": "Immunological and Autoimmune Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Advair Diskus - API Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Advanced Breast Cancer In Premenopausal Women",
    "therapeutic_area": "Other Diseases",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Advanced Cancer Pain Management (ACPM)",
    "therapeutic_area": "Oncology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Advanced Cervical Cancer",
    "therapeutic_area": "Oncology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Advanced Endometrial Cancer",
    "therapeutic_area": "Oncology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Advanced Gastric Carcinoma",
    "therapeutic_area": "Oncology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Advanced Heart Failure",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Advanced Hepatocellular Carcinoma",
    "therapeutic_area": "Oncology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Advanced Hepatocellular Carcinoma with CPB Liver Cirrhosis",
    "therapeutic_area": "Genito Urinary System and Sex Hormones",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2025-2032",
    "total_reports": 2
  },
  {
    "indication_name": "Advanced Kidney Cancer",
    "therapeutic_area": "Oncology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Advanced Liver Cancer",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2032-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Advanced Liver Cancer Pipeline Insight",
    "therapeutic_area": "Oncology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Advanced Melanoma",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Advanced Merkel cell carcinoma",
    "therapeutic_area": "Oncology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Advanced Non-Squamous and Squamous NSCLC Pipeline Insight",
    "therapeutic_area": "Oncology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Advanced Ovarian Cancer",
    "therapeutic_area": "Oncology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Advanced Pancreatic Cancer",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Advanced Recurrent Ovarian Cancer",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Advanced Renal Cell Carcinoma (RCC)",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Advanced Therapy Medicinal Products",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Advanced Urotheilal Carcinoma",
    "therapeutic_area": "Genito Urinary System and Sex Hormones",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Advanced Visualization System",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Advanced Wound Care - Global",
    "therapeutic_area": "Other Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Aerosol Delivery Devices - Global",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Aesthetic Implants",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Aesthetic Laser",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Aesthetic Thread",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Afinitor (everolimus)",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "African Trypanosomiasis",
    "therapeutic_area": "Infectious Diseases",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Age Related Macular Degeneration",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Age-Related Vision Dysfunction",
    "therapeutic_area": "Ophthalmology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 5
  },
  {
    "indication_name": "Age-related Hearing Loss",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Age-related Macular Degeneration (AMD)",
    "therapeutic_area": "Ophthalmology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Ageing",
    "therapeutic_area": "Other Diseases",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Agitation in Alzheimer\u2019s Disease ",
    "therapeutic_area": "Neurology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Agoraphobia",
    "therapeutic_area": "Other Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2032-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Aicardi Goutieres Syndrome",
    "therapeutic_area": "Genetic Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 2
  },
  {
    "indication_name": "Airway Clearance Devices for Cystic Fibrosis",
    "therapeutic_area": "Respiratory Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Airway Management Devices",
    "therapeutic_area": "Respiratory Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Airway Stent",
    "therapeutic_area": "Respiratory Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Akt1 Inhibitor",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Akynzeo - API Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Alagille Syndrome",
    "therapeutic_area": "Rare Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Alcohol Addiction",
    "therapeutic_area": "Other Diseases",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Alcohol Use Disorder (AUD)",
    "therapeutic_area": "Neurology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Alcohol Wipes",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Alcohol use disorder Patient Pool Analysis",
    "therapeutic_area": "Rare Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Alcohol-related Liver Disease",
    "therapeutic_area": "Endocrinology and Metabolic Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Alcoholic Hepatitis",
    "therapeutic_area": "Other Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Alcoholic Liver Disease Patient Pool Analysis",
    "therapeutic_area": "Endocrinology and Metabolic Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Alcoholic Steatohepatitis",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Aldafermin Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Aldose Reductase Inhibitor",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Aldosterone Antagonist",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Aldosterone Synthase Inhibitors",
    "therapeutic_area": "Cardiovascular Diseases",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Alimta - API Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Alkaptonuria",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Allergic Asthma due to Dermatophagoides Farinae",
    "therapeutic_area": "Respiratory Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Allergic Bronchopulmonary Aspergillosis",
    "therapeutic_area": "Infectious Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Allergic Conjunctivitis",
    "therapeutic_area": "Ophthalmology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Allergic Contact Dermatitis",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Allergic Fungal Rhinosinusitis",
    "therapeutic_area": "Otolaryngology",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Allergic Rhinitis",
    "therapeutic_area": "Respiratory Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 5
  },
  {
    "indication_name": "Allergic Rhinitis Patient Pool Analysis",
    "therapeutic_area": "Respiratory Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Allergic Rhino-Conjunctivitis",
    "therapeutic_area": "Ophthalmology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 4
  },
  {
    "indication_name": "Allergic Rhino-Conjunctivitis - Global API Manufacturers, Marketed and Phase III Drugs Landscape",
    "therapeutic_area": "Ophthalmology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 3
  },
  {
    "indication_name": "Allergy Diagnostics",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Allergy Diagnostics & Therapeutics",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Allergy Sinus Pain",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Allogeneic Hematopoietic Stem Cell Transplant (Allo-HSCT)",
    "therapeutic_area": "Other Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 2
  },
  {
    "indication_name": "Allogeneic T-Cell Therapy for Autoimmune Diseases",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Allogenic Cell Therapies",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Allogenic iNKT cell therapy",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Alopecia",
    "therapeutic_area": "Dermatology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Alopecia - Global API Manufacturers, Marketed and Phase III Drugs Landscape",
    "therapeutic_area": "Dermatology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Alopecia Areata",
    "therapeutic_area": "Dermatology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 5
  },
  {
    "indication_name": "Alopecia Areata Patient Pool Analysis",
    "therapeutic_area": "Dermatology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Alopecia Treatment",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Alpha 1 Adrenergic Receptor Antagonist",
    "therapeutic_area": "Neurology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Alpha 4 Beta 2 Neuronal Nicotinic Receptor (NNR) Agonist",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Alpha 4 Beta 7 (A4b7) Integrin Inhibitor",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Alpha Antitrypsin Deficiency",
    "therapeutic_area": "Genetic Disorders",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Alpha Glucosidase Inhibitor",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Alpha Receptor Agonist",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Alpha Receptor Antagonist",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Alpha Thalassemia",
    "therapeutic_area": "Hematological Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 5
  },
  {
    "indication_name": "Alpha v Beta 3 Integrin Antagonist",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 2
  },
  {
    "indication_name": "Alpha v Beta 3/5/6 Integrin Antagonist",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Alpha-1 Agonist",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Alpha-1 Antitrypsin Deficiency (A1ATD) Liver Disease",
    "therapeutic_area": "Genetic Disorders",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Alpha-1 Antitrypsin Deficiency (AATD)",
    "therapeutic_area": "Genetic Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2030,
    "year_range": "2025-2030",
    "total_reports": 2
  },
  {
    "indication_name": "Alpha-1 Antitrypsin Deficiency \u2013 Epidemiology Forecast",
    "therapeutic_area": "Genetic Disorders",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Alpha-1 Protease Inhibitor Deficiency",
    "therapeutic_area": "Genetic Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2032-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Alpha-1A Antagonist",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 2
  },
  {
    "indication_name": "Alpha-2 Agonist",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Alpha-2 Antagonist",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Alpha-Amylase Inhibitor",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Alpha-Mannosidosis",
    "therapeutic_area": "Endocrinology and Metabolic Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 2
  },
  {
    "indication_name": "Alpha-Synuclein (alphaSyn or SNCA) Inhibitor",
    "therapeutic_area": "Neurology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Alpha-Synuclein Inhibitors",
    "therapeutic_area": "Central Nervous System",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Alpha-Synuclein Inhibitors - Target Population, Competitive Landscape, and Market Forecast",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Alpha4beta7 Integrin Antagonists",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Alphanate",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Alport Syndrome",
    "therapeutic_area": "Genetic Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Alstrom Syndrome",
    "therapeutic_area": "Genetic Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2032-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Alternating Hemiplegia of Childhood (AHC)",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Alzheimer's Disease Patient Pool Analysis",
    "therapeutic_area": "Neurology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Alzheimer's disease (AD)",
    "therapeutic_area": "Neurology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Alzheimer\u2019s Disease Diagnostic",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Alzheimer\u2019s Disease \u2013 Japan Epidemiology Forecast",
    "therapeutic_area": "Neurology",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Ambisome - API Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Amblyopia",
    "therapeutic_area": "Ophthalmology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 2
  },
  {
    "indication_name": "Ambrisentan Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Ambulance Services",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Ambulatory Surgical Centers",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Amebiasis",
    "therapeutic_area": "Infectious Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2032-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Aminopeptidase Inhibitors",
    "therapeutic_area": "Cardiovascular Diseases",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Amitiza - API Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Amniotic Membrane",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Ampion Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Amyloid Beta-Protein Inhibitors",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Amyloid Light-Chain Amyloidosis",
    "therapeutic_area": "Genetic Disorders",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Amyloid Protein Blockers",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Amyloidosis",
    "therapeutic_area": "Rare Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2032-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Amyotrophic Lateral Sclerosis (ALS)",
    "therapeutic_area": "Neurology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Amyotrophic Lateral Sclerosis - Competitive Landscape",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2027,
    "year_range": "2027",
    "total_reports": 1
  },
  {
    "indication_name": "Amyotrophic Lateral Sclerosis Epidemiology Forecast",
    "therapeutic_area": "Neurology",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Anal Cancer",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Anal Fissure",
    "therapeutic_area": "Oncology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Anal Fistula",
    "therapeutic_area": "Rare Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Anal Irrigation System",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Analgesics",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Anaphylaxis",
    "therapeutic_area": "Immunological and Autoimmune Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Anaplastic Astrocytoma",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Anaplastic Lymphoma Kinase (ALK) Inhibitors",
    "therapeutic_area": "Oncology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Anaplastic Lymphoma Kinase (ALK) Positive",
    "therapeutic_area": "Oncology",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Anaplastic Lymphoma Kinase (ALK) Positive, Advanced Non-Small Cell Lung Cancer (NSCLC)",
    "therapeutic_area": "Oncology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Anaplastic Lymphoma Kinase (ALK) inhibitors \u2013 Target Population, Competitive Landscape, and Market Forecast",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Anaplastic Lymphoma Kinase Metastatic Non-small Cell Lung Cancer",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Anaplastic Lymphoma Kinase Non-Small-Cell Lung Cancer \u2013 Epidemiology Forecast",
    "therapeutic_area": "Oncology",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Anaplastic Thyroid Cancer (ATC) ",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Anaplastic large cell lymphoma (ALCL) ",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Anaplastic lymphoma kinase Non-Small Cell Lung Cancer",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Anastomosis Device",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Anastomotic Leak Devices",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Andersen-Tawil Syndrome",
    "therapeutic_area": "Musculoskeletal",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Androgen Agonist",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Androgen Antagonist",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Androgen Insensitivity Syndrome",
    "therapeutic_area": "Genetic Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 2
  },
  {
    "indication_name": "Androgen Receptor Targeted Therapies \u2013 Market Size, Target Population, Competitive Landscape, and Market Forecast",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Androgenetic Alopecia",
    "therapeutic_area": "Dermatology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Anemia",
    "therapeutic_area": "Hematological Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Anemia Associated with Chronic Kidney",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Anemia In Chronic Kidney Disease",
    "therapeutic_area": "Genito Urinary System and Sex Hormones",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Anemia in CKD patients",
    "therapeutic_area": "Genito Urinary System and Sex Hormones",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Anemia in Elderly",
    "therapeutic_area": "Hematological Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2032-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Anesthesia Machines",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Anesthesia Ultrasound Systems",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Anesthetic Effect",
    "therapeutic_area": "Central Nervous System",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Anesthetic Effect - Global API Manufacturers, Marketed and Phase III Drugs Landscape",
    "therapeutic_area": "Neurology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Aneurysmal Subarachnoid Hemorrhage (aSAH)",
    "therapeutic_area": "Central Nervous System",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 4
  },
  {
    "indication_name": "Angelman Syndrome",
    "therapeutic_area": "Genetic Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Angina (Angina Pectoris)",
    "therapeutic_area": "Cardiovascular Diseases",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Angina - Global API Manufacturers, Marketed and Phase III Drugs Landscape",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Angina Pectoris",
    "therapeutic_area": "Cardiovascular Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Angio Suites",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Angioedema",
    "therapeutic_area": "Genetic Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 2
  },
  {
    "indication_name": "Angioedema Pipeline Insight",
    "therapeutic_area": "Dermatology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Angiofibroma",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Angioimmunoblastic T-Cell Lymphoma",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Angioplasty Balloons And Stents",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Angiopoietin 2 (Ang-2) Inhibitor",
    "therapeutic_area": "Oncology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Angiopoietin Inhibitor",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Angiopoietin-like protein 3 (ANGPTL3) Inhibitor Market, Target Population, Competitive Landscape, and Market Forecast",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Angiotensin Converting Enzyme (ACE) Inhibitor",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Angiotensin II Receptor Type 2 (AT2 Receptor) Inhibitor",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Angiotensin II Receptor Type 2 (AT2 Receptor) Modulator",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Angiotensin Modulators",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Angiotensin Receptor Agonist",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Angiotensin Type 1 Receptor Antagonists",
    "therapeutic_area": "Cardiovascular Diseases",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Angiotensin-converting Enzyme (ACE) Inhibitors Market Size, Target Population, Competitive Landscape & Market Forecast",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Angiox - API Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Animal Intestinal Health",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Animal Nutrition",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2028,
    "year_range": "2028",
    "total_reports": 1
  },
  {
    "indication_name": "Ankylosing Spondylitis (Bekhterev's Disease)",
    "therapeutic_area": "Musculoskeletal",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Ankylosing spondylitis Patient Pool Analysis",
    "therapeutic_area": "Musculoskeletal",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Anorectal Malformation",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Anorexia",
    "therapeutic_area": "Nutritional Disorders and Weight Loss",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Anorexia Nervosa",
    "therapeutic_area": "Other Diseases",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Anoro Ellipta - API Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Anovulation",
    "therapeutic_area": "Womens Health",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Antacids",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Antepartum Monitoring Devices",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Anterior Cruciate Ligament Injuries",
    "therapeutic_area": "Musculoskeletal",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2032-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Anterior Uveitis",
    "therapeutic_area": "Ophthalmology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Anterior Uveitis - Global API Manufacturers, Marketed and Phase III Drugs Landscape",
    "therapeutic_area": "Ophthalmology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Anthrax",
    "therapeutic_area": "Infectious Diseases",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Anti Cancer Vaccine Market Size, Target Population, Competitive Landscape & Market Forecast",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Anti Fungal Drugs",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Anti GM-CSF Antibody",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Anti- C-C Motif Chemokine Receptor 8 (CCR8) Antibodies \u2013 Target Population, Competitive Landscape, and Market Forecast",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2040,
    "year_range": "2040",
    "total_reports": 1
  },
  {
    "indication_name": "Anti-Aging Ingredients",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Anti-Aging Products",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Anti-CD152 Antibody",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 2
  },
  {
    "indication_name": "Anti-CD19 Antibody",
    "therapeutic_area": "Oncology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Anti-CD20 Antibody",
    "therapeutic_area": "Oncology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Anti-CD22 Therapies",
    "therapeutic_area": "Immunological and Autoimmune Disorders",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Anti-CD274 (PD-L1) Antibody",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Anti-CD279 (PD-1) Antibody",
    "therapeutic_area": "Oncology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Anti-CD28 Antibody",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Anti-CD30 Therapies",
    "therapeutic_area": "Oncology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Anti-CD33 Antibody",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 2
  },
  {
    "indication_name": "Anti-CD37 Antibody",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Anti-CD38 Antibody",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Anti-CD38 mAb \u2013 Target Population, Competitive Landscape, and Market Forecast",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Anti-CD40 Antibody",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Anti-CD80 Antibody",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Anti-Depressant Drugs",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Anti-Dickkopf-1 (Dkk-1) Antibody",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Anti-Epileptic Drugs/Epilepsy",
    "therapeutic_area": "Other Diseases",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Anti-GBM disease",
    "therapeutic_area": "Oncology",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Anti-GPC3 Targeted Therapies \u2013 Target Population, Competitive Landscape, and Market Forecast",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2040,
    "year_range": "2040",
    "total_reports": 1
  },
  {
    "indication_name": "Anti-Glomerular Basement Membrane (Anti-GBM)",
    "therapeutic_area": "Immunological and Autoimmune Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Anti-Glomerular Basement Membrane (Anti-GBM) Disease",
    "therapeutic_area": "Immunological and Autoimmune Disorders",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Anti-Hypertension ",
    "therapeutic_area": "Cardiovascular Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Anti-Infective Drugs",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Anti-Inflammatory",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Anti-Inflammatory Drugs",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Anti-Lymphotoxin",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Anti-Mucin 1 (MUC1) Antibody",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Anti-PD-1 / Anti-PD-L1 Refractory Solid Tumors",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Anti-Radiation Drugs",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Anti-Snoring Devices",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Anti-integrin Agents Market Size, Target Population, Competitive Landscape & Market Forecast",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Anti-neutrophilic cytoplasmic antibody (ANCA) associated Vasculitis",
    "therapeutic_area": "Rare Diseases",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Anti-retropulsion Devices",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Antiapoptotic Protein Targeted Degradation",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Antibiotic Resistance",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Antibiotics",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Antibody Discovery",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Antibody Drug Conjugate",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Antibody Drug Conjugate- Competitive landscape",
    "therapeutic_area": "Oncology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Antibody Drug Conjugates Market Size, Target Population, Competitive Landscape & Market Forecast",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Antibody-Mediated Graft Rejection",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2025-2032",
    "total_reports": 2
  },
  {
    "indication_name": "Antibody-Mediated Graft Rejection Patient Pool Analysis",
    "therapeutic_area": "Immunological and Autoimmune Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Antibody-Mediated Rejection",
    "therapeutic_area": "Other Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 2
  },
  {
    "indication_name": "Antibody\u2013drug Conjugates (ADCs) in Oncology - Competitive landscape",
    "therapeutic_area": "Oncology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Anticoagulants",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Antidote",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Antiemetics Drugs",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Antimicrobial Resistance (AMR)",
    "therapeutic_area": "Other Diseases",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Antiphospholipid Syndrome (APS)",
    "therapeutic_area": "Genetic Disorders",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Antipsychotic Drugs",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Antisense Oligonucleotide Therapeutics Pipeline Insight",
    "therapeutic_area": "Oncology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Antisense Therapies Market Size, Target Population, Competitive Landscape & Market Forecast",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Antiviral Drugs",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Anus Neoplasms",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Aortic Aneurysm Stent Grafts",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Aortic Stenosis",
    "therapeutic_area": "Other Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 2
  },
  {
    "indication_name": "Apheresis",
    "therapeutic_area": "Hematological Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Aplastic Anemia",
    "therapeutic_area": "Hematological Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Aplastic Anemia - Global API Manufacturers, Marketed and Phase III Drugs Landscape",
    "therapeutic_area": "Hematological Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Apolipoprotein B (ApoB) Inhibitor",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Apolipoprotein C-III Inhibitors",
    "therapeutic_area": "Cardiovascular Diseases",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Apoptosis Inhibitor",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Apraxia",
    "therapeutic_area": "Neurology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Aptamers",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Aptiom - API Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Aramchol Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Arbaclofen ER Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Arbovirus Infection ",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Arfolitixorin Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Arginine Depletors",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Argininosuccinic aciduria (ASA)",
    "therapeutic_area": "Rare Diseases",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Aristada - API Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Aromatase Inhibitors (AIs) Market Size, Target Population, Competitive Landscape & Market Forecast",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Arterial Thrombosis",
    "therapeutic_area": "Cardiovascular Diseases",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Arteriotomy Closure Devices",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Arteriovenous (AV) Fistula",
    "therapeutic_area": "Other Diseases",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Arteriovenous Malformations",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Arthralgia",
    "therapeutic_area": "Immunological and Autoimmune Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Arthrogryposis",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Arthroscopic Shavers",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Arthroscopy Devices",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Artificial Cornea and Corneal Implant",
    "therapeutic_area": "Ophthalmology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Artificial Disc",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Artificial Intelligence (AI) In Drug Discovery",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Artificial Intelligence (AI) in Cancer Diagnostics",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Artificial Intelligence (AI) in Clinical Trials",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Artificial Intelligence (AI) in Diagnostics",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Artificial Intelligence (AI) in Drug Commercialization",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Artificial Intelligence (AI) in Life Sciences",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Artificial Intelligence (AI) in Medical Diagnostics",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Artificial Intelligence (AI) in Medical Imaging",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Artificial Intelligence (AI) in Precision Medicine",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Artificial Intelligence (AI) in Remote Patient Monitoring",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Artificial Iris",
    "therapeutic_area": "Ophthalmology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Artificial Kidney",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Artificial Lung",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Artificial Lung Devices Pipeline Insight and Competitive Landscape",
    "therapeutic_area": "Respiratory Diseases",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2023,
    "year_range": "2023",
    "total_reports": 1
  },
  {
    "indication_name": "Artificial Pancreas Device System",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Artificial Sweeteners",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Artificial Tears",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Artificial blood vessels",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Aryl Hydrocarbon Receptor (AHR) Agonist Market Size, Target Population, Competitive Landscape & Market Forecast",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 2
  },
  {
    "indication_name": "Ascites",
    "therapeutic_area": "Other Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2030-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Ascites Epidemiology Forecast",
    "therapeutic_area": "Other Diseases",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Ascites Pipeline Insight",
    "therapeutic_area": "Central Nervous System",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Asherman's Syndrome",
    "therapeutic_area": "Womens Health",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2032-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Asia-Pacific Contact Lens",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Asia-Pacific Vital Sign Monitoring Devices",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Asperger Syndrome",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Aspergillosis",
    "therapeutic_area": "Infectious Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Aspergillosis - Global API Manufacturers, Marketed and Phase III Drugs Landscape",
    "therapeutic_area": "Infectious Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Asphyxia",
    "therapeutic_area": "Respiratory Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2032-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Asthma",
    "therapeutic_area": "Respiratory Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Asthma Diagnostic Devices",
    "therapeutic_area": "Respiratory Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Asthma Patient Pool Analysis",
    "therapeutic_area": "Respiratory Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Asthma Spacers",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Asthma Treatment",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Asthma- Competitive landscape",
    "therapeutic_area": "Respiratory Diseases",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Astigmatism",
    "therapeutic_area": "Ophthalmology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2032-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Astrocytoma",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Ataxia",
    "therapeutic_area": "Neurology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Ataxia Telangiectasia (AT)",
    "therapeutic_area": "Rare Diseases",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Atherectomy Devices",
    "therapeutic_area": "Cardiovascular Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Atherosclerosis",
    "therapeutic_area": "Cardiovascular Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Atherosclerotic Cardiovascular Disease",
    "therapeutic_area": "Cardiovascular Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 2
  },
  {
    "indication_name": "Athlete's Foot (Tinea Pedis)",
    "therapeutic_area": "Infectious Diseases",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Athlete\u2019s foot",
    "therapeutic_area": "Infectious Diseases",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Atopic Dermatitis (AD)",
    "therapeutic_area": "Dermatology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2030-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Atopic Dermatitis Epidemiology Forecast",
    "therapeutic_area": "Dermatology",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Atopic Dermatitis Patient Pool Analysis",
    "therapeutic_area": "Dermatology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Atopic Keratoconjuctivitis",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Atopic Keratoconjunctivitis (AKC)",
    "therapeutic_area": "Immunological and Autoimmune Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2032-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Atopic dermatitis - Competitive Landscape",
    "therapeutic_area": "Dermatology",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Atrial Fibrillation",
    "therapeutic_area": "Cardiovascular Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 2
  },
  {
    "indication_name": "Atrial Fibrillation Pipeline Insight",
    "therapeutic_area": "Cardiovascular Diseases",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Atrial Flutter",
    "therapeutic_area": "Cardiovascular Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 2
  },
  {
    "indication_name": "Atripla - API Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Atrophic Vaginitis",
    "therapeutic_area": "Womens Health",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 2
  },
  {
    "indication_name": "Attention Deficit Hyperactivity Disorder",
    "therapeutic_area": "Neurology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Attention Deficit Hyperactivity Disorder Epidemiology Forecast",
    "therapeutic_area": "Central Nervous System",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Attention Deficit Hyperactivity Disorder Pipeline Insight",
    "therapeutic_area": "Neurology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Atypical Hemolytic Uremic Syndrome (aHUS)",
    "therapeutic_area": "Hematological Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2030-2034",
    "total_reports": 4
  },
  {
    "indication_name": "Atypical Teratoid Rhabdoid Tumors (ATRT)",
    "therapeutic_area": "Oncology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Audiology Devices",
    "therapeutic_area": "Otolaryngology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Aurora Kinase Inhibitor",
    "therapeutic_area": "Oncology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Aurora-GT Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Autism",
    "therapeutic_area": "Central Nervous System",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Autism Spectrum Disorder (ASD)",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Autistic Disorder",
    "therapeutic_area": "Neurology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Autoimmune Diseases Diagnostics",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Autoimmune Encephalitis (AIE) ",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 2
  },
  {
    "indication_name": "Autoimmune Gastritis",
    "therapeutic_area": "Gastroenterology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2032-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Autoimmune Hepatitis",
    "therapeutic_area": "Immunological and Autoimmune Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Autoimmune Psychosis ",
    "therapeutic_area": "Immunological and Autoimmune Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Autoimmune Pulmonary Alveolar Proteinosis (aPAP)",
    "therapeutic_area": "Immunological and Autoimmune Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Autoimmune Uveitis",
    "therapeutic_area": "Ophthalmology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Autoimmune uveitis Patient Pool Analysis",
    "therapeutic_area": "Ophthalmology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Autoinjectors",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Automated Cell Culture",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Automated Compounding Devices",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Automated External Defibrillator (AED) - Global",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Automated Suturing Devices",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Automatic Mechanical Cardiopulmonary Resuscitation (CPR) Devices",
    "therapeutic_area": "Cardiovascular Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Autophagy Modulators",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Autosomal Dominant Optic Atrophy",
    "therapeutic_area": "Ophthalmology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 2
  },
  {
    "indication_name": "Autosomal Dominant Polycystic Kidney Disease",
    "therapeutic_area": "Genito Urinary System and Sex Hormones",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Autosomal Recessive Congenital Ichthyoses (ARCI) ",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Autosomal Recessive Congenital Ichthyosis",
    "therapeutic_area": "Dermatology",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Autotransfusion Systems",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Avascular Necrosis",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Avascular Necrosis Epidemiology Forecast",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Avenciguat Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Axial Spondyloarthritis (axSpA)",
    "therapeutic_area": "Immunological and Autoimmune Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 4
  },
  {
    "indication_name": "Axillary Hyperhidrosis",
    "therapeutic_area": "Other Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2032-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Axillary Hyperhidrosis Epidemiology Forecast",
    "therapeutic_area": "Dermatology",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Axillary Hyperhidrosis Pipeline Insight",
    "therapeutic_area": "Rare Diseases",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Axiron - API Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Azilect - API Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Azor - API Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "B Cell Chronic Lymphocytic Leukemia",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "B-Cell Activating Factor (BAFF) Inhibitor",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "B-Cell Chronic Lymphocytic Leukemia - Global API Manufacturers, Marketed and Phase III Drugs Landscape",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "B-Cell Lymphomas",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "B-Cell Lymphomas - Global API Manufacturers, Marketed and Phase III Drugs Landscape",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "B-Cell Maturation Antigen Targeted Therapies",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "B-Cell Non-Hodgkin Lymphoma\\n",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "B-cell Inhibitors Market Size, Target Population, Competitive Landscape & Market Forecast",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 3
  },
  {
    "indication_name": "B244 Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "B7-H3 Market Size, Target Population, Competitive Landscape & Market Forecast",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 5
  },
  {
    "indication_name": "B7-H4 Targeting Therapies Market Size, Target Population, Competitive Landscape & Market Forecast",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2040,
    "year_range": "2040",
    "total_reports": 1
  },
  {
    "indication_name": "BAFF- and APRIL-targeted Therapies \u2013 Target Population, Competitive Landscape, and Market Forecast",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "BALVERSA Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "BAVENCIO Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "BB2603 Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "BBP-631 Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "BCG-unresponsive Non Muscle Invasive Bladder Cancer",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "BCMA Targeted Therapies Market Size, Target Population, Competitive Landscape & Market Forecast",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "BELEODAQ Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "BENLYSTA Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "BERCOLAGENE TELSERPAVEC (KB103)",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "BESREMi Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "BI 1015550 Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "BI 690517 + Empagliflozin Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "BIKTARVY Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "BIO-11006 Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "BIO89-100 Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "BIVV020 (SAR445088)",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "BK Virus (BKV) Infection",
    "therapeutic_area": "Infectious Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "BL-8040 Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "BLU 782",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "BLU-5937 Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "BNC210",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "BOMEDEMSTAT Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "BOS-580 Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "BRAF Mutated Non-small Cell Lung Cancer (NSCLC)",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "BRAF-Mutant Metastatic Melanoma",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "BRAF-mutant Non-Small Cell Lung Cancer (BRAF + NSCLC)",
    "therapeutic_area": "Oncology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "BRAFV600 mutation (B-Raf proto-oncogene, serine/threonine kinase) Inhibiotors",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "BRD4 Protein Inhibitor",
    "therapeutic_area": "Oncology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "BREYANZI Market Size",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "BRII-835 + BRII-179 Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "BROLUCIZUMAB",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "BT-11 Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Babesiosis",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Baby Warming Devices",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Baby Wipes",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Bacteremia",
    "therapeutic_area": "Infectious Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Bacteremia - Global API Manufacturers, Marketed and Phase III Drugs Landscape",
    "therapeutic_area": "Infectious Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Bacterial (Pyogenic) Meningitis",
    "therapeutic_area": "Infectious Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Bacterial (Pyogenic) Meningitis - Global API Manufacturers, Marketed and Phase III Drugs Landscape",
    "therapeutic_area": "Infectious Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Bacterial Conjunctivitis",
    "therapeutic_area": "Ophthalmology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Bacterial Pneumonia",
    "therapeutic_area": "Infectious Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Bacterial Pneumonia - Global API Manufacturers, Marketed and Phase III Drugs Landscape",
    "therapeutic_area": "Infectious Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Bacterial Pneumonia Epidemiology Forecast",
    "therapeutic_area": "Infectious Diseases",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Bacterial Pneumonia Pipeline Insight",
    "therapeutic_area": "Infectious Diseases",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Bacterial Skin Diseases",
    "therapeutic_area": "Infectious Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Bacterial Vaginosis",
    "therapeutic_area": "Womens Health",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Bacterial Vaginosis - Global API Manufacturers, Marketed and Phase III Drugs Landscape",
    "therapeutic_area": "Womens Health",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Bag3-related Gene Therapies",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Balloon Catheters",
    "therapeutic_area": "Cardiovascular Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Balloon Valvuloplasty Device",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 2
  },
  {
    "indication_name": "Baraklyud - API Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Bardet-Biedl Syndrome",
    "therapeutic_area": "Rare Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Bardoxolone methyl Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Barett Esophagus",
    "therapeutic_area": "Gastroenterology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 2
  },
  {
    "indication_name": "Bariatric Surgery Devices",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Barlow\u2019s Syndrome",
    "therapeutic_area": "Cardiovascular Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Baropodometry Platforms",
    "therapeutic_area": "Otolaryngology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Barrett's Esophagus with Dysplasia",
    "therapeutic_area": "Gastroenterology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Bartonellosis",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Basal Cell Carcinoma (Basal Cell Epithelioma)",
    "therapeutic_area": "Oncology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Basal Cell Neoplasms",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Basal Cell Nevus Syndrome (BCNS)",
    "therapeutic_area": "Rare Diseases",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Batoclimab Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Batten Disease",
    "therapeutic_area": "Rare Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 4
  },
  {
    "indication_name": "Bcl-xL Protein Inhibitor",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Bcr-Abl Tyrosine Kinase Inhibitor",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Beating Heart Stabilizers",
    "therapeutic_area": "Cardiovascular Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Becker muscular dystrophy (BMD) ",
    "therapeutic_area": "Rare Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Behcet's Disease",
    "therapeutic_area": "Immunological and Autoimmune Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Behcet's Disease - Global API Manufacturers, Marketed and Phase III Drugs Landscape",
    "therapeutic_area": "Immunological and Autoimmune Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Behcet's Disease Epidemiology Forecast",
    "therapeutic_area": "Immunological and Autoimmune Disorders",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Behcet's Disease Pipeline Insight",
    "therapeutic_area": "Immunological and Autoimmune Disorders",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Beh\u00e7et Disease",
    "therapeutic_area": "Rare Diseases",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Beh\u00e7et Syndrome",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Beleodaq - API Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "BeneFIX - API Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Benign Breast Disease and Early Breast Cancer",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 2
  },
  {
    "indication_name": "Benign Prostatic Hyperplasia Devices",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Benign prostatic hyperplasia (BPH)",
    "therapeutic_area": "Male Health",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Benlysta (belimumab)",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Benralizumab Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 2
  },
  {
    "indication_name": "Benzodiazepine Receptor Agonist",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Bepanthene - API Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Bepirovirsen Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Bertilimumab Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Berubicin Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Beta Receptor Agonist",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Beta Receptor Antagonist",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Beta Secretase Inhibitor",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Beta Selective Thyroid Hormone Receptor Agonist",
    "therapeutic_area": "Endocrinology and Metabolic Disorders",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Beta Thalassemia",
    "therapeutic_area": "Hematological Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Beta Thalassemia Epidemiology Forecast",
    "therapeutic_area": "Hematological Disorders",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Beta-1 Receptors Agonist",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 3
  },
  {
    "indication_name": "Beta-1 Receptors Antagonist",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 2
  },
  {
    "indication_name": "Beta-Lactamase Inhibitor",
    "therapeutic_area": "Infectious Diseases",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Beta-thalassemia (B-thal)",
    "therapeutic_area": "Hematological Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Bevacizumab Biosimilars Insight",
    "therapeutic_area": "Oncology",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Big Data in Healthcare",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Bile Duct Cancer (Cholangiocarcinoma)",
    "therapeutic_area": "Oncology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Bile Duct Cancer Epidemiology Forecast",
    "therapeutic_area": "Oncology",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Bile Duct Neoplasms",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Biliary Atresia (BA)",
    "therapeutic_area": "Hematological Disorders",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Biliary Stents",
    "therapeutic_area": "Gastroenterology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Biliary Tract Cancer",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Biliary Tract Cancer (BTC) Patient Pool Analysis",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Biliary Tract Cancers (BTCs)",
    "therapeutic_area": "Oncology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Biliary Tumor",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Biliary Tumor - Global API Manufacturers, Marketed and Phase III Drugs Landscape",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Bimekizumab Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 2
  },
  {
    "indication_name": "Binge (Eating) Disorders",
    "therapeutic_area": "Neurology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 2
  },
  {
    "indication_name": "Binge-Eating Disorder",
    "therapeutic_area": "Neurology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Bioanalytical Testing Services",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Biochips",
    "therapeutic_area": "Other Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Bioinformatics",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Biologics",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Biologics Contract Manufacturing",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Biologics Drug Substance Fill and Finish Manufacturing",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Biologics Drug Substance Manufacturing",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Biomarkers",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Biomaterials",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Biopharmaceuticals",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Biopharmaceuticals Contract Manufacturing",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Biopreservation",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Biopsy Devices",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Biopsy Devices Pipeline Insight and Competitive Landscape",
    "therapeutic_area": "Other Diseases",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2023,
    "year_range": "2023",
    "total_reports": 1
  },
  {
    "indication_name": "Bioreactors",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Biosensors",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Biosimilars",
    "therapeutic_area": "Other Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2028,
    "year_range": "2028",
    "total_reports": 1
  },
  {
    "indication_name": "Biosimulation",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Biosurgery",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Bipolar Depression",
    "therapeutic_area": "Neurology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Bipolar Disorder (Manic Depression)",
    "therapeutic_area": "Neurology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 4
  },
  {
    "indication_name": "Bipolar Disorder (Manic Depression) - Global API Manufacturers, Marketed and Phase III Drugs Landscape",
    "therapeutic_area": "Neurology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Birch Allergy",
    "therapeutic_area": "Immunological and Autoimmune Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Birch Pollen Allergy",
    "therapeutic_area": "Immunological and Autoimmune Disorders",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Birtamimab Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Bispecific antibody - Competitive landscape",
    "therapeutic_area": "Oncology",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Bispecifics Market Size, Target Population, Competitive Landscape & Market Forecast",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Bispecifics in Oncology Market Size, Target Population, Competitive Landscape & Market Forecast",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2040,
    "year_range": "2040",
    "total_reports": 1
  },
  {
    "indication_name": "Bispecifics/BITE \u2013 Target Population, Competitive Landscape, and Market Forecast",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Bispecifics/Trispecifics Market Size, Target Population, Competitive Landscape, and Market Forecast",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2035,
    "year_range": "2035",
    "total_reports": 1
  },
  {
    "indication_name": "Bivalirudin Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Bladder Pain",
    "therapeutic_area": "Central Nervous System",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Bladder Pain Syndrome",
    "therapeutic_area": "Genito Urinary System and Sex Hormones",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2032-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Bladder Scanners",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Bladder cancer",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2030-2034",
    "total_reports": 4
  },
  {
    "indication_name": "Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) Malignancy",
    "therapeutic_area": "Neurology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2025-2032",
    "total_reports": 2
  },
  {
    "indication_name": "Blastomycosis",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Bleeding Control",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Blepharitis",
    "therapeutic_area": "Ophthalmology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Blincyto",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Blood Bank",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Blood Cancer Diagnostics",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Blood Coagulation Factor Activators",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Blood Collection Devices",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Blood Flow Measurement Devices",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Blood Gas and Electrolyte Analyzers",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Blood Glucose Monitoring Systems",
    "therapeutic_area": "Cardiovascular Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Blood Pressure Monitoring Devices",
    "therapeutic_area": "Cardiovascular Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Blood Purification Devices",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Blood and Fluid Warming Medical Devices",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Body Contouring Devices",
    "therapeutic_area": "Other Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Body Fat Measurement Devices",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Body Temperature Monitoring",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Bone Anchored Hearing Systems",
    "therapeutic_area": "Otolaryngology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Bone Cement",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Bone Densitometers",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Bone Distractors/Distraction Osteogenesis Devices",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Bone Graft and Substitute",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Bone Growth Stimulators",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2030-2032",
    "total_reports": 2
  },
  {
    "indication_name": "Bone Marrow Failure",
    "therapeutic_area": "Genetic Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 2
  },
  {
    "indication_name": "Bone Marrow Transplant Infection",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Bone Metastasis",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Bone Metastasis In Solid Tumors",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2030-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Bone Metastasis in Solid Tumors \u2013 Epidemiology Forecast to",
    "therapeutic_area": "Oncology",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Bone Neoplasms",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Bone Resorption",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Bone Staple Systems/Staple Internal Fixation/ Staple Fixation Devices",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Bone Void Fillers",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Bone and Joint Infection",
    "therapeutic_area": "Other Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Borderline Personality Disorders",
    "therapeutic_area": "Other Diseases",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Botox - API Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Botulism",
    "therapeutic_area": "Infectious Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Bowel Management Systems",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Bowel Obstruction",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Bowen's Disease",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Brachytherapy",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Bradycardia Treatment Devices",
    "therapeutic_area": "Cardiovascular Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Bradykinesia",
    "therapeutic_area": "Neurology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2032-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Bradykinin Antagonist",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Bradykinin Receptor B1 Antagonist",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 2
  },
  {
    "indication_name": "Braftovi (encorafenib) + Erbitux (cetuximab) \u00b1 Mektovi (binimetinib) Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Brain Aneurysm Stents",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Brain Cancer",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2030-2034",
    "total_reports": 4
  },
  {
    "indication_name": "Brain Hemorrhage",
    "therapeutic_area": "Central Nervous System",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Brain Imaging Devices",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Brain Implants - Global",
    "therapeutic_area": "Neurology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Brain Ischemia",
    "therapeutic_area": "Central Nervous System",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Brain Metastases",
    "therapeutic_area": "Oncology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Brain Metastasis",
    "therapeutic_area": "Oncology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Brain Metastasis from Breast Cancer",
    "therapeutic_area": "Other Diseases",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Brain Monitoring Devices - Global",
    "therapeutic_area": "Neurology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Brain PET-MRI Systems",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Brain/Cranial Implants",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Brazikumab Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Breast Biopsy",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Breast Cancer",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2025-2032",
    "total_reports": 2
  },
  {
    "indication_name": "Breast Cancer Biomarker",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Breast Cancer Diagnostics",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Breast Implants",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Breast Pumps",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Breast Reconstruction",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Breath Analyzers",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Breo Ellipta - API Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Brepocitinib Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Broad Spectrum Chemokine Inhibitor (BSCIs)",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Brolucizumab Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Bronchial Dysplasia",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Bronchial Hyperreactivity",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Bronchial Neoplasm",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Bronchial Spasms",
    "therapeutic_area": "Respiratory Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2032-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Bronchiectasis",
    "therapeutic_area": "Respiratory Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 4
  },
  {
    "indication_name": "Bronchiectasis Epidemiology Forecast",
    "therapeutic_area": "Respiratory Diseases",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Bronchiolitis",
    "therapeutic_area": "Respiratory Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 2
  },
  {
    "indication_name": "Bronchiolitis Obliterans Syndrome",
    "therapeutic_area": "Respiratory Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 5
  },
  {
    "indication_name": "Bronchitis ",
    "therapeutic_area": "Respiratory Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Bronchitis Epidemiology Forecast",
    "therapeutic_area": "Respiratory Diseases",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Bronchopulmonary Dysplasia",
    "therapeutic_area": "Pediatrics",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Bronchopulmonary Dysplasia Patient Pool Analysis",
    "therapeutic_area": "Neurology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Bronchoscope",
    "therapeutic_area": "Respiratory Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Brucellosis",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Brucellosis \u2013 Epidemiology Forecast",
    "therapeutic_area": "Infectious Diseases",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Bruton Tyrosine Kinase (BTK) Inhibitor Market Size, Target Population, Competitive Landscape & Market Forecast",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Bruton's Tyrosine Kinase (BTK) Inhibitors \u2013 Competitive Landscape, Market and Pipeline Analysis",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2020,
    "year_range": "2020",
    "total_reports": 1
  },
  {
    "indication_name": "Bruton's Tyrosine Kinase Hematological Cancer",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Brutons Tyrosine Kinase (BTK) Inhibitors",
    "therapeutic_area": "Immunological and Autoimmune Disorders",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Budesonide Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Buerger's Disease",
    "therapeutic_area": "Rare Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Bulimia Nervosa",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Bulimia Nervosa \u2013 Epidemiology Forecast",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Bullous Keratopathy",
    "therapeutic_area": "Ophthalmology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Bullous Keratopathy\u2014Epidemiology Forecast",
    "therapeutic_area": "Ophthalmology",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Bullous Pemphigoid",
    "therapeutic_area": "Dermatology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 5
  },
  {
    "indication_name": "Bunion",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Buntanetap Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Burkitt Lymphoma",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 2
  },
  {
    "indication_name": "Burn",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Burn Ointment",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Burn Pain",
    "therapeutic_area": "Dermatology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 2
  },
  {
    "indication_name": "Burns",
    "therapeutic_area": "Dermatology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 5
  },
  {
    "indication_name": "Byetta - API Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "B\u2010rapidly Accelerated Fibrosarcoma (BRAF) Targeted Therapies \u2013 Target Population, Competitive Landscape, and Market Forecast",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "B\u2010rapidly accelerated fibrosarcoma (BRAF) Metastatic Non-small Cell Lung Cancer ",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "C-Arms",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "C-MET Metastatic Non-small Cell Lung Cancer",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "C-MET Non-Small Cell Lung Cancer (C-MET+ NSCLC)",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "C-Met Mutated Non-Small Cell Lung Cancer (NSCLC)",
    "therapeutic_area": "Oncology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "C-Raf Kinase Inhibitor",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "C-X-C Chemokine Receptor (CXCR) Inhibitors",
    "therapeutic_area": "Oncology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "C1 Esterase Inhibitor",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "C3 Complement inhibitor Market Forecast, Target Population, and Competitive Landscape",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "C5 Complement inhibitor Market Size, Target Population, Competitive Landscape, and Market Forecast",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 2
  },
  {
    "indication_name": "C5a Receptor Antagonist",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "CA002 Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "CABLIVI Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "CAEL-101 Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "CAM2029 Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "CAM2038 Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "CAN-2409 Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "CAN04 Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "CANDIN Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "CAP-1002",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "CAPLYTA (lumateperone) Market Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "CAPLYTA Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "CAR T - Cell Therapy - Competitive Landscape",
    "therapeutic_area": "Oncology",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "CAR T-Cell Therapy for Acute Lymphoblastic Leukemia",
    "therapeutic_area": "Hematological Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 2
  },
  {
    "indication_name": "CAR T-Cell Therapy for Acute Lymphoblastic Leukemia Epidemiology Forecast",
    "therapeutic_area": "Oncology",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "CAR T-Cell Therapy for Multiple Myeloma",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "CAR T-Cell Therapy for Non-Hodgkin's lymphoma (NHL)",
    "therapeutic_area": "Oncology",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "CAR-T Pipeline Insight",
    "therapeutic_area": "Hematological Disorders",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "CART related Neurotoxicity (NT)",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "CARTISTEM Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 2
  },
  {
    "indication_name": "CARVYKTI Market Size",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "CCR1 Inhibitor",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 2
  },
  {
    "indication_name": "CCR2 Inhibitor",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "CCR3 Inhibitor",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "CCR5 Inhibitor",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "CD (Cluster of Differentiation) Inhibitor",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "CD 19 Inhibitor",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "CD 33 Inhibitor",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 2
  },
  {
    "indication_name": "CD 40 Inhibitor",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "CD137 Agonist Antibody",
    "therapeutic_area": "Oncology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "CD152 Inhibitor",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "CD19/CD20 Bi-specific CAR-T",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "CD223 Antigen Inhibitors Market Size, Target Population, Competitive Landscape & Market Forecast",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 2
  },
  {
    "indication_name": "CD33 Antigen Inhibitors",
    "therapeutic_area": "Oncology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 2
  },
  {
    "indication_name": "CD40 Agonist",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "CD40/CD40L Inhibitors Market, Target Population, Competitive Landscape, and Market Forecast",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "CD47 Antigen Inhibitors",
    "therapeutic_area": "Oncology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "CDK 7 Inhibitors Market Size, Target Population, Competitive Landscape & Market Forecast",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 12
  },
  {
    "indication_name": "CDK12 Inhibitor",
    "therapeutic_area": "Oncology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "CEACAM5 Market Size, Target Population, Competitive Landscape & Market Forecast",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "CER-0001 Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "CERC-007",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "CFZ533 Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "CG0070 Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "CHRONOCORT Market Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "CIMZIA (Certolizumab pegol) Market Size",
    "therapeutic_area": "Other Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "CIN-107 Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "CINGAL Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "CL2020 Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "CLK Inhibitors \u2013 Market Forecast, Target Population, and Competitive Landscape",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "CLN1",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "CNM-Au8 Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "CNP-201 Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "CNS Bacterial Infections",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "CNS Lymphoma",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "CNSA-001 (PTC923) Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "CNTX-4975 Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 3
  },
  {
    "indication_name": "CO2 Removal Devices (Extracorporeal)",
    "therapeutic_area": "Respiratory Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "COLLATEGENE Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "COMP 360 Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 2
  },
  {
    "indication_name": "CONTRAVE (Naltrexon-Bupropion)",
    "therapeutic_area": "Other Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "CORECTIM Market Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "COSENTYX Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 3
  },
  {
    "indication_name": "COVID 19 (Novel Coronavirus 19) Therapeutic Pipeline, Vaccines, and Diagnostics Competitive Landscape",
    "therapeutic_area": "Infectious Diseases",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2020,
    "year_range": "2020",
    "total_reports": 1
  },
  {
    "indication_name": "COVID-19 (Novel Coronavirus 19) - Therapeutic Pipeline for Vaccines",
    "therapeutic_area": "Immunological and Autoimmune Disorders",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2020,
    "year_range": "2020",
    "total_reports": 1
  },
  {
    "indication_name": "COVID-19(CoronaVirus)",
    "therapeutic_area": "Infectious Diseases",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2021-2025",
    "total_reports": 2
  },
  {
    "indication_name": "COVID-19- Competitive Landscape",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "CP101 Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "CR-845 Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "CRF1 Receptor Antagonist",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "CRISPR Market Size, Target Population, Competitive Landscape & Market Forecast",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 8
  },
  {
    "indication_name": "CRISPR Therapies",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "CRISPR Therapies Pipeline Insight",
    "therapeutic_area": "Hematological Disorders",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "CS1 Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "CSL112 Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "CT-388 Sales Forecast, and Market Size Analysis",
    "therapeutic_area": "Other Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "CTLA-4 inhibitors- Competitive landscape",
    "therapeutic_area": "Oncology",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "CUTX-101 Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "CXCR Inhibitors Market, Target Population, Competitive Landscape, and Market",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "CXCR4 Inhibitor",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 2
  },
  {
    "indication_name": "CXCR4 Receptor Antagonists",
    "therapeutic_area": "Oncology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Cachexia Pipeline Insight",
    "therapeutic_area": "Endocrinology and Metabolic Disorders",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Caduet - API Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Calcific Aortic Valve Stenosis (CAVS)",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Calcinosis Cutis ",
    "therapeutic_area": "Dermatology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Calciphylaxis",
    "therapeutic_area": "Cardiovascular Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Calcitonin Gene-Related Peptide Receptor (CRLR) Antagonist",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Campylobacter Infections",
    "therapeutic_area": "Infectious Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Canaloplasty",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Cancer Anorexia",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2030-2034",
    "total_reports": 4
  },
  {
    "indication_name": "Cancer Anorexia-Cachexia Syndrome (CACS)",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Cancer Biomarkers",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Cancer Cachexia (CC)",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 2
  },
  {
    "indication_name": "Cancer Diagnostics - Global",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Cancer Immunotherapy",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2028,
    "year_range": "2028",
    "total_reports": 1
  },
  {
    "indication_name": "Cancer Monoclonal Antibodies",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Cancer Pain",
    "therapeutic_area": "Musculoskeletal",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 2
  },
  {
    "indication_name": "Cancer Supportive Care Drugs",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Cancer Therapy",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Cancer Therapy Related Diarrhea",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Cancer Vaccines - Competitive landscape",
    "therapeutic_area": "Oncology",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Cancer Vaccines Market- Target Population, Competitive Landscape, and Market Forecast",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Candidemia",
    "therapeutic_area": "Infectious Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Candidiasis",
    "therapeutic_area": "Infectious Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Cannabidiol (CBD) Pain",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Cannabinoid Agonist",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Cannabinoid Receptor CB1 Inverse Agonists",
    "therapeutic_area": "Endocrinology and Metabolic Disorders",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Cannabinoid Receptor Type 1 (CB1) Antagonist",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 2
  },
  {
    "indication_name": "Cannabinoid Receptor Type 2 (CB2) Agonist",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Cannabinoids",
    "therapeutic_area": "Endocrinology and Metabolic Disorders",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Cannabis Testing",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Cannabis Use Disorder (CUD)",
    "therapeutic_area": "Other Diseases",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Cannabis-Induced psychosis (CIP)",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Cansidas - API Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Capnography Devices",
    "therapeutic_area": "Respiratory Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Capnometer Device",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Capsid Protein Inhibitors",
    "therapeutic_area": "Infectious Diseases",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Capsule Endoscopy",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Carbapenem-Resistant Enterobacteriaceae",
    "therapeutic_area": "Other Diseases",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Carbapenem-resistant Enterobacteriaceae Infection",
    "therapeutic_area": "Infectious Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2030-2034",
    "total_reports": 4
  },
  {
    "indication_name": "Carbonic Anhydrase Inhibitor",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Carcinoid Syndrome",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Carcinoid Tumor",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Carcinoid Tumor Syndrome",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Cardiac AI Monitoring and Diagnostics",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Cardiac Ablation Devices - Global",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Cardiac Amyloidosis",
    "therapeutic_area": "Cardiovascular Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Cardiac Arrest Treatment",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Cardiac Arrhythmia Monitoring Devices",
    "therapeutic_area": "Cardiovascular Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Cardiac Arrythmia",
    "therapeutic_area": "Cardiovascular Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2032-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Cardiac Assist Devices",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Cardiac Biomarkers Testing Devices",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Cardiac Implantable Electronic Devices",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Cardiac Insufficiency",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Cardiac Mapping System",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Cardiac Monitoring Devices",
    "therapeutic_area": "Cardiovascular Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Cardiac Monitoring System",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Cardiac Output Monitors",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Cardiac Restoration Systems",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Cardiac Resynchronization Therapy",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Cardiac Rhythm Management Devices",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Cardiac Valvulotome",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "CardioPulmonary Management Device (CPM)",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Cardiogenic Shock",
    "therapeutic_area": "Cardiovascular Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Cardiogenic Shock Epidemiology Forecast",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Cardiogenic Shock Pipeline Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Cardiometabolic Risk Syndrome",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Cardiopulmonary Autotransfusion Devices",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Cardiopulmonary Bypass Equipment - Global",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Cardiorenal Syndrome",
    "therapeutic_area": "Cardiovascular Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 2
  },
  {
    "indication_name": "Cardiotoxicity",
    "therapeutic_area": "Cardiovascular Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Cardiovascular Calcification",
    "therapeutic_area": "Endocrinology and Metabolic Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Cardiovascular Devices",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Cardiovascular Imaging Equipment",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Cardiovascular Ultrasound System",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Carisbamate Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Carnitine Palmitoyltransferase I (CPT 1) Inhibitor",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Carotenoids",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Carotid Artery Disease",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Carotid Artery Stent Market",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Carotid Stenotic Scan Devices",
    "therapeutic_area": "Neurology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Carpal Tunnel Release System",
    "therapeutic_area": "Musculoskeletal",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Carpal Tunnel Syndrome",
    "therapeutic_area": "Neurology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2032-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Cartilage Diseases",
    "therapeutic_area": "Musculoskeletal",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Casein Kinase 2 Inhibitor",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Casimersen",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Caspase 3 (CPP32, Apopain or YAMA) Activators",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Caspases Activators",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Caspases Inhibitor",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Cast Saw Devices",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Castleman Disease",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Castrate Resistant Prostrate Cancer",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Castrate-Resistant Prostate Cancer Epidemiology Forecast",
    "therapeutic_area": "Oncology",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Castrate-Sensitive Prostate Cancer (CSPC)",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Castration-Resistant Prostate Cancer (CRPC)",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2030-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Castration-sensitive Prostate Cancer",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Castration-sensitive Prostate Cancer (CSPC) \u2013 Epidemiology Forecast",
    "therapeutic_area": "Oncology",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Cataplexy",
    "therapeutic_area": "Neurology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Cataract",
    "therapeutic_area": "Ophthalmology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2025-2032",
    "total_reports": 2
  },
  {
    "indication_name": "Cataract Surgery Complications",
    "therapeutic_area": "Ophthalmology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Cataract Surgery Devices",
    "therapeutic_area": "Ophthalmology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Catechol-O-methyltransferase (COMT) Inhibitor",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Catechol-O-methyltransferase (COMT) Inhibitor Market Size, Target Population, Competitive Landscape & Market Forecast",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Cathepsin K/S Inhibitor",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 3
  },
  {
    "indication_name": "Catheter Stabilization/Securement Device",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Catheter-Related Bloodstream Infections (CRBSIs)",
    "therapeutic_area": "Infectious Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 4
  },
  {
    "indication_name": "Cefepime-zidebactam Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Cefepime/enmetazobactam Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Cefepime/taniborbactam Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Celiac Disease (CD)",
    "therapeutic_area": "Immunological and Autoimmune Disorders",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Cell Analysis",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Cell And Gene Therapy For Multiple Myeloma",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Cell Division Cycle 7 (CDC7) Related Protein Kinase Inhibitor",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Cell Harvesting Systems",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Cell Isolation",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Cell Therapy",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2028,
    "year_range": "2028",
    "total_reports": 1
  },
  {
    "indication_name": "Cell Wall Synthesis Inhibitors",
    "therapeutic_area": "Infectious Diseases",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Cell and Gene Therapies in Rare Disorders",
    "therapeutic_area": "Rare Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Cell and Gene Therapy Manufacturing",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Cell and Gene Therapy in Parkinson\u2019s Disease",
    "therapeutic_area": "Neurology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Cellular-mesenchymal Epithelial Transition Factor (C-Met) Mutated Non-small Cell Lung Cancer (NSCLC)",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Cellulitis",
    "therapeutic_area": "Dermatology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2032-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Cendakimab Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Central Nervous System Lymphoma",
    "therapeutic_area": "Central Nervous System",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Central Pain Syndrome",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Central Precocious Puberty",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Central Retinal Vein Occlusion",
    "therapeutic_area": "Other Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Central Retinal Venous Occlusion",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2032-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Central Serous Chorioretinopathy",
    "therapeutic_area": "Ophthalmology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Central Venous Catheters",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Centronuclear Myopathy (CNM)",
    "therapeutic_area": "Rare Diseases",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Centronuclear Myopathy (CNM) \u2013 Epidemiology Forecast",
    "therapeutic_area": "Ophthalmology",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Cereblon E3 Ligase Modulators Market Size, Target Population, Competitive Landscape & Market Forecast",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Cerebral Adrenoleukodystrophy (CALD)",
    "therapeutic_area": "Genetic Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Cerebral Amyloid Angiopathy",
    "therapeutic_area": "Other Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Cerebral Aneurysm",
    "therapeutic_area": "Neurology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Cerebral Aneurysm Epidemiology Forecast",
    "therapeutic_area": "Neurology",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Cerebral Infarction",
    "therapeutic_area": "Other Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Cerebral Palsy",
    "therapeutic_area": "Central Nervous System",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2030-2034",
    "total_reports": 4
  },
  {
    "indication_name": "Cerebral Vein Thrombosis",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Cerebral vein thrombosis Epidemiology Forecast",
    "therapeutic_area": "Central Nervous System",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Cerebrospinal Fluid Management",
    "therapeutic_area": "Neurology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Cerebrotendinous Xanthomatosis",
    "therapeutic_area": "Genetic Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2032-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Cervical Cancer",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Cervical Cancer Patient Pool Analysis",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Cervical Dysplasia",
    "therapeutic_area": "Womens Health",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 5
  },
  {
    "indication_name": "Cervical Dystonia",
    "therapeutic_area": "Central Nervous System",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Cervical Intraepithelial Neoplasia",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Cervix Lesion",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Chagas Disease",
    "therapeutic_area": "Infectious Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2025-2032",
    "total_reports": 2
  },
  {
    "indication_name": "Chagas Disease Epidemiology Forecast",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Charcot Marie Tooth Disease",
    "therapeutic_area": "Genetic Disorders",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Charcot-Marie-Tooth Disease",
    "therapeutic_area": "Genetic Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2030-2034",
    "total_reports": 4
  },
  {
    "indication_name": "Checkpoint Inhibitor Refractory Cancer",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2030-2034",
    "total_reports": 4
  },
  {
    "indication_name": "Checkpoint Kinase 1 (Chk1) Inhibitor",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Checkpoint Kinase 2 (Chk2) Inhibitor",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Checkpoint Kinase Inhibitor",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Checkpoint inhibitors - Competitive landscape",
    "therapeutic_area": "Oncology",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Chemiluminescence Immunoassay",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Chemokine Receptor Antagonist",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Chemotherapy Drugs",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Chemotherapy Induced Anemia",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2025-2032",
    "total_reports": 2
  },
  {
    "indication_name": "Chemotherapy Induced Anemia - Global API Manufacturers, Marketed and Phase III Drugs Landscape",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Chemotherapy Induced Anemia Epidemiology Forecast",
    "therapeutic_area": "Oncology",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Chemotherapy Induced Diarrhea",
    "therapeutic_area": "Other Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Chemotherapy Induced Febrile Neutropenia",
    "therapeutic_area": "Hematological Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Chemotherapy Induced Nausea and Vomiting",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Chemotherapy Induced Neutropenia (CIN)",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2030-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Chemotherapy Induced Neutropenia Pipeline Insight",
    "therapeutic_area": "Oncology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Chemotherapy Induced Pain",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2032-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Chemotherapy Induced Peripheral Neuropathy (CIPN)",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Chemotherapy-Induced Bone Marrow Toxicities",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Chemotherapy-Induced Peripheral Neuropathy (CIPN) Patient Pool Analysis",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Chemotherapy-induced Hearing Loss",
    "therapeutic_area": "Other Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2032-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Chemotherapy-induced nausea and vomiting (CINV)",
    "therapeutic_area": "Other Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2032-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Chemotherapy-induced thrombocytopenia (CIT)",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Chest Drainage Catheters",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Chiari Malformation",
    "therapeutic_area": "Neurology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Chicken Pox",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Chikungunya",
    "therapeutic_area": "Infectious Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2025-2032",
    "total_reports": 2
  },
  {
    "indication_name": "Childhood Atropine For Myopia Progression",
    "therapeutic_area": "Ophthalmology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Chimeric Antigen Receptor (CAR) T cell Immunotherapy - Competitive Landscape, Pipeline and Market Analysis",
    "therapeutic_area": "Immunological and Autoimmune Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2021,
    "year_range": "2017-2021",
    "total_reports": 2
  },
  {
    "indication_name": "Chimeric Antigen Receptor Macrophage (CAR-M) Immunotherapy",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Chimeric Antigen Receptor T-Cell Therapy (CAR-T)",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Chlamydia",
    "therapeutic_area": "Infectious Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Chlamydia Infections Pipeline Insight",
    "therapeutic_area": "Infectious Diseases",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Cholangiocarcinoma (CCA)",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Cholbam - API Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Cholecystokinin Receptor (CCK) Antagonist",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Cholera",
    "therapeutic_area": "Infectious Diseases",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Cholestatic Pruritus",
    "therapeutic_area": "Dermatology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 4
  },
  {
    "indication_name": "Cholesterol Absorption Inhibitor",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Cholesterylester Transfer Protein (CETP) Inhibitor",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Cholinesterase (ChE) Inhibitors Market Size, Target Population, Competitive Landscape & Market Forecast",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Chondrosarcoma",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Choroidal Neovascularization",
    "therapeutic_area": "Ophthalmology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Choroideremia",
    "therapeutic_area": "Ophthalmology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Chromatography Instrument",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Chronic Back Pain",
    "therapeutic_area": "Central Nervous System",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Chronic Brain Damage",
    "therapeutic_area": "Neurology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Chronic Bronchitis",
    "therapeutic_area": "Respiratory Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Chronic Constipation",
    "therapeutic_area": "Gastroenterology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 2
  },
  {
    "indication_name": "Chronic Cough",
    "therapeutic_area": "Respiratory Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2032-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Chronic Cutaneous Ulcers",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2032-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Chronic Fatigue Syndrome",
    "therapeutic_area": "Other Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 2
  },
  {
    "indication_name": "Chronic Focal Epilepsy",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Chronic Gout",
    "therapeutic_area": "Musculoskeletal",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 4
  },
  {
    "indication_name": "Chronic Gout\u2013Epidemiology Forecast",
    "therapeutic_area": "Musculoskeletal",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Chronic Granulomatous Disease",
    "therapeutic_area": "Immunological and Autoimmune Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Chronic Hand Eczema (CHE)",
    "therapeutic_area": "Dermatology",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Chronic Heart Failure",
    "therapeutic_area": "Cardiovascular Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 2
  },
  {
    "indication_name": "Chronic Heart Failure Pipeline Insight",
    "therapeutic_area": "Cardiovascular Diseases",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Chronic Hemodialysis Catheter",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Chronic Hepatitis B (CHB)",
    "therapeutic_area": "Infectious Diseases",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 2
  },
  {
    "indication_name": "Chronic Hepatitis B Patient Pool Analysis",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Chronic Hepatitis B Virus (CHB)",
    "therapeutic_area": "Infectious Diseases",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Chronic Hepatitis C Virus Infection",
    "therapeutic_area": "Infectious Diseases",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Chronic Hepatitis Delta Virus (HDV) Infection",
    "therapeutic_area": "Infectious Diseases",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Chronic Idiopathic Constipation (CIC)",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Chronic Idiopathic Urticaria (CIU)",
    "therapeutic_area": "Immunological and Autoimmune Disorders",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Chronic Inducible Urticaria",
    "therapeutic_area": "Dermatology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)",
    "therapeutic_area": "Neurology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) - Global API Manufacturers, Marketed and Phase III Drugs Landscape",
    "therapeutic_area": "Neurology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Chronic Inflammatory Demyelinating Polyradiculoneuropathy",
    "therapeutic_area": "Immunological and Autoimmune Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2032-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Chronic Insomnia",
    "therapeutic_area": "Sleep Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2030-2034",
    "total_reports": 4
  },
  {
    "indication_name": "Chronic Kidney Disease (CKD)",
    "therapeutic_area": "Endocrinology and Metabolic Disorders",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Chronic Kidney Disease (Chronic Renal Failure) - Global API Manufacturers, Marketed and Phase III Drugs Landscape",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Chronic Kidney Disease - Competitive landscape",
    "therapeutic_area": "Genito Urinary System and Sex Hormones",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Chronic Kidney Disease Patient Pool Analysis",
    "therapeutic_area": "Genito Urinary System and Sex Hormones",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Chronic Liver Disease",
    "therapeutic_area": "Gastroenterology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Chronic Liver Disease - Global API Manufacturers, Marketed and Phase III Drugs Landscape",
    "therapeutic_area": "Gastroenterology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Chronic Lower Back Pain (CLBP)",
    "therapeutic_area": "Musculoskeletal",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2028-2034",
    "total_reports": 4
  },
  {
    "indication_name": "Chronic Lymphocytic Leukemia (CLL)",
    "therapeutic_area": "Oncology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Chronic Myelocytic Leukemia (CML)",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Chronic Myelogenous Leukemia",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2032-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Chronic Myeloid Leukemia",
    "therapeutic_area": "Other Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Chronic Myelomonocytic Leukaemia",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Chronic Neuropathic Pain (CNP)",
    "therapeutic_area": "Infectious Diseases",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Chronic Neuropathic Pain Epidemiology Forecast",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Chronic Neuropathic Pain Pipeline Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Chronic Non-healing Wounds",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Chronic Norovirus Enteritis",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Chronic Obstructive Lung Disease",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Chronic Obstructive Pulmonary Disease (COPD)",
    "therapeutic_area": "Respiratory Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2030-2034",
    "total_reports": 4
  },
  {
    "indication_name": "Chronic Obstructive Pulmonary Disease (COPD) Patient Pool Analysis",
    "therapeutic_area": "Respiratory Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Chronic Obstructive Pulmonary Disease Pipeline Insight",
    "therapeutic_area": "Respiratory Diseases",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Chronic Obstructive Pulmonary Disease Treatment Devices",
    "therapeutic_area": "Respiratory Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Chronic Obstructive Pulmonary Disorder Epidemiology Forecast",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Chronic Ocular Pain",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Chronic Otitis Media (COM)",
    "therapeutic_area": "Otolaryngology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Chronic Pain",
    "therapeutic_area": "Musculoskeletal",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 5
  },
  {
    "indication_name": "Chronic Pain associated with Painful Diabetic Neuropathy ",
    "therapeutic_area": "Neurology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2030-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Chronic Pancreatitis",
    "therapeutic_area": "Gastroenterology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2025-2032",
    "total_reports": 2
  },
  {
    "indication_name": "Chronic Pancreatitis Epidemiology Forecast",
    "therapeutic_area": "Gastroenterology",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Chronic Pancreatitis Pain",
    "therapeutic_area": "Gastroenterology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Chronic Periodontitis",
    "therapeutic_area": "Infectious Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Chronic Phase Chronic Myeloid Leukemia",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2032-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Chronic Plaque Psoriasis",
    "therapeutic_area": "Immunological and Autoimmune Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Chronic Plaque Psoriasis - Global API Manufacturers, Marketed and Phase III Drugs Landscape",
    "therapeutic_area": "Dermatology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 2
  },
  {
    "indication_name": "Chronic Post-Amputation Pain",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Chronic Progressive Multiple Sclerosis",
    "therapeutic_area": "Neurology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Chronic Pruritus",
    "therapeutic_area": "Dermatology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 2
  },
  {
    "indication_name": "Chronic Pseudomonas Aeruginosa Pulmonary Infections",
    "therapeutic_area": "Infectious Diseases",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Chronic Pulmonary Hypertension",
    "therapeutic_area": "Cardiovascular Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Chronic Pulmonary Hypertension \u2013 Epidemiology Forecast to",
    "therapeutic_area": "Cardiovascular Diseases",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Chronic Pulmonary Infections",
    "therapeutic_area": "Infectious Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Chronic Pulmonary Infections Due To Pseudomonas Aeruginosa In Patients With Cystic Fibrosis",
    "therapeutic_area": "Infectious Diseases",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Chronic Refractory Cough (CRC)",
    "therapeutic_area": "Respiratory Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2028-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Chronic Refractory Gout",
    "therapeutic_area": "Endocrinology and Metabolic Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 2
  },
  {
    "indication_name": "Chronic Renal/Kidney Transplant Rejection",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Chronic Rhinosinusitis",
    "therapeutic_area": "Infectious Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Chronic Rhinosinusitis Phenotype With Nasal Polyps",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Chronic Rhinosinusitis with Nasal Polyps",
    "therapeutic_area": "Otolaryngology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 4
  },
  {
    "indication_name": "Chronic Rhinosinusitis without Nasal Polyps (CRSsNP)",
    "therapeutic_area": "Otolaryngology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Chronic Rhinosinusitis without Nasal Polyps\u2013Epidemiology Forecast",
    "therapeutic_area": "Otolaryngology",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Chronic Sialorrhea",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Chronic Smell and Flavor Loss",
    "therapeutic_area": "Otolaryngology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Chronic Smell and Flavor Loss \u2013 Epidemiology Forecast",
    "therapeutic_area": "Otolaryngology",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Chronic Spinal Cord Injury",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Chronic Spontaneous Urticaria (CSU)",
    "therapeutic_area": "Dermatology",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 2
  },
  {
    "indication_name": "Chronic Spontaneous Urticaria (CSU) Patient Pool Analysis",
    "therapeutic_area": "Rare Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Chronic Stable Angina",
    "therapeutic_area": "Cardiovascular Diseases",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Chronic Thromboembolic Pulmonary Hypertension (CTEPH)",
    "therapeutic_area": "Cardiovascular Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 2
  },
  {
    "indication_name": "Chronic Traumatic Encephalopathy",
    "therapeutic_area": "Neurology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2025-2032",
    "total_reports": 2
  },
  {
    "indication_name": "Chronic Urticaria",
    "therapeutic_area": "Immunological and Autoimmune Disorders",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Chronic Urticaria Therapeutics",
    "therapeutic_area": "Dermatology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2032-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Chronic Venous Insufficiency",
    "therapeutic_area": "Hematological Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Chronic Venous Ulceration (CVU)",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Chronic Wounds",
    "therapeutic_area": "Dermatology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 4
  },
  {
    "indication_name": "Chronic and Acute Pain",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Chronic hemodialysis",
    "therapeutic_area": "Genito Urinary System and Sex Hormones",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Cialis - API Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Cilofexor Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Cimdelirsen Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Circadian Rhythm Disorders",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Circadian Rhythm Sleep Disorders",
    "therapeutic_area": "Neurology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Cirrhosis",
    "therapeutic_area": "Gastroenterology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Claudin 18.2 Directed Therapies\u2013 Target Population, Competitive Landscape, and Market Forecast",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Clazakizumab Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Clear Cell Ovarian Cancer",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Clear Cell Ovarian Cancer Epidemiology Forecast",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Clear Cell Renal Cell Carcinoma (ccRCC)",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Clear Cell Sarcoma",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Clinical Chemistry Analyzers",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Clinical Decision Support Systems",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Clinical Diagnostics - Global",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Clinical Laboratory Service",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Clinical Microbiology",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Clinical Nutrition",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Clinical Trial Support Services",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Clinical Workflow Solutions",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Clinically Isolated Syndrome (CIS)",
    "therapeutic_area": "Neurology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Clostridioides Difficile Infection ",
    "therapeutic_area": "Infectious Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 2
  },
  {
    "indication_name": "Clostridium Difficile Infections",
    "therapeutic_area": "Infectious Diseases",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Clostridium Difficile Infections Patient Pool Analysis",
    "therapeutic_area": "Infectious Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Clot Management Devices",
    "therapeutic_area": "Cardiovascular Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Cluster Headache",
    "therapeutic_area": "Neurology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 4
  },
  {
    "indication_name": "Cluster Headache Syndrome",
    "therapeutic_area": "Other Diseases",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Coagulation Analyzers",
    "therapeutic_area": "Cardiovascular Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Coagulation Factor Deficiency",
    "therapeutic_area": "Hematological Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Coagulation Factor Deficiency Epidemiology Forecast",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Cobitolimod Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Cocaine Intoxication",
    "therapeutic_area": "Toxicology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Cocaine Use Disorder",
    "therapeutic_area": "Toxicology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Coccidioidomycosis",
    "therapeutic_area": "Infectious Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Cochlear Implants",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Cognitive Impairment Associated With Schizophrenia (CIAS)",
    "therapeutic_area": "Neurology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Colcrys - API Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Cold Agglutinin Disease (CAD)",
    "therapeutic_area": "Rare Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2028,
    "year_range": "2028",
    "total_reports": 1
  },
  {
    "indication_name": "Cold Agglutinin Disease Epidemiology Forecast",
    "therapeutic_area": "Hematological Disorders",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Cold Agglutinin Disease Pipeline Insight",
    "therapeutic_area": "Immunological and Autoimmune Disorders",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Collagen Inhibitors",
    "therapeutic_area": "Ophthalmology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Collagen Meniscus Implant",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Colonoscopes",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Colonoscopes Pipeline Insight and Competitive Landscape",
    "therapeutic_area": "Gastroenterology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2023,
    "year_range": "2023",
    "total_reports": 1
  },
  {
    "indication_name": "Colorectal Cancer (CRC)",
    "therapeutic_area": "Oncology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Colorectal Neoplasm",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Colorectal Surgical Devices",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Colorectal cancer Patient Pool Analysis",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Colposcopy Devices",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Combivir - API Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Common Cold",
    "therapeutic_area": "Infectious Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Common Warts",
    "therapeutic_area": "Dermatology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 5
  },
  {
    "indication_name": "Community Acquired Pneumonia",
    "therapeutic_area": "Infectious Diseases",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Community Acquired Uncomplicated UTI",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Community-Acquired Bacterial Pneumonia (CABP)",
    "therapeutic_area": "Infectious Diseases",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Community-acquired Pneumonia (CAP)",
    "therapeutic_area": "Infectious Diseases",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Companion Diagnostics- Global",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Compartment Syndrome",
    "therapeutic_area": "Musculoskeletal",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Compartment Syndrome Epidemiology Forecast",
    "therapeutic_area": "Central Nervous System",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Complement 3 Glomerulopathy (C3G)",
    "therapeutic_area": "Genito Urinary System and Sex Hormones",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2030-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Complement C1s Inhibitors",
    "therapeutic_area": "Genetic Disorders",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 2
  },
  {
    "indication_name": "Complement C3 Inhibitors",
    "therapeutic_area": "Immunological and Autoimmune Disorders",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 2
  },
  {
    "indication_name": "Complement Factor B (CFB) Inhibitor Market Size, Target Population, Competitive Landscape & Market Forecast",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Complement Inhibitors",
    "therapeutic_area": "Immunological and Autoimmune Disorders",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Complex Regional Pain Syndrome (CRPS)",
    "therapeutic_area": "Neurology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2028-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Complicated Intra-abdominal Infections (cIAI)",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Complicated Skin and Soft Tissue Infections (cSSTI)",
    "therapeutic_area": "Dermatology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Complicated Urinary Tract Infections (cUTIs)",
    "therapeutic_area": "Genito Urinary System and Sex Hormones",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Computational Biology",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Computed Tomography (CT) Devices",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Concerta - API Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Concussions",
    "therapeutic_area": "Central Nervous System",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 2
  },
  {
    "indication_name": "Condom",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Conductive Hearing Loss",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Condyloma",
    "therapeutic_area": "Infectious Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Cone Rod Dystrophy",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Cone-Rod Dystrophies",
    "therapeutic_area": "Genetic Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Confectionery Ingredients",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Congenital Adrenal Hyperplasia",
    "therapeutic_area": "Genetic Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Congenital Adrenal Hyperplasia (CAH) \u2013 Epidemiology Forecast to",
    "therapeutic_area": "Endocrinology and Metabolic Disorders",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Congenital Diarrheal Disorders",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Congenital Heart Defect",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Congenital Heart Defect Devices",
    "therapeutic_area": "Cardiovascular Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Congenital Heart Disease",
    "therapeutic_area": "Cardiovascular Diseases",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Congenital Hyperinsulinism",
    "therapeutic_area": "Endocrinology and Metabolic Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 4
  },
  {
    "indication_name": "Congenital Ichthyosis",
    "therapeutic_area": "Genetic Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Congenital Myasthenic Syndromes",
    "therapeutic_area": "Genetic Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2032-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Congestive Heart Failure (CHF)",
    "therapeutic_area": "Cardiovascular Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2030-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Congestive Heart Failure (CHF)\u2014Epidemiology Forecast",
    "therapeutic_area": "Cardiovascular Diseases",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Congestive Heart Failure Patient Pool Analysis",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Congestive Heart Failure Treatment Devices",
    "therapeutic_area": "Cardiovascular Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Connected Drug Delivery Devices",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Connected Health and Wellness Solutions",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Connective Tissue Disease Associated With Interstitial Lung Disease (CTD-ILD) \u2013 Epidemiology Forecast",
    "therapeutic_area": "Respiratory Diseases",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Connective Tissue Disease associated with Interstitial Lung Disease",
    "therapeutic_area": "Respiratory Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Connective Tissue Growth Factor (CTGF) Inhibitors Market Size, Target Population, Competitive Landscape & Market Forecast",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Connective tissue disease-associated ILD (CTD-ILD) Patient Pool Analysis",
    "therapeutic_area": "Respiratory Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Constipation",
    "therapeutic_area": "Gastroenterology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Contact Dermatitis",
    "therapeutic_area": "Dermatology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Contact Lenses",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Continuous Manufacturing",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Continuous Renal Replacement Therapy Machines (CRRT) - Global",
    "therapeutic_area": "Other Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Contraceptive Devices",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Contraceptive Drugs",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Contraceptives",
    "therapeutic_area": "Womens Health",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2025-2030",
    "total_reports": 2
  },
  {
    "indication_name": "Contract Development Manufacturing Organization (CDMO)",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Contrast Media Injectors",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Contrast-Induced Nephropathy",
    "therapeutic_area": "Endocrinology and Metabolic Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Contusion",
    "therapeutic_area": "Dermatology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2032-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Convulsive Seizures",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2032-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Copaxone - API Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Corlanor - API Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Corneal Dystrophy",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Corneal Edema",
    "therapeutic_area": "Ophthalmology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Corneal Edema \u2013 Epidemiology Forecast",
    "therapeutic_area": "Neurology",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Corneal Endothelial Dystrophy (CED)",
    "therapeutic_area": "Ophthalmology",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Corneal Epithelial Defect",
    "therapeutic_area": "Ophthalmology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Corneal Graft Rejection",
    "therapeutic_area": "Immunological and Autoimmune Disorders",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Corneal Implant",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Corneal Pachymetery/Pachymeter",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Corneal Topographers",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Corneal Transplant Market",
    "therapeutic_area": "Ophthalmology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Corneal Ulcer",
    "therapeutic_area": "Ophthalmology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Coronary Angiography Devices",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Coronary Angioplasty With or Without Stenting",
    "therapeutic_area": "Cardiovascular Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Coronary Artery Disease (CAD)",
    "therapeutic_area": "Other Diseases",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Coronary Guidewires",
    "therapeutic_area": "Cardiovascular Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Coronary Microvascular Dysfunction",
    "therapeutic_area": "Cardiovascular Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 2
  },
  {
    "indication_name": "Coronary Occlusion (Includes CAD also)",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Coronary Pressure Market",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Coronary Stents",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Coronary Stents Pipeline Insight and Competitive Landscape",
    "therapeutic_area": "Cardiovascular Diseases",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2023,
    "year_range": "2023",
    "total_reports": 1
  },
  {
    "indication_name": "Coronavirus-3C-like-Proteinase Inhibitors",
    "therapeutic_area": "Respiratory Diseases",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Corporate Wellness",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Corticobasal Degeneration (CBD)",
    "therapeutic_area": "Central Nervous System",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Cough Assisted Devices",
    "therapeutic_area": "Respiratory Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Cough In IPF Patient Pool Analysis",
    "therapeutic_area": "Respiratory Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Cough in Idiopathic Pulmonary Fibrosis (IPF)",
    "therapeutic_area": "Respiratory Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Coxsackievirus Infections",
    "therapeutic_area": "Infectious Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Cranial & Auricular Electrotherapy Stimulation Devices",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Cranial Fixation System",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Cranial Perforators",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Cranio Maxillofacial Fixation Devices",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Craniopharyngioma",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2025-2032",
    "total_reports": 2
  },
  {
    "indication_name": "Crestor - API Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Crinecerfont Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Critical Limb Ischemia",
    "therapeutic_area": "Cardiovascular Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 5
  },
  {
    "indication_name": "Crohn's Disease (CD)",
    "therapeutic_area": "Gastroenterology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2030-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Crohn's Disease Patient Pool Analysis",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Crohn\u2019s Disease \u2013 Epidemiology Forecast",
    "therapeutic_area": "Gastroenterology",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Crohn\u2019s disease",
    "therapeutic_area": "Gastroenterology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 2
  },
  {
    "indication_name": "Crovalimab Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 2
  },
  {
    "indication_name": "Crows Feet",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Cryoablation Devices - Global",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Cryoglobulinemia",
    "therapeutic_area": "Hematological Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Cryopyrin-associated Periodic Syndromes (CAPS)",
    "therapeutic_area": "Rare Diseases",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Cryotherapy",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Cryptococcal Meningitis (CM)",
    "therapeutic_area": "Central Nervous System",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Cryptococcosis",
    "therapeutic_area": "Infectious Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2025-2032",
    "total_reports": 2
  },
  {
    "indication_name": "Cryptococcus",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Cubicin - API Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Cushing Syndrome",
    "therapeutic_area": "Endocrinology and Metabolic Disorders",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Cushing's Syndrome",
    "therapeutic_area": "Endocrinology and Metabolic Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2032-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Cushing\u2019s Disease",
    "therapeutic_area": "Endocrinology and Metabolic Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Cushing\u2019s Disease \u2013 Epidemiology Forecast",
    "therapeutic_area": "Endocrinology and Metabolic Disorders",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Cutaneous Angiosarcoma",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Cutaneous Lupus Erythematosus (CLE)",
    "therapeutic_area": "Dermatology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Cutaneous Lupus Erythematosus (CLE) Patient Pool Analysis",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Cutaneous Lupus Erythematosus \u2013 Epidemiology Forecast",
    "therapeutic_area": "Immunological and Autoimmune Disorders",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Cutaneous Melanoma",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Cutaneous Melanoma Epidemiology Forecast",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Cutaneous Squamous cell Carcinoma (CsCC)",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Cutaneous T-Cell Lymphoma (CTCL)",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Cyclin-Dependent Kinase 1 (CDK1) Inhibitor",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 2
  },
  {
    "indication_name": "Cyclin-Dependent Kinase 6/4 (CDK6/4) Inhibitor",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Cyclin-Dependent Kinase 9 Inhibitor Pipeline Insight",
    "therapeutic_area": "Oncology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Cyclin-Dependent Kinase Inhibitor",
    "therapeutic_area": "Oncology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Cyclin-Dependent Kinase-Like 5 (CDKL5) Deficiency Disorder",
    "therapeutic_area": "Genetic Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Cyclo-Oxygenase 2 Inhibitors",
    "therapeutic_area": "Musculoskeletal",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Cyclophilin Inhibitor",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Cystic Fibrosis",
    "therapeutic_area": "Respiratory Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Cystic Fibrosis Pipeline Insight",
    "therapeutic_area": "Genetic Disorders",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Inhibitor",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Cystic Fibrosis Transmembrane Conductance Regulators (CFTR)",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Cystinosis",
    "therapeutic_area": "Endocrinology and Metabolic Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 5
  },
  {
    "indication_name": "Cystinuria",
    "therapeutic_area": "Genetic Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 4
  },
  {
    "indication_name": "Cystitis",
    "therapeutic_area": "Genito Urinary System and Sex Hormones",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Cytidine Deaminase Inhibitors (CDA)",
    "therapeutic_area": "Oncology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Cytochrome P450 17 (CYP17) Inhibitor",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Cytochrome P450 Superfamily (CYP or CYP450) Inhibitor",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Cytokine Release Syndrome (CRS)",
    "therapeutic_area": "Immunological and Autoimmune Disorders",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Cytokines",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Cytomegalovirus (CMV) Infections",
    "therapeutic_area": "Infectious Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 5
  },
  {
    "indication_name": "D Agonist",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "D-Dimer Testing",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "D1 Agonist",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "D1 Antagonist",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 2
  },
  {
    "indication_name": "D2 Agonist",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "D3 Agonist",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "D3 Antagonist",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "D4 Agonist",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "D4 Antagonist",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "DARZALEX Market Size",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "DB-102 Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "DCVax-L Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "DDR Defective Tumors",
    "therapeutic_area": "Genetic Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2032-2034",
    "total_reports": 2
  },
  {
    "indication_name": "DDR defect tumors",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "DE-117 Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "DE-130A (Latanoprost)",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "DELYTACT Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 2
  },
  {
    "indication_name": "DEXCYU Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "DEXTENZA Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 2
  },
  {
    "indication_name": "DHODH Inhibitor Pipeline Insight",
    "therapeutic_area": "Infectious Diseases",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "DIFICID Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "DMX-200 Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "DNA Methyltransferase Inhibitor",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "DNA Sequencing",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "DNA Synthesis Inhibitor Market Size, Target Population, Competitive Landscape & Market Forecast",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "DNA Topoisomerase I Inhibitors",
    "therapeutic_area": "Oncology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "DNA and Gene Cloning Services",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "DNA-Dependent RNA Polymerase Inhibitor",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "DNX-2401 Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "DOPTELET Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 2
  },
  {
    "indication_name": "DP1 Receptor (Prostaglandin D2 receptor) Antagonist",
    "therapeutic_area": "Immunological and Autoimmune Disorders",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "DP2 Receptor (G Protein-Coupled Receptor 44 or Chemoattractant Receptor-Homologous Molecule On Th2 Cells (CRTH2)) Antagonist",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "DS107 Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "DSUVIA Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "DTX301",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "DUB Inhibitors Competitive Landscape, Market and Pipeline Analysis",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2020,
    "year_range": "2020",
    "total_reports": 1
  },
  {
    "indication_name": "DUPIXENT Market Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "DUPIXENT Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 3
  },
  {
    "indication_name": "DUR-928",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "DURYSTA (Bimatoprost SR) Market Size",
    "therapeutic_area": "Other Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "DUX4 Protein Inhibitors",
    "therapeutic_area": "Genetic Disorders",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Daklinza - API Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Danaparoid Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Danicopan Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Danon Disease",
    "therapeutic_area": "Endocrinology and Metabolic Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Daratumumab Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Darbepoetin alfa\u2013 Biosimilar Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2024,
    "year_range": "2024",
    "total_reports": 1
  },
  {
    "indication_name": "Datopotamab deruxtecan Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Decompensated Cirrhosis",
    "therapeutic_area": "Gastroenterology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 2
  },
  {
    "indication_name": "Deep Brain Stimulation Devices",
    "therapeutic_area": "Neurology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Deep Brain Stimulation Devices Pipeline Insight and Competitive Landscape",
    "therapeutic_area": "Neurology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2023,
    "year_range": "2023",
    "total_reports": 1
  },
  {
    "indication_name": "Deep Partial-Thickness Thermal Burns",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Deep Vein Thrombosis (DVT)",
    "therapeutic_area": "Cardiovascular Diseases",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Defibrillator",
    "therapeutic_area": "Cardiovascular Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Deflectable Catheters",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Degenerative Disc Disease (DDD)",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Delayed Cerebral Ischaemia (DCI)",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Delete- Interleukin Inhibitors",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Delirium",
    "therapeutic_area": "Other Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2032-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Delta Antagonist",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Delta-like Ligand 3 (DLL3)-targeted Therapies \u2013 Target Population, Competitive Landscape, and Market Forecast",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Dementia",
    "therapeutic_area": "Neurology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Dementia Associated With Alzheimer's Disease",
    "therapeutic_area": "Central Nervous System",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Dementia Drugs",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Dementia with Diabetes",
    "therapeutic_area": "Neurology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Dementia with Lewy Bodies (DLB) \u2013 Epidemiology Forecast",
    "therapeutic_area": "Neurology",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Dementia with Lewy Bodies Patient Pool Analysis",
    "therapeutic_area": "Neurology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Demineralized Bone Fiber Technology",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Dengue",
    "therapeutic_area": "Infectious Diseases",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Dengue Fever",
    "therapeutic_area": "Infectious Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2025-2032",
    "total_reports": 2
  },
  {
    "indication_name": "DenovoSkin (EHSG-KF) Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Dense Deposit Disease",
    "therapeutic_area": "Genito Urinary System and Sex Hormones",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 2
  },
  {
    "indication_name": "Dental Air Polishing Unit",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Dental Bone Graft Substitutes",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Dental Cement",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Dental Compressor",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Dental Consumables",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Dental Equipment",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Dental Implants",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Dental Implants and Prosthesis",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Dental Implants\u2013Pipeline Insight and Competitive Landscape",
    "therapeutic_area": "Other Diseases",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2023,
    "year_range": "2023",
    "total_reports": 1
  },
  {
    "indication_name": "Dental Lasers",
    "therapeutic_area": "Dental and Oral Health",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Dental Milling Machines",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Dental Pain",
    "therapeutic_area": "Infectious Diseases",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Dental Turbines",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Dental X-Ray Systems - Global",
    "therapeutic_area": "Dental and Oral Health",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Dentures",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Depemokimab Sales Forecast, and Market Size Analysis",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Derazantinib Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Dermal Erythema",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Dermal Fillers",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Dermal Mycosis",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Dermal Regeneration Matrix",
    "therapeutic_area": "Other Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Dermatological Drugs",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Dermatology Devices",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Dermatome Devices",
    "therapeutic_area": "Dermatology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Dermatomycoses",
    "therapeutic_area": "Infectious Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2032-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Dermatomyositis",
    "therapeutic_area": "Dermatology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Dermatomyositis Epidemiology Forecast",
    "therapeutic_area": "Dermatology",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Dermatomyositis Patient Pool Analysis",
    "therapeutic_area": "Rare Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Dermatophytic Onychomycosis",
    "therapeutic_area": "Infectious Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Dermatoscopes",
    "therapeutic_area": "Dermatology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Dersimelagon Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Desmoid Tumors",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Desmoid Tumors Epidemiology Forecast",
    "therapeutic_area": "Oncology",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Desmoplastic Small Round Cell Tumor",
    "therapeutic_area": "Oncology",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Desmoplastic Small Round Cell Tumors (DSRCTS)",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Deucravacitinib Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Developmental and Epileptic Encephalopathies (DEE)",
    "therapeutic_area": "Neurology",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Developmental and Epileptic Encephalopathies (DEE) Patient Pool Analysis",
    "therapeutic_area": "Neurology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Developmental and Epileptic Encephalopathies Pipeline Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Diabetes",
    "therapeutic_area": "Endocrinology and Metabolic Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2025-2032",
    "total_reports": 2
  },
  {
    "indication_name": "Diabetes Care Devices",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Diabetes Diagnostics",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Diabetes Drugs - Global",
    "therapeutic_area": "Endocrinology and Metabolic Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2028,
    "year_range": "2028",
    "total_reports": 1
  },
  {
    "indication_name": "Diabetes Epidemiology Forecast",
    "therapeutic_area": "Endocrinology and Metabolic Disorders",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Diabetes Gastroparesis (DGp)",
    "therapeutic_area": "Gastroenterology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2028,
    "year_range": "2028",
    "total_reports": 1
  },
  {
    "indication_name": "Diabetes Insipidus",
    "therapeutic_area": "Other Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Diabetes Pen",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Diabetic Cardiomyopathy",
    "therapeutic_area": "Cardiovascular Diseases",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Diabetic Eye Disease",
    "therapeutic_area": "Endocrinology and Metabolic Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2032-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Diabetic Foot",
    "therapeutic_area": "Endocrinology and Metabolic Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2032-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Diabetic Foot Ulcer Treatment",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Diabetic Foot Ulcers (DFUs)",
    "therapeutic_area": "Endocrinology and Metabolic Disorders",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 2
  },
  {
    "indication_name": "Diabetic Gastroparesis",
    "therapeutic_area": "Gastroenterology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Diabetic Hypoglycemia",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Diabetic Ketoacidosis (DKA)",
    "therapeutic_area": "Endocrinology and Metabolic Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Diabetic Kidney Disease (DKD)",
    "therapeutic_area": "Endocrinology and Metabolic Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Diabetic Macular Disease",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Diabetic Macular Edema (DME)",
    "therapeutic_area": "Gastroenterology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 5
  },
  {
    "indication_name": "Diabetic Nephropathy",
    "therapeutic_area": "Endocrinology and Metabolic Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 4
  },
  {
    "indication_name": "Diabetic Nephropathy Epidemiology Forecast",
    "therapeutic_area": "Endocrinology and Metabolic Disorders",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Diabetic Neuropathic Pain (DNP)",
    "therapeutic_area": "Endocrinology and Metabolic Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Diabetic Neuropathy",
    "therapeutic_area": "Endocrinology and Metabolic Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Diabetic Peripheral Neuropathy (DPN)",
    "therapeutic_area": "Neurology",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Diabetic Retinopathy",
    "therapeutic_area": "Endocrinology and Metabolic Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2030-2034",
    "total_reports": 4
  },
  {
    "indication_name": "Diabetic Retinopathy Pipeline Insight",
    "therapeutic_area": "Endocrinology and Metabolic Disorders",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Diabetic Wounds",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Diagnostic Catheters",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Diagnostic Imaging Equipment",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Dialysis Catheters",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Dialysis Devices - Global",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Diamond Blackfan Anemia",
    "therapeutic_area": "Hematological Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Diamyd Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Diarrhea",
    "therapeutic_area": "Endocrinology and Metabolic Disorders",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Dickkopf\u20101 (DKK1) - Competitive Landscape And Market Forecast",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Dietary Fibers",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2027,
    "year_range": "2027",
    "total_reports": 1
  },
  {
    "indication_name": "Dietary Supplements - Global",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2028,
    "year_range": "2028",
    "total_reports": 1
  },
  {
    "indication_name": "Difamilast Market Market Size",
    "therapeutic_area": "Dermatology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Difelikefalin Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Diffuse Intrinsic Pontine Glioma (DIPG)",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Diffuse Large B-Cell Lymphoma",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Diffuse cutaneous systemic sclerosis (dcSSc)",
    "therapeutic_area": "Dermatology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Digestive Health Products",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Digestive System Fistula",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Digital Biomarkers",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Digital Biopsy",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Digital Dentistry",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Digital Dose Inhalers",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Digital Health",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Digital Pathology",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Digital Radiography Systems",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Digital Therapeutics",
    "therapeutic_area": "Musculoskeletal",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Digital Twins in Healthcare",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Digital Wound Measurement Devices",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Digital/Electrical Sphygmomanometer",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Diglyceride Acyltransferase (DGAT) Inhibitor",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Dihydroorotate Dehydrogenase (DHODH) Inhibitor\u2013 Target Population, Competitive Landscape, and Market Forecast",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Dilated Cardiomyopathy (DCM)",
    "therapeutic_area": "Cardiovascular Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2030-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Dilators",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Dim or Night Vision Disturbances (DLD)",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Dipeptidyl Peptidase 1 (DPP1) Market, Target Population, Competitive Landscape, and Market Forecast",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Dipeptidyl Peptidase 4 Inhibitors",
    "therapeutic_area": "Endocrinology and Metabolic Disorders",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Dipeptidyl Peptidase IV (DPP -4) Inhibitors Market Size, Target Population, Competitive Landscape & Market Forecast",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Diphtheria",
    "therapeutic_area": "Gastroenterology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Diprivan EML - API Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Direct Digital Radiography (DDR) X-ray Systems",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Direct-To-Consumer (DTC) Genetic Testing",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Discoidin Domain Receptor Antagonists",
    "therapeutic_area": "Neurology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Disposable Endoscopes",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Disposable Incontinence Products (DIPs)",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Disseminated Intravascular Coagulation (DIC)",
    "therapeutic_area": "Hematological Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Distal Renal Tubular Acidosis (dRTA)",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Diverticulitis",
    "therapeutic_area": "Infectious Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Donanemab Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Donepezil Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Donohue syndrome",
    "therapeutic_area": "Endocrinology and Metabolic Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Doose Syndrome",
    "therapeutic_area": "Central Nervous System",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Dopamine D1 Receptor Antagonists",
    "therapeutic_area": "Neurology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 2
  },
  {
    "indication_name": "Dopaminergic Agonist",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Dopaminergic system Antagonist",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Down Syndrome",
    "therapeutic_area": "Genetic Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 5
  },
  {
    "indication_name": "Doxorubicin",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Dravet Syndrome (DS)",
    "therapeutic_area": "Neurology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2028-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Drill Guide Devices",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Drug Delivery Devices",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Drug Discovery",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2027,
    "year_range": "2027",
    "total_reports": 1
  },
  {
    "indication_name": "Drug Eluting Balloons",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Drug Eruptions",
    "therapeutic_area": "Dermatology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Drug Hypersensitivity",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2032-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Drug Infusion System",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Drug Resistant Epilepsy",
    "therapeutic_area": "Other Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Drug-Eluting Stents",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Drug-Induced Dyskinesia",
    "therapeutic_area": "Neurology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Drug-Resistant Refractory Epilepsy",
    "therapeutic_area": "Central Nervous System",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Dry AMD",
    "therapeutic_area": "Ophthalmology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Dry AMD Patient Pool Analysis",
    "therapeutic_area": "Ophthalmology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Dry Age-Related Macular Degeneration",
    "therapeutic_area": "Ophthalmology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Dry Eye Disease (DED)",
    "therapeutic_area": "Ophthalmology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2028,
    "year_range": "2028",
    "total_reports": 1
  },
  {
    "indication_name": "Dry Eye Disease Treatment",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Dry Powder Inhaler Devices",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Duavee - API Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Duchenne Muscular Dystrophy",
    "therapeutic_area": "Genetic Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 6
  },
  {
    "indication_name": "Ductal Carcinoma in Situ",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 2
  },
  {
    "indication_name": "Duodenal Ulcer",
    "therapeutic_area": "Genetic Disorders",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Duodenoscopes",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Dup15q Syndrome",
    "therapeutic_area": "Neurology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Dupilumab Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 2
  },
  {
    "indication_name": "Dupuytren Contracture",
    "therapeutic_area": "Musculoskeletal",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Dupuytren's Disease",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Durable Medical Equipment",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Durvalumab and Tremelimumab Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Dutogliptin Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Dysautonomia",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Dysautonomia or Autonomic Dysfunction",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Dysautonomia or Autonomic Dysfunction Epidemiology Forecast",
    "therapeutic_area": "Neurology",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Dyschromia",
    "therapeutic_area": "Dermatology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Dysfunctional Uterine Bleeding",
    "therapeutic_area": "Womens Health",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2032-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Dyskinesia",
    "therapeutic_area": "Neurology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Dyslipidemia",
    "therapeutic_area": "Endocrinology and Metabolic Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 4
  },
  {
    "indication_name": "Dyslipidemia With Hypertension",
    "therapeutic_area": "Endocrinology and Metabolic Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2032-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Dysmenorrhea",
    "therapeutic_area": "Womens Health",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Dysmenorrhea Treatment",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Dyspareunia",
    "therapeutic_area": "Other Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Dyspepsia",
    "therapeutic_area": "Gastroenterology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Dyspepsia - Global API Manufacturers, Marketed and Phase III Drugs Landscape",
    "therapeutic_area": "Gastroenterology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Dyspnea",
    "therapeutic_area": "Respiratory Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Dysport - API Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Dysthymia",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Dystonia",
    "therapeutic_area": "Musculoskeletal",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Dystrophic Epidermolysis Bullosa",
    "therapeutic_area": "Dermatology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "E-Prescribing",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "E2814 Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "EA-230 Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "EB 101",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "EB05 Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "ECG Amplifiers",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "ECG Electrode Applicator",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "ECG Monitoring Equipment",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "ECG Telemetry Device",
    "therapeutic_area": "Cardiovascular Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "EGFR Inhibitors-Induced Skin Disorders",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2030-2034",
    "total_reports": 4
  },
  {
    "indication_name": "EGFR Market Size, Target Population, Competitive Landscape & Market Forecast",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 2
  },
  {
    "indication_name": "EGFR Non-Small Cell Lung Cancer (EGFR + NSCLC)",
    "therapeutic_area": "Oncology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "ELIXCYTE Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "ELUFORSEN",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "ELX-02",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "EMGALITY Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "EMPAVELI Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "EMPAVELI/ASPAVELI Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "ENBREL Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 2
  },
  {
    "indication_name": "ENSIFENTRINE",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "ENT Devices",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "ENT Handheld Instruments",
    "therapeutic_area": "Otolaryngology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "ENTYVIO (Vedolizumab) Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "EO 2401 Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "EO2401-1 Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "EPI-589 Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "EPICEL Market Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "EPIDIOLEX Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "EPX-100 Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "ER+/ HER2 -ve Breast Cancer",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 2
  },
  {
    "indication_name": "ER+/HER2\u2212 Breast Cancer",
    "therapeutic_area": "Oncology",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "ERBB 2 Receptor Antagonists",
    "therapeutic_area": "Oncology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "ERBB 2 Receptor Antagonists Market Size, Target Population, Competitive Landscape & Market Forecast",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 2
  },
  {
    "indication_name": "ESR1 Mutated Metastatic Breast Cancer",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 5
  },
  {
    "indication_name": "EUCRISA Market Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "EVOMELA",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "EXSERVAN Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "EYLEA Market Market Size",
    "therapeutic_area": "Other Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "EYS606 Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Ear Tube Placement Devices",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Ear Tubes",
    "therapeutic_area": "Otolaryngology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Early Cardiogenic Shock (CS)",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Early Cardiogenic Shock Devices",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Early Stage Hormone Receptor Positive",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2032-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Early Stage Hormone Receptor Positive & HER2Positive Breast Cancer (LATAM)",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Ebola Fever",
    "therapeutic_area": "Infectious Diseases",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Ebola Virus- Competitive Landscape",
    "therapeutic_area": "Infectious Diseases",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Ebstein\u2019s Anomaly",
    "therapeutic_area": "Cardiovascular Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Echocardiography Devices",
    "therapeutic_area": "Cardiovascular Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Ecopipam",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Eczema",
    "therapeutic_area": "Dermatology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Edasalonexent",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Edward's syndrome",
    "therapeutic_area": "Genetic Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Efgartigimod Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Efient - API Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Efruxifermin Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 2
  },
  {
    "indication_name": "Eftilagimod alpha (IMP321) Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2035,
    "year_range": "2035",
    "total_reports": 1
  },
  {
    "indication_name": "Efzofitimod Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Eg5 Inhibitor",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Egg Allergy",
    "therapeutic_area": "Endocrinology and Metabolic Disorders",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Ehlers-Danlos Syndrome",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Eisenmenger Complex",
    "therapeutic_area": "Genetic Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Elacestrant Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Elafibranor Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Elamipretide",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Elastase Inhibitor",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Elastomeric Pump",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Electrical Stimulation Devices",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Electroencephalography Devices",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Electroencephelographs (EEG) Pipeline Insight and Competitive Landscape",
    "therapeutic_area": "Cardiovascular Diseases",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2023,
    "year_range": "2023",
    "total_reports": 1
  },
  {
    "indication_name": "Electronic Health Record (EHR)",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Electrophoresis",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Electrophysiology Catheters",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Electrophysiology Devices",
    "therapeutic_area": "Cardiovascular Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Electrosurgical Devices - Global",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Electrotherapy Devices",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Elinzanetant Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Elotuzumab Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Embolic Protection Devices",
    "therapeutic_area": "Cardiovascular Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Embolotherapy",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Emergency Department Information System",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Emesis (Vomiting)",
    "therapeutic_area": "Other Diseases",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Empagliflozin Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Emphysema",
    "therapeutic_area": "Respiratory Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Encephalitis",
    "therapeutic_area": "Neurology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Encephalomyelitis",
    "therapeutic_area": "Neurology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Encephalopathy",
    "therapeutic_area": "Central Nervous System",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "End-Stage Coronary Artery Disease",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "End-Stage Kidney Disease",
    "therapeutic_area": "Respiratory Diseases",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "End-Stage Renal Disease (ESRD)",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2032-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Endocarditis",
    "therapeutic_area": "Cardiovascular Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Endodontic Devices",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Endogenous Cushing's Syndrome",
    "therapeutic_area": "Endocrinology and Metabolic Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Endometrial Ablation Devices",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Endometrial Cancer",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Endometrial Hyperplasia",
    "therapeutic_area": "Womens Health",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Endometriosis",
    "therapeutic_area": "Womens Health",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 4
  },
  {
    "indication_name": "Endometriosis - Global API Manufacturers, Marketed and Phase III Drugs Landscape",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Endometriosis Pain",
    "therapeutic_area": "Endocrinology and Metabolic Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2025-2032",
    "total_reports": 2
  },
  {
    "indication_name": "Endometriosis Patient Pool Analysis",
    "therapeutic_area": "Womens Health",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Endoscopes",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Endoscopic Ultrasound",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Endoscopy Cameras",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Endoscopy Fluid Management Systems",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Endothelial PAS Domain-Containing Protein 1 Inhibitors",
    "therapeutic_area": "Oncology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Endothelin Receptor A (ETA) Antagonist",
    "therapeutic_area": "Cardiovascular Diseases",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 2
  },
  {
    "indication_name": "Endotracheal Tube",
    "therapeutic_area": "Cardiovascular Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Endovascular Aneurysm Repair Devices",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Energy Drinks",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Energy-based Aesthetic Devices (EAD) - Global",
    "therapeutic_area": "Other Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Enhancer of zeste homolog 2 (EZH2) Inhibitor",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Enobosarm Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Enoyl-ACP Reductase Inhibitors",
    "therapeutic_area": "Infectious Diseases",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Entecavir",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Entecavir Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Enteral Feed Devices\u2013Pipeline Insight and Competitive Landscape",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2023,
    "year_range": "2023",
    "total_reports": 1
  },
  {
    "indication_name": "Enteral Feeding Devices",
    "therapeutic_area": "Otolaryngology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Enteral Feeding Formula",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Enteral Stents",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Entresto - API Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Enzyme Contract Manufacturing",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2028,
    "year_range": "2028",
    "total_reports": 1
  },
  {
    "indication_name": "Enzyme Inhibitors",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Enzyme Linked Immunosorbent Assay (ELISA)",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Eosinophilia",
    "therapeutic_area": "Hematological Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Eosinophilic Asthma",
    "therapeutic_area": "Respiratory Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Eosinophilic Disorder",
    "therapeutic_area": "Hematological Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Eosinophilic Esophagitis",
    "therapeutic_area": "Gastroenterology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 4
  },
  {
    "indication_name": "Eosinophilic Esophagitis (EoE) \u2013 Epidemiology Forecast",
    "therapeutic_area": "Gastroenterology",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Eosinophilic Gastroenteritis (EGE)",
    "therapeutic_area": "Gastroenterology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2030-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Eosinophilic Gastroenteritis (EGE) \u2013 Epidemiology Forecast",
    "therapeutic_area": "Gastroenterology",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Eosinophilic Granulomatosis with Polyangiitis",
    "therapeutic_area": "Immunological and Autoimmune Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Eotaxin-1 Inhibitor Market Size, Target Population, Competitive Landscape & Market Forecast",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Epclusa",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Epeleuton Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Ependymoma",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Ephrin (EPH) Receptor Antagonist",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Ephrin Type A Receptor 2 (EPH Receptor A2 or EPHA2) Antagonist",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Epidemic Parotitis",
    "therapeutic_area": "Infectious Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2032-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Epidemic keratoconjunctivitis ",
    "therapeutic_area": "Infectious Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Epidemic keratoconjunctivitis (EKC)\u2014Epidemiology Forecast",
    "therapeutic_area": "Infectious Diseases",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Epidermal Growth Factor Receptor Antagonists",
    "therapeutic_area": "Oncology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Epidermal Growth Factor Receptor Metastatic Non-small Cell Lung Cancer ",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Epidermal Growth Factor Receptor Non-small Cell Lung Cancer (EGFR-NSCLC)\u2013 Epidemiology Forecast",
    "therapeutic_area": "Oncology",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Epidermal Growth Factor Receptor-Non Small Cell Lung Cancer (EGFR-NSCLC)",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Epidermolysis Bullosa (EB)",
    "therapeutic_area": "Dermatology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2028-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Epidermolysis Bullosa Patient Pool Analysis",
    "therapeutic_area": "Dermatology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Epidiolex (cannabidiol)",
    "therapeutic_area": "Other Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Epigenetics",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Epilepsy",
    "therapeutic_area": "Neurology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2027-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Epilepsy Epidemiology Forecast",
    "therapeutic_area": "Neurology",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Epilepsy Patient Pool Analysis",
    "therapeutic_area": "Neurology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Epilepsy Pipeline Insight",
    "therapeutic_area": "Neurology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Epilepsy\u2013 Competitive Landscape, Market and Pipeline Analysis",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2020,
    "year_range": "2020",
    "total_reports": 1
  },
  {
    "indication_name": "Epithelial Ovarian Cancer",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Epithelial Ovarian Cancer - Global API Manufacturers, Marketed and Phase III Drugs Landscape",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Epithelial Sodium Channel (ENaC) Inhibitor",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Epithelioid Sarcoma",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2032-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Epoetin alfa\u2013 Biosimilar Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2024,
    "year_range": "2024",
    "total_reports": 1
  },
  {
    "indication_name": "Epstein Barr virus (EBV)",
    "therapeutic_area": "Infectious Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease",
    "therapeutic_area": "Infectious Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2025-2032",
    "total_reports": 2
  },
  {
    "indication_name": "Epzicom - API Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Equine Encephalitis",
    "therapeutic_area": "Infectious Diseases",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Erdheim-Chester Disease (ECD)",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Erectile Dysfunction",
    "therapeutic_area": "Male Health",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Erectile Dysfunction - Global API Manufacturers, Marketed and Phase III Drugs Landscape",
    "therapeutic_area": "Male Health",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Erectile Dysfunction Devices",
    "therapeutic_area": "Male Health",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Erectile Dysfunction or Female Sexual Dysfunction",
    "therapeutic_area": "Male Health",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Erleada",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Erosive Esophagitis (EE)",
    "therapeutic_area": "Rare Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Erosive Hand Osteoarthritis",
    "therapeutic_area": "Musculoskeletal",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Erythema",
    "therapeutic_area": "Dermatology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Erythromelalgia Pain",
    "therapeutic_area": "Cardiovascular Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Erythropoietic Protoporphyria\\n",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Esbriet (pirfenidone)",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Esbriet - API Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "EscharEx Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Esketamine DPI Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Esophageal Achalasia",
    "therapeutic_area": "Gastroenterology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2032-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Esophageal Cancer",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Esophageal Cancer Patient Pool Analysis",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Esophageal Squamous Carcinoma",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Esophageal Squamous Cell Carcinoma",
    "therapeutic_area": "Oncology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Essential Thrombocythemia (ET)",
    "therapeutic_area": "Hematological Disorders",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Essential Tremor",
    "therapeutic_area": "Neurology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Estetrol Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Estrogen Receptor Beta Partial Agonist",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Etanercept Biosimilar Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Etrasimod Market Size",
    "therapeutic_area": "Dermatology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 3
  },
  {
    "indication_name": "Europe Peripheral Vascular Interventions\\n",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Eviplera - API Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Evobrutinib (M2951)",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Ewing Sarcoma",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Exanthema",
    "therapeutic_area": "Dermatology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2032-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Excessive Daytime Sleepiness (EDS)",
    "therapeutic_area": "Neurology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 2
  },
  {
    "indication_name": "Exjade - API Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "ExoFlo Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Exocrine Pancreatic Insufficiency (EPI)",
    "therapeutic_area": "Gastroenterology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 5
  },
  {
    "indication_name": "Exophthalmos",
    "therapeutic_area": "Ophthalmology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Exosome",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Exosome Diagnostics",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Exosome Therapies Market, Target Population, Competitive Landscape, and Market Forecast",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Exosomes",
    "therapeutic_area": "Infectious Diseases",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Exosomes Pipeline Insight",
    "therapeutic_area": "Infectious Diseases",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Exparel Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Extensive-Stage Small Cell Lung Cancer (ESCLC)",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Extensive-Stage Small Cell Lung Cancer (ESCLC) Pipeline Insight",
    "therapeutic_area": "Oncology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "External Defibrillators",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "External Fixation System/External Fixator Devices",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "External Urinary Catheters",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Extracorporeal Circulation System",
    "therapeutic_area": "Hematological Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Extracorporeal Membrane Oxygenation (ECMO) Devices",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Extracorporeal Shock Wave Therapy Devices",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Eye Health Supplements",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Eye Infections",
    "therapeutic_area": "Infectious Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Eye Neoplasms",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 4
  },
  {
    "indication_name": "Eyewear",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "F-351 Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "FABHALTA Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "FABRAZYME",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "FARICIMAB",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "FARXIGA Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 3
  },
  {
    "indication_name": "FASENRA (Benralizumab) Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "FB825 Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "FCX-007",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "FDY-5301 Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "FENEBRUTINIB",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "FGFR inhibitors \u2013 Market Size, Target Population, Competitive Landscape, and Market Forecast",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2040,
    "year_range": "2034-2040",
    "total_reports": 5
  },
  {
    "indication_name": "FGFR positive Gastroesophageal Cancer",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "FIASP Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "FILSPARI Market Size",
    "therapeutic_area": "Genito Urinary System and Sex Hormones",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "FINTEPLA Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "FLT190",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "FLU-v Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "FLUAD QUADRIVALENT Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "FLUARIX QUADRIVALENT Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "FLUBLOK QUADRIVALENT Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "FLUCELVAX QUADRIVALENT Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "FLUMIST QUADRIVALENT Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "FLUZONE QUADRIVALENT Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "FOLOTYN Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "FOSMANOGEPIX",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "FS118 Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2035,
    "year_range": "2035",
    "total_reports": 1
  },
  {
    "indication_name": "FT218 (Sodium oxybate)",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "FTase Inhibitors Market Size, Target Population, Competitive Landscape & Market Forecast",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 3
  },
  {
    "indication_name": "FYARRO Market Size",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Fabry Disease",
    "therapeutic_area": "Genetic Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2028-2034",
    "total_reports": 4
  },
  {
    "indication_name": "Fabry Disease - Global API Manufacturers, Marketed and Phase III Drugs Landscape",
    "therapeutic_area": "Genetic Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Fabry Disease Epidemiology Forecast",
    "therapeutic_area": "Genetic Disorders",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Fabry Disease Pipeline Insight",
    "therapeutic_area": "Genetic Disorders",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Facial Implants",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Facial Lines",
    "therapeutic_area": "Dermatology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2032-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Facioscapulohumeral Muscular Dystrophy",
    "therapeutic_area": "Rare Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Facioscapulohumeral Muscular Dystrophy Epidemiology Forecast",
    "therapeutic_area": "Genetic Disorders",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Factor D Inhibitor Market Size, Target Population, Competitive Landscape & Market Forecast",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Factor II (Prothrombin) Inhibitor",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Factor IIa (Thrombin) Inhibitor",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Factor IX",
    "therapeutic_area": "Hematological Disorders",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Factor IX A Inhibitor",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Factor VIIa Inhibitor",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 2
  },
  {
    "indication_name": "Factor X Inhibitors Therapies \u2013 Competitive Landscape And Market Forecast",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Factor XI Inhibitors",
    "therapeutic_area": "Hematological Disorders",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Factor Xa Inhibitors Market Size, Target Population, Competitive Landscape & Market Forecast",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 2
  },
  {
    "indication_name": "Failed Back Surgery Syndrome",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2032-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Fallopian Tube Cancer",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Familial Adenomatous Polyposis",
    "therapeutic_area": "Genetic Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 5
  },
  {
    "indication_name": "Familial Adenomatous Polyposis Coli",
    "therapeutic_area": "Gastroenterology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Familial Amyloid Polyneuropathy (Transthyretin Amyloidosis, Corino de Andrade's Disease)",
    "therapeutic_area": "Endocrinology and Metabolic Disorders",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Familial Amyloid Polyneuropathy - Global API Manufacturers, Marketed and Phase III Drugs Landscape",
    "therapeutic_area": "Endocrinology and Metabolic Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Familial Chylomicronemia (Type I Hyperlipoproteinemia)",
    "therapeutic_area": "Endocrinology and Metabolic Disorders",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Familial Chylomicronemia Syndrome (FCS)",
    "therapeutic_area": "Cardiovascular Diseases",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Familial Hypercholesterolemia (Type II Hyperlipoproteinemia)",
    "therapeutic_area": "Endocrinology and Metabolic Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2032-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Familial Lipoprotein Lipase Deficiency",
    "therapeutic_area": "Endocrinology and Metabolic Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 2
  },
  {
    "indication_name": "Familial Lipoprotein Lipase Deficiency Pipeline Insight",
    "therapeutic_area": "Rare Diseases",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Familial Mediterranean Fever (FMF)",
    "therapeutic_area": "Rare Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Familial Primary Pulmonary Hypertension",
    "therapeutic_area": "Genetic Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 2
  },
  {
    "indication_name": "Fampyra - API Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Fanconi Anemia (FA)",
    "therapeutic_area": "Genetic Disorders",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Farber's Disease",
    "therapeutic_area": "Endocrinology and Metabolic Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Farnesoid X Receptor (FXR) Agonist",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Fatigue",
    "therapeutic_area": "Endocrinology and Metabolic Disorders",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Fatty Acid Amide Hydrolase (FAAH) Inhibitor",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Fatty Acid Oxidation Disorders (FAODs)",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Fatty Acid Synthase (FAS) Inhibitor",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Fatty Pancreas",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Favezelimab (MK-4280) Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2035,
    "year_range": "2035",
    "total_reports": 1
  },
  {
    "indication_name": "Fc-Gamma Receptor Antagonist",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Febrile Neutropenia",
    "therapeutic_area": "Hematological Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Febrile Neutropenia - Global API Manufacturers, Marketed and Phase III Drugs Landscape",
    "therapeutic_area": "Hematological Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Fecal Incontinence",
    "therapeutic_area": "Gastroenterology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 4
  },
  {
    "indication_name": "Feed Additives",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Feed Testing",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "FemTech",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Female Infertility",
    "therapeutic_area": "Womens Health",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Female Trichomoniasis Vaginalis",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Fertility Monitoring Devices",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Fertility Supplement",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2028,
    "year_range": "2028",
    "total_reports": 1
  },
  {
    "indication_name": "Fetal & Neonatal Care Equipment",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Fetal Monitoring Devices",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Fetal and Neonatal Monitoring Devices",
    "therapeutic_area": "Other Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Fezolinetant Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Fianlimab (REGN3767) Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2035,
    "year_range": "2035",
    "total_reports": 1
  },
  {
    "indication_name": "Fiberscopes",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Fibrinogen Concentrate",
    "therapeutic_area": "Other Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Fibroblast Activation Protein (FAP or Seprase) Inhibitor",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Fibroblast Growth Factor 1 (FGF-1) Inhibitor",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 2
  },
  {
    "indication_name": "Fibroblast Growth Factor 2 (FGFR2)",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Fibroblast Growth Factor Receptor 4 (FGFR4) Inhibitors",
    "therapeutic_area": "Oncology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 2
  },
  {
    "indication_name": "Fibrocystic Breast Condition",
    "therapeutic_area": "Non-Malignant Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2032-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Fibrodysplasia Ossificans Progressiva (FOP)",
    "therapeutic_area": "Musculoskeletal",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 4
  },
  {
    "indication_name": "Fibromyalgia",
    "therapeutic_area": "Central Nervous System",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Filariasis",
    "therapeutic_area": "Infectious Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Filgotinib",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Filgrastim Biosimilar Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2024,
    "year_range": "2024",
    "total_reports": 1
  },
  {
    "indication_name": "Fill Finish Manufacturing",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Fipaxalparant Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Firdapse (amifampridine)",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Flow Cytometry",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Flow Diverters",
    "therapeutic_area": "Neurology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Fluid Management Systems",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Fluoroscopy Equipment",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Focal Adhesion Kinase (FAK) Inhibitor",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Focal Adhesion Kinase (FAK) Inhibitor Market Size, Target Population, Competitive Landscape, and Market Forecast",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Focal Epilepsy",
    "therapeutic_area": "Neurology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Focal Segmental Glomerulosclerosis (FSGS)",
    "therapeutic_area": "Rare Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2028-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Focal segmental glomerulosclerosis (FSGS) Patient Pool Analysis",
    "therapeutic_area": "Endocrinology and Metabolic Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Foley Catheters",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Follicular Lymphoma",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 5
  },
  {
    "indication_name": "Follitropin alfa\u2013 Biosimilar Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2024,
    "year_range": "2024",
    "total_reports": 1
  },
  {
    "indication_name": "Food Allergy ",
    "therapeutic_area": "Other Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 6
  },
  {
    "indication_name": "Food Allergy \u2013 Epidemiology Forecast",
    "therapeutic_area": "Other Diseases",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Food Hypersensitivity",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Food Processing Equipment",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Foot Drop Treatment Devices",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Foot and Ankle Devices",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Forteo - API Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Fosamax - API Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Fragile X Syndrome (FXS)",
    "therapeutic_area": "Genetic Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 2
  },
  {
    "indication_name": "France Healthcare Outlook Report",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Friedreich's Ataxia",
    "therapeutic_area": "Rare Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Frontotemporal Dementia (FTD)",
    "therapeutic_area": "Central Nervous System",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Frontotemporal Dementia Patient Pool Analysis",
    "therapeutic_area": "Neurology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Frozen Food",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2028,
    "year_range": "2028",
    "total_reports": 1
  },
  {
    "indication_name": "Fruquintinib Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Fuchs Dystrophy",
    "therapeutic_area": "Ophthalmology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Fuchs Endothelial Corneal Dystrophy (FECD) ",
    "therapeutic_area": "Ophthalmology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2030-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Fuchs Endothelial Corneal Dystrophy (FECD) \u2013 Epidemiology Forecast",
    "therapeutic_area": "Ophthalmology",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Fucosidosis",
    "therapeutic_area": "Endocrinology and Metabolic Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Fumarate De Formoterol - API Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Functional Constipation",
    "therapeutic_area": "Gastroenterology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Functional Dyspepsia",
    "therapeutic_area": "Gastroenterology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 5
  },
  {
    "indication_name": "Fungal Pneumonia",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Fusilev - API Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Fusion Inhibitor",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "G Protein-Coupled Receptor (GPCR)",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "G-Protein Coupled Receptor (GPCR) Agonist",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "G2 Checkpoint Inhibitor",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "G207 Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "GABA Receptor Agonist",
    "therapeutic_area": "Neurology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "GABA Receptor Antagonist",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "GABA Receptor Modulators",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "GABA Transaminase Inhibitor",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "GABAA Agonist",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "GABAA Modulators",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "GABAB Agonist",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "GABLOFEN Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "GALAFOLD",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "GARETOSMAB (REGN2477)",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "GB-102",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "GB002 Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "GDC-0084 Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "GIVINOSTAT Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "GL-ONC1 Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "GLASSIA Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "GLIOVAC Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "GM-CSF Inhibitor",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "GM1 Gangliosidosis",
    "therapeutic_area": "Central Nervous System",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "GM2 (TaySachs, Sandhoff)",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "GM2 Gangliosidosis",
    "therapeutic_area": "Genetic Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 2
  },
  {
    "indication_name": "GNE Myopathy",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "GPCR Inhibitors Market Size, Target Population, Competitive Landscape, and Market",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "GPCR-Targeting Therapies",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "GPRC5D-directed Therapies Market Size, Target Population, Competitive Landscape, and Market Forecast",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "GSK 3 Inhibitor Market Target Population, Competitive Landscape, and Market",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2040,
    "year_range": "2040",
    "total_reports": 1
  },
  {
    "indication_name": "GSK2140944 (Gepotidacin) Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "GSK3228836",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "GSK3511294 Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "GSK3528869A \u00b1 Bepirovirsen Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "GSK3844766A Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "GT005",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "GVAX Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Galactosemia",
    "therapeutic_area": "Genetic Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Galantamine Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Galectin Inhibitor",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Gallbladder Cancer",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Gallbladder Neoplasms",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Gamma Secretase Inhibitor",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Gamma Secretase Inhibitors (GSIs) \u2013 Target Population, Competitive Landscape, and Market Forecast",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Gamma-aminobutyric Acid (GABA) Inhibitor Market Size, Target Population, Competitive Landscape & Market Forecast",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Ganaxolone",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Gasmotin - API Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Gaster D - API Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Gastric Cancer",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Gastric Cancer Diagnostics",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Gastric Neuroendocrine Tumors",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Gastric Ulcers",
    "therapeutic_area": "Gastroenterology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Gastric Ulcers - Global API Manufacturers, Marketed and Phase III Drugs Landscape",
    "therapeutic_area": "Gastroenterology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 2
  },
  {
    "indication_name": "Gastritis",
    "therapeutic_area": "Gastroenterology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Gastritis - Global API Manufacturers, Marketed and Phase III Drugs Landscape",
    "therapeutic_area": "Gastroenterology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 2
  },
  {
    "indication_name": "Gastro Intestinal Bleeding",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Gastro-Esophageal Junction Neuroendocrine Tumor (GEJ-NET)",
    "therapeutic_area": "Gastroenterology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2028-2032",
    "total_reports": 2
  },
  {
    "indication_name": "Gastroendoscopes",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs)",
    "therapeutic_area": "Oncology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Gastroesophageal Adenocarcinoma",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 2
  },
  {
    "indication_name": "Gastroesophageal Junction Adenocarcinoma",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Gastroesophageal Reflux Disease (GERD)",
    "therapeutic_area": "Gastroenterology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Gastroesophageal Reflux Disease (GERD) Devices",
    "therapeutic_area": "Gastroenterology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Gastrointestinal Anastomosis",
    "therapeutic_area": "Gastroenterology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Gastrointestinal Cancer",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Gastrointestinal Endoscopic Stricture Management Devices",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Gastrointestinal Neuroendocrine Tumors",
    "therapeutic_area": "Gastroenterology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Gastrointestinal Stromal Tumor (GIST)",
    "therapeutic_area": "Gastroenterology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Gastrointestinal Stromal Tumor (GIST) - Global API Manufacturers, Marketed and Phase III Drugs Landscape",
    "therapeutic_area": "Gastroenterology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Gastroparesis",
    "therapeutic_area": "Gastroenterology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 4
  },
  {
    "indication_name": "Gastroparesis - Global API Manufacturers, Marketed and Phase III Drugs Landscape",
    "therapeutic_area": "Gastroenterology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Gastrostomy Devices",
    "therapeutic_area": "Gastroenterology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Gaucher disease Type 1",
    "therapeutic_area": "Genetic Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Gaucher's Disease",
    "therapeutic_area": "Endocrinology and Metabolic Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Gaucher's Disease Type III",
    "therapeutic_area": "Genetic Disorders",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 2
  },
  {
    "indication_name": "Gazyva Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Gemcabene",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Gemzar - API Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Gender Dysphoria",
    "therapeutic_area": "Rare Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Gene And Cell Therapies Targeting CNS Disorders Pipeline Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Gene Therapies For Cardiomyopathies",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Gene Therapies In Ophthalmology- Competitive landscape",
    "therapeutic_area": "Ophthalmology",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Gene Therapies for Cardiomyopathies Epidemiology Forecast",
    "therapeutic_area": "Cardiovascular Diseases",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Gene Therapy",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Gene Therapy - Competitive Landscape",
    "therapeutic_area": "Oncology",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Gene Therapy For Ocular Rare Disease Pipeline Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Gene Therapy for Ocular Rare Disease ",
    "therapeutic_area": "Ophthalmology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2030-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Gene Therapy in CNS Disorder",
    "therapeutic_area": "Central Nervous System",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Gene Therapy in Oncology: Innovation to Commercialization, Competitive Landscape, Technological Advancements, Market Opportunities & Future Directions",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": "",
    "year_range": "",
    "total_reports": 1
  },
  {
    "indication_name": "Gene Therapy in Ophthalmology",
    "therapeutic_area": "Ophthalmology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Gene and Cell Therapies Targeting CNS Disorders ",
    "therapeutic_area": "Central Nervous System",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2026-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Gene and Cell Therapies in Rare Disorder",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Gene and Cell Therapies targeting CNS disorders Epidemiology Forecast",
    "therapeutic_area": "Oncology",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Gene therapy in rare diseases",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "General Anxiety Disorder (GAD)",
    "therapeutic_area": "Neurology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 2
  },
  {
    "indication_name": "General Surgery Devices",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Generalized Anxiety Disorder",
    "therapeutic_area": "Neurology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 2
  },
  {
    "indication_name": "Generalized Anxiety Disorder Pipeline Insight",
    "therapeutic_area": "Neurology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Generalized Myasthenia Gravis (gMG)",
    "therapeutic_area": "Immunological and Autoimmune Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Generalized Pustular Psoriasis (GPP)",
    "therapeutic_area": "Dermatology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2028,
    "year_range": "2028",
    "total_reports": 1
  },
  {
    "indication_name": "Generalized Pustular Psoriasis Epidemiology Forecast",
    "therapeutic_area": "Dermatology",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Generalized anxiety disorder Patient Pool Analysis",
    "therapeutic_area": "Neurology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Genetic Testing",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Geninax - API Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Genital Herpes",
    "therapeutic_area": "Infectious Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2027-2034",
    "total_reports": 6
  },
  {
    "indication_name": "Genital Herpes Pipeline Insight",
    "therapeutic_area": "Infectious Diseases",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Genital Warts (Condyloma Acuminatum)",
    "therapeutic_area": "Infectious Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 3
  },
  {
    "indication_name": "Genital Warts Pipeline Insight",
    "therapeutic_area": "Womens Health",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Genome Editing",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Genomics",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2027,
    "year_range": "2027",
    "total_reports": 1
  },
  {
    "indication_name": "Genotyping",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Genvoya - API Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Geographic Atrophy (GA)",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Geographic Atrophy (GA) Pipeline Insight",
    "therapeutic_area": "Ophthalmology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Geriatric Medicine",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Germ Cell Tumor",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Germ Cell Tumors\u2013 Epidemiology Forecast",
    "therapeutic_area": "Oncology",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Germany Healthcare Outlook Report",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Gestational Diabetes",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Ghrelin Receptor Agonist",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Giant Axonal Neuropathy (GAN)",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Giant Cell Arteritis Epidemiology Forecast",
    "therapeutic_area": "Cardiovascular Diseases",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Giant Papillary Conjunctivitis",
    "therapeutic_area": "Ophthalmology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2032-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Giant cell arteritis (GCA)",
    "therapeutic_area": "Immunological and Autoimmune Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2028,
    "year_range": "2028",
    "total_reports": 1
  },
  {
    "indication_name": "Giant-Cell Arteritis",
    "therapeutic_area": "Cardiovascular Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 5
  },
  {
    "indication_name": "Gigantism",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Gilles de la Tourette's Syndrome",
    "therapeutic_area": "Genetic Disorders",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Gilvec - API Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Gingival Recession",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Gingivitis",
    "therapeutic_area": "Dental and Oral Health",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2025-2032",
    "total_reports": 2
  },
  {
    "indication_name": "Giredestrant Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Givinostat",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Glabellar Frown Lines",
    "therapeutic_area": "Otolaryngology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Glabellar Lines",
    "therapeutic_area": "Dermatology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Glaucoma",
    "therapeutic_area": "Ophthalmology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 5
  },
  {
    "indication_name": "Glaucoma - Competitive Landscape",
    "therapeutic_area": "Ophthalmology",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Glaucoma Drainage Devices",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Glaucoma Patient Pool Analysis",
    "therapeutic_area": "Ophthalmology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Glioblastoma",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 4
  },
  {
    "indication_name": "Glioblastoma Multiforme (GBM)",
    "therapeutic_area": "Neurology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Glioma",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 4
  },
  {
    "indication_name": "Glioma - Competitive Landscape",
    "therapeutic_area": "Oncology",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Gliosarcoma",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Global Kinase Inhibitor in Autoimmune Diseases",
    "therapeutic_area": "Immunological and Autoimmune Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2030-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Global Medical Aesthetic Devices",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Global Messenger RNA",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2032-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Global Messenger RNA (mRNA)-based Vaccines and Therapeutics",
    "therapeutic_area": "Other Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Global Orthopedic Devices",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Global Viscosupplementation Devices",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Glomerulonephritis",
    "therapeutic_area": "Genito Urinary System and Sex Hormones",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Glucagon Receptor Antagonist",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Glucagon-Like Peptide (GLP) Agonist",
    "therapeutic_area": "Endocrinology and Metabolic Disorders",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Glucagon-like Peptide-1 (GLP-1) Agonists Market Size, Target Population, Competitive Landscape & Market Forecast",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Glucocorticoid Induced Tumor Necrosis Factor Pipeline Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Glucocorticoid Receptor Antagonist",
    "therapeutic_area": "Endocrinology and Metabolic Disorders",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Glucokinase Activators",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Glucose Syrup",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Glucose-dependent Insulinotropic Polypeptide (GIP) Agonist Market Size, Target Population, Competitive Landscape & Market Forecast",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Glucosylceramide Synthase Inhibitor Pipeline Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Glutamate Receptor Antagonist",
    "therapeutic_area": "Neurology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Gluten Sensitivity",
    "therapeutic_area": "Gastroenterology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2032-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Glycan Inhibitor",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Glycine Transporter Type-1 (Glyt-1) Inhibitor",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Glycogen Storage Disease",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Glycogen Synthase Kinase 3 (GSK-3) Inhibitor",
    "therapeutic_area": "Genetic Disorders",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Glycomics",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Goitre",
    "therapeutic_area": "Endocrinology and Metabolic Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2032-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Golidocitinib Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Gonadotropin-Releasing Hormone (GnRH) Receptor (LHRH Receptor) Antagonist",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Gonorrhea",
    "therapeutic_area": "Infectious Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 2
  },
  {
    "indication_name": "Gonorrhoea Pipeline Insight",
    "therapeutic_area": "Infectious Diseases",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Gorlin Syndrome",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Gout",
    "therapeutic_area": "Genito Urinary System and Sex Hormones",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2025-2032",
    "total_reports": 2
  },
  {
    "indication_name": "Gouty Arthritis (Gout)",
    "therapeutic_area": "Endocrinology and Metabolic Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2032-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Graceptor - API Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Graft Preparation System",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Graft Versus Host Disease (GvHD)",
    "therapeutic_area": "Immunological and Autoimmune Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2030-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Graft Vs Host Diseases Patient Pool Analysis",
    "therapeutic_area": "Immunological and Autoimmune Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Graft versus host disease Pipeline Insight",
    "therapeutic_area": "Immunological and Autoimmune Disorders",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Granulomatosis With Polyangiitis ",
    "therapeutic_area": "Ophthalmology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 5
  },
  {
    "indication_name": "Graves Ophthalmopathy Patient Pool Analysis",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Graves Orbitopathy",
    "therapeutic_area": "Ophthalmology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 2
  },
  {
    "indication_name": "Graves' Disease",
    "therapeutic_area": "Endocrinology and Metabolic Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2028-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Graves' Ophthalmopathy",
    "therapeutic_area": "Ophthalmology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Graves' Orbitopathy\\n",
    "therapeutic_area": "Immunological and Autoimmune Disorders",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Graves\u2019 Disease",
    "therapeutic_area": "Immunological and Autoimmune Disorders",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Group B Streptococcus",
    "therapeutic_area": "Infectious Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2040,
    "year_range": "2040",
    "total_reports": 1
  },
  {
    "indication_name": "Group B Streptococcus (GBS) \u2013 Epidemiology Forecast",
    "therapeutic_area": "Infectious Diseases",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Growth Hormone (GH) Agonist",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Growth Hormone Antagonist Pipeline Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Growth Hormone Deficiency (GHD)",
    "therapeutic_area": "Endocrinology and Metabolic Disorders",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Guanylate Cyclase (Guanyl Cyclase or Guanylyl Cyclase or GC) Activators",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Guanylate Cyclase-Coupled Receptor Activators",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Guillain-Barre Syndrome (GBS)",
    "therapeutic_area": "Central Nervous System",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 2
  },
  {
    "indication_name": "Gummy Vitamins",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2028,
    "year_range": "2028",
    "total_reports": 1
  },
  {
    "indication_name": "Gyneco-Obstetric Ultrasound Systems",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Gynecological Devices",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "H 2 Antagonist",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "H 3 Antagonist",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "H 4 Antagonist",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "H Antagonist",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "H. Pylori Infection Patient Pool Analysis",
    "therapeutic_area": "Infectious Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "H1N1 (Swine Influenza)",
    "therapeutic_area": "Infectious Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2032-2034",
    "total_reports": 2
  },
  {
    "indication_name": "H1N1 infection",
    "therapeutic_area": "Infectious Diseases",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "H3N2 Infection",
    "therapeutic_area": "Infectious Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "HALNEURON Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "HAVCR2 Protein Inhibitors",
    "therapeutic_area": "Oncology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "HC 1119",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "HDAC inhibitors",
    "therapeutic_area": "Other Diseases",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "HER2 Lung Cancer",
    "therapeutic_area": "Oncology",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "HER2 Metastatic Non-small Cell Lung Cancer ",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "HER2 Negative Metastatic Breast Cancer",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "HER2 Positive Gastric Cancer",
    "therapeutic_area": "Oncology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "HER2+ Directed Therapies Market Size, Target Population, Competitive Landscape, and Market Forecast",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "HER2+ Gastric Cancer",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2030-2034",
    "total_reports": 6
  },
  {
    "indication_name": "HER2+ Gastric Cancer\u2014Epidemiology Forecast",
    "therapeutic_area": "Oncology",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "HER2+ Non Small Cell Lung Cancer",
    "therapeutic_area": "Other Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 2
  },
  {
    "indication_name": "HER2-Negative Breast Cancer",
    "therapeutic_area": "Other Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "HER2-Positive Breast Cancer",
    "therapeutic_area": "Other Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "HER2-Positive Early Breast Cancer",
    "therapeutic_area": "Other Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "HER2-low Cancers \u2013 Epidemiology Forecast",
    "therapeutic_area": "Oncology",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "HER2-low Cancers \u2013 Market Size, Target Population, Competitive Landscape, and Market Forecast",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "HER2-mutant Non-Small Cell Lung Cancer",
    "therapeutic_area": "Oncology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "HET Obesity/POMC Deficiency Obesity",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 2
  },
  {
    "indication_name": "HIF-1 Alpha Inhibitor",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "HIV (Human Immunodeficiency Virus)",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "HIV Associated Neurocognitive Disorders (HAND) ",
    "therapeutic_area": "Neurology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "HIV Associated Neurocognitive Disorders (HAND) \u2013 Epidemiology Forecast",
    "therapeutic_area": "Neurology",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "HIV Attachment Inhibitor",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "HIV-associated Lipodystrophy",
    "therapeutic_area": "Endocrinology and Metabolic Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "HIYASTA Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "HIZENTRA Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "HMBD-001 Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "HMI-102",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "HMR59",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "HMTM Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "HORA-PDE6B",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "HP-5000 Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 2
  },
  {
    "indication_name": "HPG1860 Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "HPK1 Inhibitor \u2013 Competitive Landscape And Market Forecast",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "HPK1 inhibitors",
    "therapeutic_area": "Oncology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "HPV Testing and Pap Test",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "HPV+ Recurrent/Metastatic Head and Neck Cancer",
    "therapeutic_area": "Oncology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "HPV-Induced Cancers",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "HPV-Positive Cancer",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "HPV-induced Cutaneous Tumors",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "HPV16+ Cancer Patient Pool Analysis",
    "therapeutic_area": "Endocrinology and Metabolic Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "HPV16-Positive Head and Neck Squamous Cell Carcinoma (HNSCC) ",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 2
  },
  {
    "indication_name": "HPV16-positive Anogenital Cancer",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "HR Positive/ HER2 Negative Breast Cancer",
    "therapeutic_area": "Oncology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "HR-Positive-HER-negative",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 2
  },
  {
    "indication_name": "HSG Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "HSV-1 Keratitis- Competitive landscape",
    "therapeutic_area": "Infectious Diseases",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "HTD1801 Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "HU6 Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "HUMIRA (Adalimumab) Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Haemochromatosis",
    "therapeutic_area": "Genetic Disorders",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 2
  },
  {
    "indication_name": "Haemodialysis Machines",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Hair Diseases",
    "therapeutic_area": "Dermatology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Hair Removal Devices",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Hairy Cell Leukemia (HCL)",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2028-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Hairy Cell Leukemia - Global API Manufacturers, Marketed and Phase III Drugs Landscape",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Hairy Cell Leukemia Pipeline Insight",
    "therapeutic_area": "Oncology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Hallux Valgus",
    "therapeutic_area": "Musculoskeletal",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Hand Eczema",
    "therapeutic_area": "Dermatology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Hand Eczema (HE)\u2014Epidemiology Forecast",
    "therapeutic_area": "Dermatology",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Hand Foot Syndrome",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Hand Foot Syndrome/Palmar-Plantar Erythrodysesthesia Syndrome",
    "therapeutic_area": "Dermatology",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Hand Sanitizer",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Harvoni",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Harvoni - API Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Hashimoto's Thyroiditis ",
    "therapeutic_area": "Immunological and Autoimmune Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 2
  },
  {
    "indication_name": "Hay Fever Conjunctivitis",
    "therapeutic_area": "Ophthalmology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Hay Fever Conjunctivitis Epidemiology Forecast",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Hay Fever Conjunctivitis Pipeline Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Head & Neck Carcinoma",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Head and Neck Squamous Cell Carcinoma",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Head and Neck Squamous Cell Carcinoma Epidemiology Forecast",
    "therapeutic_area": "Oncology",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Head and Neck cancer (HNC)",
    "therapeutic_area": "Oncology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Head and neck squamous cell carcinomas (HNSCCs) Patient Pool Analysis",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Healthcare Analytics",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Healthcare Asset Management",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Healthcare Cybersecurity",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Healthcare ERP",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Healthcare Healthcare Claims Management",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Healthcare IT",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Healthcare IT Consulting",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Healthcare Mobility Solutions",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Healthcare Payer Services",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Healthcare Regulatory Affairs Outsourcing",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Healthcare Supply Chain Management",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Healthcare Testing, Inspection, and Certification (TIC)",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Hearing Aid Adjustment System",
    "therapeutic_area": "Otolaryngology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Hearing Aid Devices",
    "therapeutic_area": "Otolaryngology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Hearing Implants",
    "therapeutic_area": "Otolaryngology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Hearing Loss",
    "therapeutic_area": "Otolaryngology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Hearing Screening Devices",
    "therapeutic_area": "Otolaryngology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Hearing Screening and Diagnostic Devices",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Heart Closure Devices",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Heart Failure",
    "therapeutic_area": "Cardiovascular Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2032-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Heart Failure Pipeline Insight",
    "therapeutic_area": "Cardiovascular Diseases",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Heart Failure with Preserved Ejection Fraction (HFpEF)",
    "therapeutic_area": "Cardiovascular Diseases",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Heart Pump Device",
    "therapeutic_area": "Cardiovascular Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Heart Sounds Sensors/Electronic Stethoscope",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Heart failure (HF) with Reduced Ejection Fraction (HFrEF)",
    "therapeutic_area": "Cardiovascular Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 4
  },
  {
    "indication_name": "Heat Shock Protein (Hsp) Inhibitor",
    "therapeutic_area": "Oncology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Heavy Menstrual Bleeding (HMB)",
    "therapeutic_area": "Womens Health",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Heavy Metal Poisoning",
    "therapeutic_area": "Other Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 2
  },
  {
    "indication_name": "Hedgehog Pathway Inhibitors",
    "therapeutic_area": "Oncology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Hedgehog Signaling Pathway Antagonist",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Helicobacter Pylori (H. pylori) Infection",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2032-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Helicobacter Pylori Infections",
    "therapeutic_area": "Infectious Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Helicobacter Pylori Infections - Global API Manufacturers, Marketed and Phase III Drugs Landscape",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Helicobacter Pylori Infections Epidemiology Forecast",
    "therapeutic_area": "Infectious Diseases",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Hematological Cancer (Blood Cancer) Therapeutics",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2027,
    "year_range": "2027",
    "total_reports": 1
  },
  {
    "indication_name": "Hematology",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Hematopoietic Progenitor Kinase 1 Inhibitors",
    "therapeutic_area": "Oncology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Hematopoietic Stem Cell Transplantation",
    "therapeutic_area": "Immunological and Autoimmune Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Hematopoietic Stem Cell Transplantation - Global API Manufacturers, Marketed and Phase III Drugs Landscape",
    "therapeutic_area": "Immunological and Autoimmune Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Hematopoietic Stem Cell Transplantation Epidemiology Forecast",
    "therapeutic_area": "Immunological and Autoimmune Disorders",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Hematopoietic Stem Cell Transplantation Pipeline Insight",
    "therapeutic_area": "Immunological and Autoimmune Disorders",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Hematuria",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Hemiplegia",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Hemlibra (emicizumab-kxwh)",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Hemoconcentrators",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Hemodialysis Catheter",
    "therapeutic_area": "Hematological Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Hemodialysis Catheters Pipeline Insight and Competitive Landscape",
    "therapeutic_area": "Hematological Disorders",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2023,
    "year_range": "2023",
    "total_reports": 1
  },
  {
    "indication_name": "Hemodynamic Flow Alteration Devices",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Hemodynamic Monitoring Systems",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Hemoglobinopathies",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Hemolytic Disease of the Fetus and Newborn",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Hemophagocytic Lymphohistiocytosis",
    "therapeutic_area": "Immunological and Autoimmune Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Hemophilia",
    "therapeutic_area": "Hematological Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2032-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Hemophilia A",
    "therapeutic_area": "Hematological Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 4
  },
  {
    "indication_name": "Hemophilia A Patient Pool Analysis",
    "therapeutic_area": "Hematological Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 2
  },
  {
    "indication_name": "Hemophilia B",
    "therapeutic_area": "Hematological Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 5
  },
  {
    "indication_name": "Hemophilia B - Global API Manufacturers, Marketed and Phase III Drugs Landscape",
    "therapeutic_area": "Hematological Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Hemophilia Pipeline Insight",
    "therapeutic_area": "Hematological Disorders",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Hemophilia with Inhibitor",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Hemorrhage Control System",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Hemorrhagic Cystitis",
    "therapeutic_area": "Genito Urinary System and Sex Hormones",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2032-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Hemorrhagic Fever",
    "therapeutic_area": "Infectious Diseases",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Hemorrhagic Shock",
    "therapeutic_area": "Hematological Disorders",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Hemorrhagic Stroke",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Hemorrhoids",
    "therapeutic_area": "Gastroenterology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 2
  },
  {
    "indication_name": "Hemorrhoids Pipeline Insight",
    "therapeutic_area": "Gastroenterology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Hemostasis",
    "therapeutic_area": "Hematological Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Hemostasis - Global API Manufacturers, Marketed and Phase III Drugs Landscape",
    "therapeutic_area": "Hematological Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Hemostasis and Tissue Sealing Agents",
    "therapeutic_area": "Hematological Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Hemostats",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Heparin",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Heparin-Induced Thrombocytopenia (HIT)",
    "therapeutic_area": "Hematological Disorders",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Hepatic - Colorectal Metastasis",
    "therapeutic_area": "Oncology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Hepatic Cirrhosis",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Hepatic Encephalopathy",
    "therapeutic_area": "Gastroenterology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2028-2034",
    "total_reports": 4
  },
  {
    "indication_name": "Hepatic Encephalopathy Epidemiology Forecast",
    "therapeutic_area": "Gastroenterology",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Hepatic Encephalopathy Pipeline Insight",
    "therapeutic_area": "Gastroenterology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Hepatic Impairment",
    "therapeutic_area": "Gastroenterology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 2
  },
  {
    "indication_name": "Hepatic Tumor",
    "therapeutic_area": "Oncology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Hepatitis A",
    "therapeutic_area": "Infectious Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Hepatitis B",
    "therapeutic_area": "Infectious Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Hepatitis B Virus (HBV) Infection",
    "therapeutic_area": "Infectious Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Hepatitis C",
    "therapeutic_area": "Infectious Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Hepatitis C Virus (HCV)",
    "therapeutic_area": "Infectious Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2032-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Hepatitis C Virus (HCV) Protease Inhibitor",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Hepatitis C Virus Infection",
    "therapeutic_area": "Infectious Diseases",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Hepatitis D",
    "therapeutic_area": "Infectious Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 4
  },
  {
    "indication_name": "Hepatitis D - Global API Manufacturers, Marketed and Phase III Drugs Landscape",
    "therapeutic_area": "Infectious Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Hepatocellular Carcinoma",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 4
  },
  {
    "indication_name": "Hepatorenal Syndrome (HRS)",
    "therapeutic_area": "Hematological Disorders",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 2
  },
  {
    "indication_name": "Hepcidin Antagonist",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Herbal Medicine - Global",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Hereditary ATTR (hATTR) amyloidosis",
    "therapeutic_area": "Genetic Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Hereditary Angioedema",
    "therapeutic_area": "Genetic Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 6
  },
  {
    "indication_name": "Hereditary Angioedema - Global API Manufacturers, Marketed and Phase III Drugs Landscape",
    "therapeutic_area": "Genetic Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Hereditary Deafness",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Hereditary Deafness Medical Device",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Hereditary Hemochromatosis (HH)",
    "therapeutic_area": "Endocrinology and Metabolic Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Hereditary Spastic Paraplegias",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Hereditary Transthyretin Amyloidosis (hATTR)",
    "therapeutic_area": "Genetic Disorders",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Hermansky Pudlak Syndrome",
    "therapeutic_area": "Endocrinology and Metabolic Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Hernia Repair Devices",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Herpes Genitalis",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Herpes Keratitis",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Herpes Labialis",
    "therapeutic_area": "Infectious Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Herpes Simplex",
    "therapeutic_area": "Infectious Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Herpes Zoster",
    "therapeutic_area": "Infectious Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Herpes Zoster Oticus",
    "therapeutic_area": "Infectious Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2032-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Herpetic Keratitis",
    "therapeutic_area": "Infectious Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Heterozygous Familial Hypercholesterolemia (HeFH)",
    "therapeutic_area": "Endocrinology and Metabolic Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Hiatal Hernia",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Hidradenitis",
    "therapeutic_area": "Dermatology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Hidradenitis Suppurativa",
    "therapeutic_area": "Dermatology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Hidradenitis Suppurativa Epidemiology Forecast",
    "therapeutic_area": "Dermatology",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Hidradenitis Suppurativa Pipeline Insight",
    "therapeutic_area": "Dermatology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Hidradenitis suppurativa Patient Pool Analysis",
    "therapeutic_area": "Dermatology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "High Content Screening",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "High Flow Oxygen Therapy Devices",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "High Grade Glioma",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "High Potency Active Pharmaceutical Ingredients (HPAPI)",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "High Risk HPV Infections",
    "therapeutic_area": "Infectious Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "High Tibial Osteotomy (HTO) Plates",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "High-Grade Glioma",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "High-Throughput Screening",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Higher-Risk Chronic Myelomonocytic Leukemia",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Hip Replacement Devices",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Histamine H1 Receptor Antagonists",
    "therapeutic_area": "Immunological and Autoimmune Disorders",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Histone Deacetylase 6 (HDAC 6) Inhibitors",
    "therapeutic_area": "Endocrinology and Metabolic Disorders",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Histone Deacetylase 6 (HDAC6) Inhibitors Market Size, Target Population, Competitive Landscape & Market Forecast",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Hodgkin Lymphoma",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Hodgkin's Lymphoma Pipeline Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Hodgkin's lymphoma",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Hodgkin's lymphoma (HL) Epidemiology Forecast",
    "therapeutic_area": "Oncology",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Holter Monitor",
    "therapeutic_area": "Cardiovascular Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Home Healthcare",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Homocystinuria",
    "therapeutic_area": "Endocrinology and Metabolic Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Homozygous Familial Hypercholesterolemia",
    "therapeutic_area": "Endocrinology and Metabolic Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Homozygous Familial Hypercholesterolemia Patient Pool Analysis",
    "therapeutic_area": "Rare Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Hormone Receptor (HR)-positive/ Human Epidermal Receptor 2 (HER2)-negative Breast Cancer",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2028,
    "year_range": "2028",
    "total_reports": 1
  },
  {
    "indication_name": "Hormone Replacement Therapy",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Hormone Sensitive Advanced Prostate Cancer",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Horner\u2019s Syndrome",
    "therapeutic_area": "Neurology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Hospital Acquired Candida Infections Epidemiology Forecast",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Hospital Acquired Infection Control",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2027,
    "year_range": "2027",
    "total_reports": 1
  },
  {
    "indication_name": "Hospital Acquired Methicillin-Resistant Staphylococcus Aureus Infections",
    "therapeutic_area": "Infectious Diseases",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Hospital Beds",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Hospital-Acquired and Ventilator-Associated Bacterial Pneumonia (HABP/VABP)",
    "therapeutic_area": "Infectious Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2028-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Hot Flashes",
    "therapeutic_area": "Womens Health",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 4
  },
  {
    "indication_name": "Hot Flashes - Global API Manufacturers, Marketed and Phase III Drugs Landscape",
    "therapeutic_area": "Womens Health",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Hot Flashes in Prostate Cancer",
    "therapeutic_area": "Womens Health",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "House Dust Mite Allergy",
    "therapeutic_area": "Immunological and Autoimmune Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 5
  },
  {
    "indication_name": "House Dust Mite Disease (HDMD) ",
    "therapeutic_area": "Immunological and Autoimmune Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "House Dust Mite Disease (HDMD)\u2013 Epidemiology Forecast",
    "therapeutic_area": "Immunological and Autoimmune Disorders",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Hpv16+ Anogenital Cancers",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Humalog - API Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Human Epidermal Growth Factor Receptor 4 (HER-4 or ErbB-4) Inhibitor",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Human Growth Hormone (HGH)",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Human Immunodeficiency Virus (HIV 1) Infection",
    "therapeutic_area": "Infectious Diseases",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Human Immunodeficiency Virus Type 1 (HIV-1) Infection",
    "therapeutic_area": "Infectious Diseases",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 2
  },
  {
    "indication_name": "Human Immunodeficiency Virus Type-1 (HIV-1)",
    "therapeutic_area": "Infectious Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2030-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Human Microbiome",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Human Papillomavirus (HPV)",
    "therapeutic_area": "Infectious Diseases",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Human Papillomavirus (HPV) Associated Disorders",
    "therapeutic_area": "Infectious Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2032-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Human Papillomavirus 16-positive (HPV16+) Cancers",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 5
  },
  {
    "indication_name": "Human Papillomavirus Associated Diseases",
    "therapeutic_area": "Central Nervous System",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Human Papillomavirus-positive Oropharyngeal Cancer",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Human papillomavirus (HPV) Associated Cancer",
    "therapeutic_area": "Infectious Diseases",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Human papillomavirus (HPV) Associated Cancer - Global API Manufacturers, Marketed and Phase III Drugs Landscape",
    "therapeutic_area": "Cardiovascular Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Humatrope - API Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Hunter Syndrome",
    "therapeutic_area": "Endocrinology and Metabolic Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Huntington's Disease",
    "therapeutic_area": "Genetic Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2030-2034",
    "total_reports": 4
  },
  {
    "indication_name": "Huntington\u2019s Disease",
    "therapeutic_area": "Genetic Disorders",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Hutchinson-Gilford Progeria Syndrome (HGPS)",
    "therapeutic_area": "Genetic Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "HyBryte Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Hyaluronic Acid Viscosupplementation",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Hydrocephalus",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Hydrocephalus Epidemiology Forecast",
    "therapeutic_area": "Central Nervous System",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Hydrocephalus Shunts",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Hydrocephalus Treatment",
    "therapeutic_area": "Neurology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Hydroxychloroquine \u2013 Drug Insights",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2020,
    "year_range": "2020",
    "total_reports": 1
  },
  {
    "indication_name": "Hyperalgesia",
    "therapeutic_area": "Neurology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Hyperammonemia",
    "therapeutic_area": "Endocrinology and Metabolic Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Hyperbaric Oxygen Therapy Equipment",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Hypercalcemia",
    "therapeutic_area": "Endocrinology and Metabolic Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2032-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Hypercholesterolaemia",
    "therapeutic_area": "Endocrinology and Metabolic Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 4
  },
  {
    "indication_name": "Hypercoagulability",
    "therapeutic_area": "Hematological Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Hypereosinophilic Syndrome",
    "therapeutic_area": "Hematological Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Hyperglycemia",
    "therapeutic_area": "Endocrinology and Metabolic Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Hyperhidrosis",
    "therapeutic_area": "Dermatology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Hyperinsulinemic Hypoglycemia",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Hyperkalemia",
    "therapeutic_area": "Endocrinology and Metabolic Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 4
  },
  {
    "indication_name": "Hyperkalemia Japan",
    "therapeutic_area": "Endocrinology and Metabolic Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Hyperlipidemia",
    "therapeutic_area": "Cardiovascular Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Hyperopia",
    "therapeutic_area": "Ophthalmology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 5
  },
  {
    "indication_name": "Hyperoxaluria",
    "therapeutic_area": "Endocrinology and Metabolic Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Hyperparathyroidism",
    "therapeutic_area": "Endocrinology and Metabolic Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Hyperparathyroidism - Global API Manufacturers, Marketed and Phase III Drugs Landscape",
    "therapeutic_area": "Endocrinology and Metabolic Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Hyperphosphatemia",
    "therapeutic_area": "Endocrinology and Metabolic Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 5
  },
  {
    "indication_name": "Hyperphosphatemia - Global API Manufacturers, Marketed and Phase III Drugs Landscape",
    "therapeutic_area": "Endocrinology and Metabolic Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Hyperpigmentation",
    "therapeutic_area": "Dermatology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Hypersomnia",
    "therapeutic_area": "Neurology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Hypersomnia - Global API Manufacturers, Marketed and Phase III Drugs Landscape",
    "therapeutic_area": "Neurology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Hypertension ",
    "therapeutic_area": "Cardiovascular Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Hypertension Drugs",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2028,
    "year_range": "2028",
    "total_reports": 1
  },
  {
    "indication_name": "Hypertriglyceridemia",
    "therapeutic_area": "Endocrinology and Metabolic Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Hypertriglyceridemia - Global API Manufacturers, Marketed and Phase III Drugs Landscape",
    "therapeutic_area": "Endocrinology and Metabolic Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Hypertrophic Cardiomyopathy (HCM)",
    "therapeutic_area": "Cardiovascular Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2030-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Hypertrophic Scar",
    "therapeutic_area": "Dermatology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 2
  },
  {
    "indication_name": "Hyperuricemia",
    "therapeutic_area": "Endocrinology and Metabolic Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Hyperuricemia - Global API Manufacturers, Marketed and Phase III Drugs Landscape",
    "therapeutic_area": "Endocrinology and Metabolic Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Hypoactive Sexual Desire Disorder (HSDD)",
    "therapeutic_area": "Immunological and Autoimmune Disorders",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Hypofibrinogenemia",
    "therapeutic_area": "Hematological Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Hypoglycemia",
    "therapeutic_area": "Endocrinology and Metabolic Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2025-2032",
    "total_reports": 2
  },
  {
    "indication_name": "Hypogonadism",
    "therapeutic_area": "Genito Urinary System and Sex Hormones",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Hypoparathyroidism",
    "therapeutic_area": "Endocrinology and Metabolic Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 4
  },
  {
    "indication_name": "Hypoparathyroidism Patient Pool Analysis",
    "therapeutic_area": "Endocrinology and Metabolic Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Hypophosphatasia",
    "therapeutic_area": "Endocrinology and Metabolic Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Hypopituitarism",
    "therapeutic_area": "Endocrinology and Metabolic Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Hypoplastic Left Heart Syndrome (hlhs)",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Hypothalamic Obesity (HO)",
    "therapeutic_area": "Male Health",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Hypothyroidism",
    "therapeutic_area": "Endocrinology and Metabolic Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Hypotrichosis",
    "therapeutic_area": "Rare Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2032-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Hypoventilation",
    "therapeutic_area": "Respiratory Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Hypovolemia",
    "therapeutic_area": "Hematological Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Hypovolemic Shock",
    "therapeutic_area": "Other Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Hypoxia",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Hypoxia Inducible Factor 1 (HIF-1) Inhibitor",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Hypoxia Inducible Factor Prolyl-4-Hydroxylase (HIF-PH) Inhibitor",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Hypoxia-inducible Factor Prolyl Hydroxylase (HIF-PH) Enzyme Inhibitors Market Size, Target Population, Competitive Landscape & Market Forecast",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Hypoxic Ischemic Encephalopathy (HIE)",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Hysterometer",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Hysteroscopy Devices",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "I/ONTAK (E7777) Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "IBAT inhibitors (Ileal bile acid transporter Inhibitors) \u2013 Market Size, Target Population, Competitive Landscape, and Market Forecast",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "IBREXAFUNGERP",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "IGALMI Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "IL-6 Receptor Antagonist",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "ILUVIEN Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "IMCIVREE (Setmelanotide)",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "IMCY-0098 Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "IMFINZI Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "IMLYGIC Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "INBRIJA Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "INCB050465 (Parsaclisib)",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "INGREZZA Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 2
  },
  {
    "indication_name": "INO-5401 + INO-9012 + LIBTAYO Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "INP20 Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "INVEGA HAFYERA Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "INVELTYS Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 2
  },
  {
    "indication_name": "INVOKANA Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 2
  },
  {
    "indication_name": "INVOSSA Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 3
  },
  {
    "indication_name": "ION363",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "IONIS ENAC 2.5",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "IONIS FB LRX",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "IONIS-AGT-LRx Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "IPSC derived NK cells",
    "therapeutic_area": "Oncology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "ISATUXIMAB",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "ISTODAX Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "ITI-1000-1 Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 2
  },
  {
    "indication_name": "IVIG \u2013 Target Population, Competitive Landscape, and Market Forecast",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Ianalumab Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Ibrance (palbociclib)",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Ichthyosis",
    "therapeutic_area": "Dermatology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Idebenone",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Idiopathic CD4+ Lymphocytopenia",
    "therapeutic_area": "Genetic Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Idiopathic Inflammatory Myositis ",
    "therapeutic_area": "Immunological and Autoimmune Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Idiopathic Interstitial Pneumonia",
    "therapeutic_area": "Respiratory Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Idiopathic Membranous Nephropathy (IMN) ",
    "therapeutic_area": "Genito Urinary System and Sex Hormones",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Idiopathic Multicentric Castleman's Disease (iMCD)",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Idiopathic Pulmonary Fibrosis (IPF)",
    "therapeutic_area": "Respiratory Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2028,
    "year_range": "2027-2028",
    "total_reports": 2
  },
  {
    "indication_name": "Idiopathic Pulmonary Fibrosis - Global API Manufacturers, Marketed and Phase III Drugs Landscape",
    "therapeutic_area": "Respiratory Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Idiopathic Pulmonary Fibrosis Patient Pool Analysis",
    "therapeutic_area": "Respiratory Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Idiopathic Scoliosis",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Idiopathic Short Stature",
    "therapeutic_area": "Endocrinology and Metabolic Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Idiopathic Short Stature - Global API Manufacturers, Marketed and Phase III Drugs Landscape",
    "therapeutic_area": "Endocrinology and Metabolic Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Idiopathic Thrombocytopenic Purpura",
    "therapeutic_area": "Hematological Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "IgA Nephropathy (IgAN)",
    "therapeutic_area": "Immunological and Autoimmune Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 6
  },
  {
    "indication_name": "IgE Receptor Antagonists",
    "therapeutic_area": "Immunological and Autoimmune Disorders",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "IgG4-Related Disease",
    "therapeutic_area": "Immunological and Autoimmune Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 4
  },
  {
    "indication_name": "IkappaB Kinase (IKK) Inhibitor",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Ilaris",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Ilofotase alfa Emerging Drug Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": "",
    "year_range": "",
    "total_reports": 1
  },
  {
    "indication_name": "Image Guided Surgery Devices",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Imbruvica (ibrutinib)",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Imbruvica - API Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Imitrex - API Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Immune Checkpoint Inhibitors",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Immune Checkpoint Inhibitors - Competitive Landscape And Market Forecast",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Immune Checkpoints Activators - Competitive Landscape, Technology and Pipeline Analysis",
    "therapeutic_area": "Other Diseases",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2023,
    "year_range": "2017-2023",
    "total_reports": 2
  },
  {
    "indication_name": "Immune Complex Membranoproliferative Glomerulonephritis (IC-MPGN) ",
    "therapeutic_area": "Genito Urinary System and Sex Hormones",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Immune Complex Membranoproliferative Glomerulonephritis (IC-MPGN) \u2013 Epidemiology Forecast",
    "therapeutic_area": "Genito Urinary System and Sex Hormones",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Immune Health Supplements",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Immune Thrombocytopenia (ITP)",
    "therapeutic_area": "Hematological Disorders",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Immune Thrombocytopenic Purpura (ITP) ",
    "therapeutic_area": "Immunological and Autoimmune Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Immune Thrombocytopenic Purpura Epidemiology Forecast",
    "therapeutic_area": "Hematological Disorders",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Immune-Mediated Depression",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Immunoassay",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Immunodiagnostics",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Immunohistochemistry (IHC)",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Immunologic Deficiency Syndrome",
    "therapeutic_area": "Immunological and Autoimmune Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2025-2032",
    "total_reports": 2
  },
  {
    "indication_name": "Immunologic Deficiency Syndrome Epidemiology Forecast",
    "therapeutic_area": "Immunological and Autoimmune Disorders",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Immunomodulators",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Immunoprotein Diagnostic Testing",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Immunosuppressants",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Immunotherapy Drugs",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Impaired Glucose Tolerance",
    "therapeutic_area": "Endocrinology and Metabolic Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Impetigo",
    "therapeutic_area": "Dermatology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Impetigo - Global API Manufacturers, Marketed and Phase III Drugs Landscape",
    "therapeutic_area": "Dermatology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Implantable Cardiac Monitors (ICM)",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Implantable Cardioverter Defibrillators (ICD)\u2013Pipeline Insight and Competitive Landscape",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2023,
    "year_range": "2023",
    "total_reports": 1
  },
  {
    "indication_name": "Implantable Cardioverter Defibrillators (ICDs)",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Implantable Drug Delivery Devices",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Implantable Infusion Pumps",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Implantable Neurostimulation Devices",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Implanted Brain-Computer Interface (BCI) Devices",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Imprida - API Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Imusera - API Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "In Situ Hybridization",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "In Vitro Diagnostics",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "In Vitro Fertilization",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Inclisiran Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Inclusion Body Myositis",
    "therapeutic_area": "Rare Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "India Healthcare Outlook Report",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Indolent Lymphoma",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Indolent Lymphoma - Global API Manufacturers, Marketed and Phase III Drugs Landscape",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Inducible Nitric Oxide Synthase (iNOS or Type II NOS) Inhibitor",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Indwelling Catheters",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Infant Formula",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Infantile Neuroaxonal Dystrophy",
    "therapeutic_area": "Genetic Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Infantile Spasm",
    "therapeutic_area": "Neurology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Infantile Spasm - Global API Manufacturers, Marketed and Phase III Drugs Landscape",
    "therapeutic_area": "Neurology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Infection Prevention and Control",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Infectious Arthritis/Septic Arthritis",
    "therapeutic_area": "Musculoskeletal",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Infectious Disease Diagnostics - Global",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Inferior Vena Cava Filters (IVCF)",
    "therapeutic_area": "Respiratory Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Inflammation and Pain Post Cataract Surgery",
    "therapeutic_area": "Ophthalmology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Inflammatory Bowel Disease (IBD)",
    "therapeutic_area": "Gastroenterology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Inflammatory Bowel Disease (IBD) Diagnostic",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Inflammatory Bowel Disease (IBD)\u2014Epidemiology Forecast",
    "therapeutic_area": "Gastroenterology",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Inflammatory Breast Cancer",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 2
  },
  {
    "indication_name": "Inflammatory Myositis (IM)",
    "therapeutic_area": "Immunological and Autoimmune Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Inflammatory Myositis \u2013 Epidemiology Forecast",
    "therapeutic_area": "Immunological and Autoimmune Disorders",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Inflammatory Pain",
    "therapeutic_area": "Neurology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Inflammatory breast disease",
    "therapeutic_area": "Womens Health",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Infliximab Biosimilars Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2024,
    "year_range": "2024",
    "total_reports": 1
  },
  {
    "indication_name": "Influenza",
    "therapeutic_area": "Infectious Diseases",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Influenza A Infections",
    "therapeutic_area": "Infectious Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Influenza A Infections - Global API Manufacturers, Marketed and Phase III Drugs Landscape",
    "therapeutic_area": "Infectious Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Influenza A Virus H5N1 Subtype",
    "therapeutic_area": "Infectious Diseases",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Influenza Vaccine",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Influenza virus B infections",
    "therapeutic_area": "Infectious Diseases",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Infrared Thermometer",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Infusion Pumps",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Infusion Therapy Devices",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Inguinal Hernia",
    "therapeutic_area": "Other Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 4
  },
  {
    "indication_name": "Inhalable Drugs",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Inherited Retinal Disease",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Inhibitor of Apoptosis (IAP) Antagonist",
    "therapeutic_area": "Oncology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Injectable Drug Delivery Devices",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Injection Site Irritation",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Insect Protein",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Insomnia",
    "therapeutic_area": "Sleep Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Insomnia Patient Pool Analysis",
    "therapeutic_area": "Neurology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Insulin Delivery Device",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Insulin Glargine Biosimilar Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2024,
    "year_range": "2024",
    "total_reports": 1
  },
  {
    "indication_name": "Insulin Infusion Pumps",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Insulin Like Growth Factor (IGF) Inhibitor",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Insulin Like Growth Factor 1 (IGF-1) Activators",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Insulin Pens",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Insulin Resistance",
    "therapeutic_area": "Endocrinology and Metabolic Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Insulin Resistance - Global API Manufacturers, Marketed and Phase III Drugs Landscape",
    "therapeutic_area": "Endocrinology and Metabolic Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Insulin icodec Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Integrase Inhibitor",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Integrilin - API Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Integrin Alpha 4beta1/Very Late Antigen-4 (VLA-4) Inhibitor",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Integrin Alpha4beta1 Antagonists",
    "therapeutic_area": "Neurology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Inter Alpha Inhibitor Proteins",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Inter-alpha-inhibitor Proteins",
    "therapeutic_area": "Other Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Interbody Cages",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Interferon - Biosimilar Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2024,
    "year_range": "2024",
    "total_reports": 1
  },
  {
    "indication_name": "Interferons",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Interleukin 1 Beta Inhibitors",
    "therapeutic_area": "Oncology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Interleukin 4 Inhibitors",
    "therapeutic_area": "Respiratory Diseases",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 2
  },
  {
    "indication_name": "Interleukin 8 Receptor Antagonists",
    "therapeutic_area": "Oncology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Interleukin Inhibitors Market Size, Target Population, Competitive Landscape, and Market Forecast",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Interleukin Receptor Inhibitor (IL-1/4/5/6/7/12/13/17/23/36) Market Size, Target Population, Competitive Landscape & Market Forecast",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Interleukin-10 (IL-10) Receptor Agonist",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Interleukin-12 (IL-12) Inhibitor",
    "therapeutic_area": "Oncology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 3
  },
  {
    "indication_name": "Interleukin-12 Expression Stimulants",
    "therapeutic_area": "Oncology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Interleukin-13 (IL-13) Inhibitor",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Interleukin-13 (IL-13) Inhibitors Market size, Target Population, Competitive Landscape, and",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Interleukin-17 (IL-17) Inhibitor",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Interleukin-17 (IL-17) Inhibitors Market, Target Population, Competitive Landscape, and Market Forecast",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Interleukin-18 (IL-18) Inhibitor",
    "therapeutic_area": "Other Diseases",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 2
  },
  {
    "indication_name": "Interleukin-2 (IL-2) Market Size, Target Population, Competitive Landscape & Market Forecast",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Interleukin-2 (IL-2) Receptor Agonist",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Interleukin-23 (IL-23) Inhibitor",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Interleukin-23 Inhibitors Market, Target Population, Competitive Landscape, and Market Metadata",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Interleukin-4 (IL-4) Inhibitor",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Interleukin-5 (IL-5) Inhibitor",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Intermediate AMD",
    "therapeutic_area": "Ophthalmology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Intermediate AMD \u2013 Epidemiology Forecast",
    "therapeutic_area": "Ophthalmology",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Intermittent Claudication",
    "therapeutic_area": "Musculoskeletal",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Intermittent Urinary Catheters",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Internal Trauma Fixation Devices",
    "therapeutic_area": "Other Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Interspinous Spacers",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Interstitial Cystitis",
    "therapeutic_area": "Genito Urinary System and Sex Hormones",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 5
  },
  {
    "indication_name": "Interstitial Cystitis - Global API Manufacturers, Marketed and Phase III Drugs Landscape",
    "therapeutic_area": "Genito Urinary System and Sex Hormones",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Interstitial Lung Disease",
    "therapeutic_area": "Respiratory Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Interventional Cardiology Devices",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2030-2032",
    "total_reports": 2
  },
  {
    "indication_name": "Interventional Neuroradiology",
    "therapeutic_area": "Neurology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Intestinal Fistula",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Intestinal Mucosal Injury",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Intestinal Obstruction",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Intra Operative Imaging",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Intra-Cranial Pressure (ICP) Monitoring Devices",
    "therapeutic_area": "Neurology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Intra-tumoral Cancer Therapies",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 4
  },
  {
    "indication_name": "Intracardiac Echocardiography Devices",
    "therapeutic_area": "Cardiovascular Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Intracerebral Hemorrhage",
    "therapeutic_area": "Neurology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Intracranial Aneurysms",
    "therapeutic_area": "Neurology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 2
  },
  {
    "indication_name": "Intracranial Arterial Diseases",
    "therapeutic_area": "Cardiovascular Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Intracranial Atherosclerosis Epidemiology Forecast",
    "therapeutic_area": "Cardiovascular Diseases",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Intracranial Hemorrhage",
    "therapeutic_area": "Central Nervous System",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Intracranial Hemorrhage Devices",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Intracranial Hypertension",
    "therapeutic_area": "Cardiovascular Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Intracranial Pressure Monitoring Devices",
    "therapeutic_area": "Neurology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Intracranial Stents",
    "therapeutic_area": "Neurology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Intragastric Balloons",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Intrahepatic Cholangiocarcinoma (ICC)",
    "therapeutic_area": "Oncology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Intrahepatic Cholangiocarcinoma Epidemiology Forecast",
    "therapeutic_area": "Oncology",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Intranasal Drug Delivery",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Intraocular Lens",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Intraocular Lens (IOL)\u2013Pipeline Insight and Competitive Landscape",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2023,
    "year_range": "2023",
    "total_reports": 1
  },
  {
    "indication_name": "Intraocular Lymphoma",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Intraoral Cameras",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Intraosseous Devices",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Intrathecal Pumps",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Intrauterine Devices - Global",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Intrauterine Growth Restriction",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Intrauterine Pressure Catheter",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Intravascular Ultrasound (IVUS)",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Intravenous Immunoglobulin (IVIG)",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Intravenous Stopcock",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Introducer Sheaths",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Intuniv - API Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Invanz - API Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Invasive Aspergillosis",
    "therapeutic_area": "Infectious Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Invasive Candidiasis",
    "therapeutic_area": "Infectious Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Invasive Fungal Infections ",
    "therapeutic_area": "Infectious Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Invasive Fungal Infections\u2013 Epidemiology Forecast",
    "therapeutic_area": "Infectious Diseases",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Invasive Pneumococcal Disease",
    "therapeutic_area": "Respiratory Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 5
  },
  {
    "indication_name": "Invega Sustenna/Xeplion - API Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Invokana - API Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Ionotropic Glutamate Receptor Antagonist",
    "therapeutic_area": "Neurology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Ipilimumab + nivolumab Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Iptacopan Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 2
  },
  {
    "indication_name": "Iressa - API Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Iris Melanoma",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Iron Deficiency Anemia",
    "therapeutic_area": "Hematological Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 5
  },
  {
    "indication_name": "Iron Deficiency Anemia - Global API Manufacturers, Marketed and Phase III Drugs Landscape",
    "therapeutic_area": "Hematological Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Iron Overload Syndrome",
    "therapeutic_area": "Endocrinology and Metabolic Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2032-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Iron overload",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Irritable Bowel Syndrome (IBS)",
    "therapeutic_area": "Gastroenterology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Irritable Bowel Syndrome (IBS) Patient Pool Analysis",
    "therapeutic_area": "Immunological and Autoimmune Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Ischemia Reperfusion Injury",
    "therapeutic_area": "Hematological Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Ischemic Cardiomyopathy",
    "therapeutic_area": "Immunological and Autoimmune Disorders",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Ischemic Stroke",
    "therapeutic_area": "Neurology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Ischemic Stroke - Global API Manufacturers, Marketed and Phase III Drugs Landscape",
    "therapeutic_area": "Neurology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Isentress - API Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Isocitrate Dehydrogenase (IDH) inhibitors \u2013 Competitive Landscape, Market and Pipeline Analysis",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Isocitrate Dehydrogenase (IDH1) Inhibitor",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Isocitrate Dehydrogenase Inhibitors Market Size, Target Population, Competitive Landscape & Market Forecast",
    "therapeutic_area": "Endocrinology and Metabolic Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Isovaleric Acidemia",
    "therapeutic_area": "Endocrinology and Metabolic Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Itacitinib Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 2
  },
  {
    "indication_name": "Italy Healthcare Outlook Report",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "JAKAFI Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 2
  },
  {
    "indication_name": "JARDIANCE Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 3
  },
  {
    "indication_name": "JCELL",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "JEMPERLI (dostarlimab) Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "JNJ-73763989 Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "JOINTSTEM Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 3
  },
  {
    "indication_name": "JORVEZA Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "JOYCLU Market Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "JOYCLU Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "JTA-004 Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 2
  },
  {
    "indication_name": "JUBLIA Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "JYNARQUE Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "JYSELECA Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 3
  },
  {
    "indication_name": "JZP150",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Jalyn - API Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Janus Kinase (JAK) Inhibitor",
    "therapeutic_area": "Immunological and Autoimmune Disorders",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 2
  },
  {
    "indication_name": "Janus Kinase (JAK) Inhibitors - Competitive Landscape, Pipeline and Market Analysis",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2017,
    "year_range": "2017",
    "total_reports": 1
  },
  {
    "indication_name": "Janus Kinase 1 (JAK1) Inhibitor",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Janus Kinase 3 (JAK3) Inhibitor",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Janus kinase Inhibitors Competitive Landscape",
    "therapeutic_area": "Immunological and Autoimmune Disorders",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Japan Healthcare Outlook Report",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Jardiance - API Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Jevtana",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Jevtana Kit - API Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "John Cunningham (JC) Virus Infection",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Joint Reconstruction Devices",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Jublia - API Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Juvenile Idiopathic arthritis (JIA)",
    "therapeutic_area": "Musculoskeletal",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Juvenile Macular Degeneration (Stargardt Disease)",
    "therapeutic_area": "Central Nervous System",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 4
  },
  {
    "indication_name": "Juvenile Rheumatoid Arthritis",
    "therapeutic_area": "Immunological and Autoimmune Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "K-232 Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "KAT6 Inhibitors Market Size, Target Population, Competitive Landscape, and Market Forecast",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2040,
    "year_range": "2040",
    "total_reports": 1
  },
  {
    "indication_name": "KB 105",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "KBP-5074 Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "KCNQ2 Developmental and Epileptic Encephalopathy (KCNQ2-DEE)",
    "therapeutic_area": "Neurology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "KERECIS OMEGA3 Market Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "KERENDIA Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 2
  },
  {
    "indication_name": "KEVZARA Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "KEYTRUDA (pembrolizumab) Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "KEYTRUDA Market Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "KFRX-01 Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "KISQALI Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "KLKB1 Inhibitors - Target Population, Competitive Landscape, and Market Forecast",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 2
  },
  {
    "indication_name": "KPL-716 Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "KRAS Inhibitors \u2013 Epidemiology Forecast",
    "therapeutic_area": "Oncology",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "KRAS Mutant Cancer",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 2
  },
  {
    "indication_name": "KRT-232 Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "KSI-301 Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "KUVAN (Sapropterin Hydrochloride)",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "KVD001",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "KY1005 Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "KYNMOBI Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Kabuki Syndrome",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Kainate Receptor Antagonist",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Kaletra - API Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Kallikrein Inhibitor",
    "therapeutic_area": "Ophthalmology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Kaposi's Sarcoma",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Kappa Antagonist",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "KarXT (xanomeline\u2013trospium) Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Kawasaki Disease",
    "therapeutic_area": "Immunological and Autoimmune Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Keloid",
    "therapeutic_area": "Dermatology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2032-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Keloids",
    "therapeutic_area": "Dermatology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Kengreal - API Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Keppra - API Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Keratitis",
    "therapeutic_area": "Ophthalmology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Keratoconus",
    "therapeutic_area": "Ophthalmology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Kernicterus",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Ketamine-Assisted Psychotherapy",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Ketone Supplements",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Kidney Transplant Rejection",
    "therapeutic_area": "Genito Urinary System and Sex Hormones",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Kivexa - API Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Klebsiella Infections",
    "therapeutic_area": "Infectious Diseases",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Klebsiella Pneumoniae Infections",
    "therapeutic_area": "Infectious Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Klebsiella Pneumoniae Infections - Global API Manufacturers, Marketed and Phase III Drugs Landscape",
    "therapeutic_area": "Infectious Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Klinefelter Syndrome",
    "therapeutic_area": "Genetic Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Knee Osteoarthritis",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Knee Osteoarthritis Pipeline Insight",
    "therapeutic_area": "Musculoskeletal",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Knee Reconstruction Devices",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Kounis Syndrome",
    "therapeutic_area": "Cardiovascular Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Krabbe Disease",
    "therapeutic_area": "Genetic Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Kv1.3 Potassium Channel Blockers",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Kv1.3/1.5 Potassium Channel Blockers",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Kymriah",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Kyphoscoliosis",
    "therapeutic_area": "Musculoskeletal",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2032-2034",
    "total_reports": 2
  },
  {
    "indication_name": "L606 Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "LAG-3 Antagonist",
    "therapeutic_area": "Oncology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "LAG-3 Next-generation Immunotherapy- Competitive Landscape and Market Forecast",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2035,
    "year_range": "2035",
    "total_reports": 1
  },
  {
    "indication_name": "LAM561 Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "LANTIDRA Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "LATUDA Market Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "LENVIMA (lenvatinib) Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "LEQEMBI Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "LEQVIO Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "LEVEMIR Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "LIQ-861 Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "LKA651 Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "LNP023 (Iptacopan) Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "LNZ100 Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "LOAd703 Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 2
  },
  {
    "indication_name": "LOTEMAX SM Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 2
  },
  {
    "indication_name": "LOU064 Market Size",
    "therapeutic_area": "Dermatology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "LP-10 Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "LP352 Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "LPCN 1144 Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "LUCENTIS Market Size",
    "therapeutic_area": "Other Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "LUM001",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "LUMAKRAS Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "LUMICEF Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "LUMINATE",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "LUPKYNIS Market Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "LY03005 Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "LY3209590 Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "LY3454738 Drug Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "LY3484356 (Imlunestrant) Market Size",
    "therapeutic_area": "Other Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "LYBALVI Market Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "LYBALVI Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "LYNPARZA Market Size",
    "therapeutic_area": "Other Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 2
  },
  {
    "indication_name": "LYTGOBI (futibatinib) Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "LYUMJEV Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Lab Automation",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Laband Syndrome",
    "therapeutic_area": "Genetic Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Laboratory Informatics",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Laboratory Information System",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Lactose Intolerance",
    "therapeutic_area": "Endocrinology and Metabolic Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Lactose Intolerance Epidemiology Forecast",
    "therapeutic_area": "Endocrinology and Metabolic Disorders",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Lactose Intolerance Pipeline Insight",
    "therapeutic_area": "Genetic Disorders",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Lacutamab Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Ladarixin Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Lambert Eaton Myasthenic Syndrome",
    "therapeutic_area": "Neurology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Lambert-Eaton Myasthenic Syndrome (LEMS)",
    "therapeutic_area": "Neurology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Lambert-Eaton Myasthenic Syndrome Epidemiology Forecast",
    "therapeutic_area": "Immunological and Autoimmune Disorders",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Lambert-Eaton Myasthenic Syndrome Pipeline Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Lamellar Ichthyosis (LI)",
    "therapeutic_area": "Dermatology",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Lamellar Icthyosis",
    "therapeutic_area": "Dermatology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Lamictal - API Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Langerhans Cell Histiocytosis",
    "therapeutic_area": "Hematological Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Lanifibranor Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Laparoscopic Devices \u2013Pipeline Insight and Competitive Landscape",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2023,
    "year_range": "2023",
    "total_reports": 1
  },
  {
    "indication_name": "Laparoscopy Devices",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Large Granular Lymphocyte Leukemia/ Aggressive NK-cell leukemia",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2032-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Large Granular Lymphocytic Leukemia (LGLL)",
    "therapeutic_area": "Hematological Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 2
  },
  {
    "indication_name": "Large hemispheric infarction (LHI) ",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Laron Syndrome (LS)",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Laryngeal Cancer",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2032-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Laryngoscope",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Larynx Cancer",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Laser Resurfacing Devices",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Lasofoxifene Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Lassa Fever",
    "therapeutic_area": "Infectious Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Late-stage chronic kidney disease (CKD)",
    "therapeutic_area": "Genito Urinary System and Sex Hormones",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Lateral Epicondylitis (Tennis Elbow) Disease",
    "therapeutic_area": "Musculoskeletal",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 2
  },
  {
    "indication_name": "Lateral Flow Readers/Assay",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Latozinemab (AL001) Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Latuda - API Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Leber Congenital Amaurosis",
    "therapeutic_area": "Ophthalmology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Leber Hereditary Optic Neuropathy",
    "therapeutic_area": "Ophthalmology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Leber's Hereditary Optic Neuropathy (LHON)",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Lebrikizumab Market Size",
    "therapeutic_area": "Dermatology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Left Atrial Appendage Closure Devices",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Left Ventricular Dysfunction",
    "therapeutic_area": "Cardiovascular Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Left Ventricular Dysfunction - Global API Manufacturers, Marketed and Phase III Drugs Landscape",
    "therapeutic_area": "Cardiovascular Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Leigh Syndrome",
    "therapeutic_area": "Neurology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Leiomyosarcoma",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Leishmaniasis",
    "therapeutic_area": "Infectious Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Lenegre's disease",
    "therapeutic_area": "Cardiovascular Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2032-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Lennox Gastaut Syndrome",
    "therapeutic_area": "Neurology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 5
  },
  {
    "indication_name": "Lenti-D",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Lenvatinib + pembrolizumab Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Leptomeningeal Disease",
    "therapeutic_area": "Oncology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Leptomeningeal Metastases",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Lerapolturev + Pembrolizumab Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Leucine-Rich Repeat Kinase (LRRK)-2 Inhibitor",
    "therapeutic_area": "Neurology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Leukapheresis",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Leukocyte Adhesion Deficiency",
    "therapeutic_area": "Immunological and Autoimmune Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Leukotriene Antagonist",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Leukotriene D4 Antagonist",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Levodopa-Induced Dyskinesia (LID)",
    "therapeutic_area": "Neurology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Lewy Body Dementia (LBD)",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Lewy Body Disease",
    "therapeutic_area": "Neurology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Lice Infestations",
    "therapeutic_area": "Infectious Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2025-2032",
    "total_reports": 2
  },
  {
    "indication_name": "Lice Infestations Epidemiology Forecast",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Lichen Planus",
    "therapeutic_area": "Ophthalmology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Ligelizumab Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 2
  },
  {
    "indication_name": "Light Therapy",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Limb Girdle Muscular Dystrophy (LGMD)",
    "therapeutic_area": "Genetic Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 5
  },
  {
    "indication_name": "Limbal Stem Cells Deficiency (LSCD)",
    "therapeutic_area": "Ophthalmology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 4
  },
  {
    "indication_name": "Linerixibat Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Lip and Oral Cavity Cancer",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Lipid Regulators",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Lipodystrophy",
    "therapeutic_area": "Endocrinology and Metabolic Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Lipodystrophy Syndrome (LS)",
    "therapeutic_area": "Genetic Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 4
  },
  {
    "indication_name": "Liposarcoma",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Liposarcoma - Global API Manufacturers, Marketed and Phase III Drugs Landscape",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Liposomal Cyclosporine A Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Liposuction Surgery Devices - Global",
    "therapeutic_area": "Other Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Lipoxygenase Inhibitor (LOX Inhibitor)",
    "therapeutic_area": "Endocrinology and Metabolic Disorders",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Liquid Biopsy for Cancer Diagnostics \u2013 Competitive Landscape and Pipeline Analysis",
    "therapeutic_area": "Oncology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2023,
    "year_range": "2023",
    "total_reports": 1
  },
  {
    "indication_name": "Liquid Biopsy in Cancer Diagnostics",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Liquid Handling System",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Listeriosis",
    "therapeutic_area": "Infectious Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Lithotripsy Devices",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Liver Angiosarcoma",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2032-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Liver Cirrhosis",
    "therapeutic_area": "Gastroenterology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Liver Cirrhosis Patient Pool Analysis",
    "therapeutic_area": "Endocrinology and Metabolic Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Liver Disease Associated Pruritus",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Liver Disease Diagnostics",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Liver Disease Therapeutics",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Liver Failure",
    "therapeutic_area": "Gastroenterology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Liver Failure - Global API Manufacturers, Marketed and Phase III Drugs Landscape",
    "therapeutic_area": "Gastroenterology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Liver Fibrosis",
    "therapeutic_area": "Gastroenterology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 2
  },
  {
    "indication_name": "Liver Fibrosis Patient Pool Analysis",
    "therapeutic_area": "Endocrinology and Metabolic Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Liver Fibrosis Pipeline Insight",
    "therapeutic_area": "Gastroenterology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Liver cancer",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Local Anesthesia Drugs",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2028,
    "year_range": "2028",
    "total_reports": 1
  },
  {
    "indication_name": "Localized Scleroderma",
    "therapeutic_area": "Dermatology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Locally Advanced Pancreatic Cancer (LAPC)",
    "therapeutic_area": "Endocrinology and Metabolic Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Loestrin 24 Fe - API Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Lomitapide Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Lonsurf - API Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Loperamide Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Lorecivivint Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Lou Gehrig's Disease",
    "therapeutic_area": "Neurology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2025-2032",
    "total_reports": 2
  },
  {
    "indication_name": "Lovenox With Preservative - API Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Low Affinity Sodium Glucose Cotransporter (SGLT2) Inhibitor",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Low Grade Serous Ovarian Carcinoma",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 2
  },
  {
    "indication_name": "Low-Grade Glioma",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 2
  },
  {
    "indication_name": "Low-Grade Upper Tract Urothelial Cancer (LG UTUC)",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Lower-Limb Spasticity",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Lucinactant Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Lumateperone Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Lumbar Degenerative Disc Disease",
    "therapeutic_area": "Musculoskeletal",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Lumbar Disc Disease",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Lumbar Disc Replacement Devices",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Lumbar Facet Joint Pain",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Lumbar Spondylolisthesis",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Lumbosacral Radicular Pain",
    "therapeutic_area": "Neurology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Lumigan RC - API Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Lumizyme (alglucosidase alfa)",
    "therapeutic_area": "Other Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Lunesta - API Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Lung Adenocarcinoma",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Lung Fibrosis",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Lung Transplant",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Lung Transplant Rejection",
    "therapeutic_area": "Immunological and Autoimmune Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2025-2032",
    "total_reports": 2
  },
  {
    "indication_name": "Lupus Nephritis (LN)",
    "therapeutic_area": "Immunological and Autoimmune Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2028,
    "year_range": "2028",
    "total_reports": 1
  },
  {
    "indication_name": "Lupus Nephritis - Global API Manufacturers, Marketed and Phase III Drugs Landscape",
    "therapeutic_area": "Immunological and Autoimmune Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Lupus Nephritis Patient Pool Analysis",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Lurbinectedin Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Luxturna (voretigene neparvovec-rzyl)",
    "therapeutic_area": "Rare Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Lycopene",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Lyme Disease (LD)",
    "therapeutic_area": "Infectious Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Lymphangioleiomyomatosis (LAM)",
    "therapeutic_area": "Immunological and Autoimmune Disorders",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Lymphatic Malformations",
    "therapeutic_area": "Rare Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Lymphatic Malformations Epidemiology Forecast",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Lymphatic Malformations Pipeline Insight",
    "therapeutic_area": "Non-Malignant Disorders",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Lymphocyte-Activation Gene 3 (LAG-3) \u2014 Market Size, Target Population, Competitive Landscape, and Market Forecast",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Lymphocytopenia",
    "therapeutic_area": "Hematological Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Lymphoedema",
    "therapeutic_area": "Other Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 5
  },
  {
    "indication_name": "Lynparza - API Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Lyrica - API Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Lysine Specific Demethylase 1 (LSD-1) Inhibitors",
    "therapeutic_area": "Oncology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Lysine demethylase 1 (LSD1) \u2013 Market Size, Target Population, Competitive Landscape, and Market Forecast",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "M1Pram Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "MAC Lung Disease",
    "therapeutic_area": "Respiratory Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "MAC Lung Disease \u2013 Epidemiology Forecast",
    "therapeutic_area": "Respiratory Diseases",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "MALT Lymphoma",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "MALT1 Protein Inhibitor",
    "therapeutic_area": "Oncology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "MAP Kinase Kinase 1 Inhibitors",
    "therapeutic_area": "Oncology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "MBS2320 Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "MCL1 Protein Inhibitor",
    "therapeutic_area": "Hematological Disorders",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "MDNA55 Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "MDS",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "MEDI8897 Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "MELAS Syndrome",
    "therapeutic_area": "Rare Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2025-2032",
    "total_reports": 2
  },
  {
    "indication_name": "MEPOLIZUMAB",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "MGB-BP-3 Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "MGL-3196 Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "MIJ821",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "MIN-102 Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "MK-4280A (favezelimab and pembrolizumab) Market Size",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "MK-7264 Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "MK-8189 Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "MK5475 Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "MLLr and NPM1c Mutant Relapsed/Refractory (R/R) Acute Leukemia",
    "therapeutic_area": "Other Diseases",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 2
  },
  {
    "indication_name": "MM-120 Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "MN-166 (Ibudilast) Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "MN-202 Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "MOB-015 Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "MOG Antibody Disease",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 2
  },
  {
    "indication_name": "MPH966 Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "MPYS Protein Inhibitors",
    "therapeutic_area": "Immunological and Autoimmune Disorders",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "MPYS Protein Stimulants",
    "therapeutic_area": "Oncology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "MRT5005",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "MRx-4DP0004 Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "MTG201 + nivolumab Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "MULPLETA Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "MUNDESINE Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "MVA-BN RSV Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "MYMD-1 Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "MYTESI Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Macrophage Activation Syndrome (MAS) ",
    "therapeutic_area": "Immunological and Autoimmune Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Macrophage Activation Syndrome (MAS) \u2013 Epidemiology Forecast",
    "therapeutic_area": "Immunological and Autoimmune Disorders",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Macrophage Colony Stimulating Factor Receptor Antagonists",
    "therapeutic_area": "Oncology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Macular Edema (ME)",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2032-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Macular Telangiectasia",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Macular Telangiectasia (MacTel) Pipeline Insight",
    "therapeutic_area": "Ophthalmology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Magnetic Resonance Imaging (MRI) Devices",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Major Depressive Disorder",
    "therapeutic_area": "Neurology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 4
  },
  {
    "indication_name": "Malabsorption Syndrome",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Malaria",
    "therapeutic_area": "Infectious Diseases",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Male Hypogonadism",
    "therapeutic_area": "Male Health",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Male Hypogonadism - Global API Manufacturers, Marketed and Phase III Drugs Landscape",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Male Infertility",
    "therapeutic_area": "Male Health",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Malignant Ascites ",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Malignant Fibrous Histiocytoma",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Malignant Glioma",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Malignant Melanoma",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Malignant Mesothelioma",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Malignant Mesothelioma - Global API Manufacturers, Marketed and Phase III Drugs Landscape",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 2
  },
  {
    "indication_name": "Malignant Pleural Effusion",
    "therapeutic_area": "Respiratory Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Malignant Pleural Mesothelioma (MPM)",
    "therapeutic_area": "Oncology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Mallory-Weiss Tear",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Mammalian Target of Rapamycin (mTOR) Inhibitor Market Size, Target Population, Competitive Landscape & Market Forecast",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Mammography Devices",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Mammography Equipment",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Mannose Phosphate Isomerase (MPI) Deficiency",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Mantle Cell Lymphoma",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Manual Resuscitator",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Maple Syrup Urine Disease",
    "therapeutic_area": "Endocrinology and Metabolic Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Marburg Virus Disease",
    "therapeutic_area": "Infectious Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Marfan Syndrome",
    "therapeutic_area": "Genetic Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Marginal Zone Lymphoma",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Masitinib Market Size",
    "therapeutic_area": "Neurology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 3
  },
  {
    "indication_name": "Mastocytosis",
    "therapeutic_area": "Other Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Maternal Mental Health",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Matrix Metalloproteinase 12 (MMP-12 or Macrophage Metalloelastase) Inhibitor",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Matrix Metalloproteinase 9 (MMP-9) Inhibitor",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 2
  },
  {
    "indication_name": "Mavyret",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Maxalt - API Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Maxigesic IV Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Mccune-Albright Syndrome",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Mechanical Circulatory Support Devices - Global",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Mechanical Thrombectomy Devices",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Meconium Aspiration Syndrome",
    "therapeutic_area": "Pediatrics",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Medical Coding",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Medical Device Cleaning",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Medical Device Contract Manufacturing",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Medical Device Testing Services",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Medical Drones",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Medical Dynamometers",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Medical Exoskeleton",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Medical Gas Pressure Regulators",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Medical Gloves",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Medical Imaging Phantoms",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Medical Linear Particle Accelerator",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Medical Marijuana",
    "therapeutic_area": "Neurology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Medical Marijuana - Cannabidiol",
    "therapeutic_area": "Neurology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Medical Marijuana \u2013 Competitive Intelligence Analysis",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2019,
    "year_range": "2019",
    "total_reports": 1
  },
  {
    "indication_name": "Medical Oxygen Concentrators",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Medical Oxygen Cylinders - Global",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2028,
    "year_range": "2028",
    "total_reports": 1
  },
  {
    "indication_name": "Medical Pendants",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Medical Protective Equipment",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Medical Radiation Detection Devices",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Medical Rehabilitation Services",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Medical Second Opinion",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Medical Simulation",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Medical Sterilization Equipment",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Medical Suction Devices",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Medical Supplies",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Medical Tourism",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Medical Vacuum Regulator",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Medical Waste Management",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Medicated Intrauterine Devices",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Medication Management (MMS) System",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Medullary Thyroid Cancer",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Medullary Thyroid Cancer - Global API Manufacturers, Marketed and Phase III Drugs Landscape",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Medulloblastoma",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Meibomian Gland Dysfunction",
    "therapeutic_area": "Ophthalmology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Mekinist - API Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Melanocortin 4 Receptor (MC4R) Agonist",
    "therapeutic_area": "Other Diseases",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Melanocortin receptors (MCR) Therapies\u2013 Market Size, Target Population, Competitive Landscape, and Market Forecast",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Melanoma",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 2
  },
  {
    "indication_name": "Melanoma Pipeline Insight",
    "therapeutic_area": "Oncology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Melflufen Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Memantine Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Membranous Nephropathy",
    "therapeutic_area": "Endocrinology and Metabolic Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Memory Disorders",
    "therapeutic_area": "Neurology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Meniere's Disease (MD)",
    "therapeutic_area": "Otolaryngology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Menin Inhibitors Market, Target Population, Competitive Landscape, and Market Forecast",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Meningioma",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Meningitis",
    "therapeutic_area": "Infectious Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Meningococcal Meningitis",
    "therapeutic_area": "Infectious Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Meniscus Repair Systems",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Meniscus Tear",
    "therapeutic_area": "Musculoskeletal",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Menkes Disease",
    "therapeutic_area": "Genetic Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 3
  },
  {
    "indication_name": "Menkes Disease \u2013 Epidemiology Forecast",
    "therapeutic_area": "Genetic Disorders",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Menopause",
    "therapeutic_area": "Womens Health",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2030-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Menopause Associated Vasomotor Symptoms",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Menorrhagia Treatment Devices",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Menorrhalgia",
    "therapeutic_area": "Womens Health",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Menstrual Cups",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Mental Health Screening",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Merkel Cell Carcinoma",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Merrem PWS IV- Generic sale global - API Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Mesenchymal Epithelial Transition Factor Market Size, Target Population, Competitive Landscape & Market Forecast",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Mesenchymal-epithelial transition factor (MET) Kinase Inhibitor \u2013 Market Size, Target Population, Competitive Landscape, and Market Forecast",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Mesothelioma",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Metabolic Acidosis",
    "therapeutic_area": "Endocrinology and Metabolic Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Metabolic Dysfunction-Associated Steatohepatitis (MASH)",
    "therapeutic_area": "Gastroenterology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Metabolic Dysfunction-associated Steatohepatitis (MASH) \u2013 Epidemiology Forecast",
    "therapeutic_area": "Endocrinology and Metabolic Disorders",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Metabolic Syndrome",
    "therapeutic_area": "Endocrinology and Metabolic Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2032-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Metabotropic Glutamate Receptor Agonist",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Metachromatic Leukodystrophy (MLD)",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Metachromatic Leukodystrophy - Competitive Landscape and",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2018,
    "year_range": "2018",
    "total_reports": 1
  },
  {
    "indication_name": "Metagenomic Sequencing",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Metastatic Bone Cancer",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Metastatic Bone Pain",
    "therapeutic_area": "Musculoskeletal",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2025-2032",
    "total_reports": 3
  },
  {
    "indication_name": "Metastatic Breast Cancer",
    "therapeutic_area": "Oncology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Metastatic Castration Resistant Prostate cancer",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2032-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Metastatic Castration-Resistant Prostate Cancer (mCRPC)",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Metastatic Castration-Sensitive Prostate Cancer (mCSPC)",
    "therapeutic_area": "Male Health",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Metastatic Colorectal Cancer",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Metastatic Colorectal Cancer Epidemiology Forecast to",
    "therapeutic_area": "Oncology",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 2
  },
  {
    "indication_name": "Metastatic Conventional Chondrosarcoma",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Metastatic Cutaneous Melanoma",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Metastatic Cutaneous Squamous Cell Cancer",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Metastatic Cutaneous Squamous Cell Carcinoma",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Metastatic HER2 positive Breast Cancer",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Metastatic HER2+ve Breast Cancer Patient Pool Analysis",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Metastatic HR+/HER2- Breast Cancer",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 2
  },
  {
    "indication_name": "Metastatic HR+/HER2-ve Breast Cancer Patient Pool Analysis",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Metastatic Head and Neck Cancer",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Metastatic Hepatocellular Carcinoma",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Metastatic Hepatocellular Carcinoma - Global API Manufacturers, Marketed and Phase III Drugs Landscape",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Metastatic Hormone Refractory Prostate Cancer",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Metastatic Hormone Refractory Prostate Cancer - Global API Manufacturers, Marketed and Phase III Drugs Landscape",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Metastatic Liver Cancer",
    "therapeutic_area": "Oncology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Metastatic Melanoma",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Metastatic Merkel Cell Carcinoma",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2025-2032",
    "total_reports": 2
  },
  {
    "indication_name": "Metastatic Non-Small Cell Lung Cancer",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Metastatic Non-small Cell Lung Cancer Epidemiology Forecast",
    "therapeutic_area": "Oncology",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Metastatic Pancreatic Cancer (MPC)\\n",
    "therapeutic_area": "Oncology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Metastatic Prostate Cancer",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Metastatic Prostate Cancer - Global API Manufacturers, Marketed and Phase III Drugs Landscape",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Metastatic Prostate Cancer Patient Pool Analysis",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Metastatic Renal Cell Carcinoma (mRCC)",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Metastatic Renal Cell Carcinoma (mRCC) - Global API Manufacturers, Marketed and Phase III Drugs Landscape",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Metastatic Triple negative breast Cancer (TNBC) Patient Pool Analysis",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Metastatic Urothelial Carcinoma",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Metastatic Uveal Melanoma (MUM)",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Metastatic Uveal Melanoma Epidemiology Forecast",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Metastatic triple-negative breast cancer (mTNBC)\\n",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Metered Dose Inhaler Devices",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Metgluco - API Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Methicillin-Resistant Staphylococcus Aureus Pipeline Insight",
    "therapeutic_area": "Infectious Diseases",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Methicillin-resistant Staphylococcus Aureus Epidemiology Forecast",
    "therapeutic_area": "Infectious Diseases",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Methicillin-resistant Staphylococcus aureus",
    "therapeutic_area": "Infectious Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Methionine Aminopeptidase 2 (Metap2) Inhibitor",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Methycobal Tablets - API Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Methylmalonic Academia",
    "therapeutic_area": "Endocrinology and Metabolic Disorders",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Methylmalonic Acidemia (MMA)",
    "therapeutic_area": "Rare Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Metronidazole Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Metrorrhagia",
    "therapeutic_area": "Womens Health",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 2
  },
  {
    "indication_name": "Mezavant Xl - API Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Micro Invasive Glaucoma Surgery (MIGS) Devices",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Micro-Guide Catheter",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "MicroLine (pilocarpine) Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "MicroRNA Stimulant Market Size, Target Population, Competitive Landscape & Market Forecast",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Microbial Fermentation Technology",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Microbiome Competitive Landscape",
    "therapeutic_area": "Infectious Diseases",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Microbiome Disease",
    "therapeutic_area": "Infectious Diseases",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Microcarriers",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Microdermabrasion Devices",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Microfluidics",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Microsatellite Stable Colorectal Cancer",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Microscopic Polyangiitis (MPA)",
    "therapeutic_area": "Infectious Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2030-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Microscopy Device",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Microtome",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Microvascular Angina",
    "therapeutic_area": "Cardiovascular Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Middle East Respiratory Syndrome",
    "therapeutic_area": "Infectious Diseases",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Migraine",
    "therapeutic_area": "Neurology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 5
  },
  {
    "indication_name": "Mild Cognitive Impairment",
    "therapeutic_area": "Neurology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Mild Dry Eye",
    "therapeutic_area": "Ophthalmology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2032-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Mild To Moderate Plaque Psoriasis",
    "therapeutic_area": "Dermatology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Milk Protein Concentrate",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Mineral Metabolism Disorder",
    "therapeutic_area": "Endocrinology and Metabolic Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Minerva-35 - API Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Minimal Change Disease",
    "therapeutic_area": "Genito Urinary System and Sex Hormones",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Minimal Residual Disease",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2025-2032",
    "total_reports": 2
  },
  {
    "indication_name": "Minimal Residual Disease Testing",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Minimally Invasive Surgical Devices",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Mirikizumab Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 2
  },
  {
    "indication_name": "Mismatch Repair Deficiency",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Mitochondrial Electron Transport Inhibitor",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Mitochondrial Myopathies",
    "therapeutic_area": "Genetic Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Mitogen Activated Protein Kinase Kinase 2 (MEK-2 or MAP2K2) Inhibitor",
    "therapeutic_area": "Oncology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 2
  },
  {
    "indication_name": "Mitogen-activated Protein Kinase (MAPK) Inhibitor Market Size, Target Population, Competitive Landscape & Market Forecast",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Mitral Valve Annuloplasty Rings",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Mitral Valve Insufficiency",
    "therapeutic_area": "Cardiovascular Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Mitral Valve Regurgitation",
    "therapeutic_area": "Cardiovascular Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Mobile Clinics",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Mobility Aids",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Moderate Dry Eye",
    "therapeutic_area": "Ophthalmology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2032-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Moderate Psoriasis",
    "therapeutic_area": "Immunological and Autoimmune Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Moderate Psoriasis - Global API Manufacturers, Marketed and Phase III Drugs Landscape",
    "therapeutic_area": "Immunological and Autoimmune Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 2
  },
  {
    "indication_name": "Moderate To Severe Acute Pain",
    "therapeutic_area": "Other Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Moderate and Severe Chronic Kidney Disease",
    "therapeutic_area": "Genito Urinary System and Sex Hormones",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2025-2032",
    "total_reports": 2
  },
  {
    "indication_name": "Moderate to Severe Acne",
    "therapeutic_area": "Dermatology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Moderate to Severe Atopic Dermatitis (AD)",
    "therapeutic_area": "Dermatology",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Moderate to Severe Inflammatory Acne Vulgaris",
    "therapeutic_area": "Dermatology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Moderate to Severe Plaque Psoriasis",
    "therapeutic_area": "Dermatology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Moderate to Severe Psoriasis",
    "therapeutic_area": "Immunological and Autoimmune Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Molecular Diagnostics",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Molecular Glues - Competitive landscape",
    "therapeutic_area": "Oncology",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Molecular Glues Market Size, Target Population, Competitive Landscape & Market Forecast",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Molecular Modeling",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Molecular Spectroscopy- Global",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2028,
    "year_range": "2028",
    "total_reports": 1
  },
  {
    "indication_name": "Molluscum Contagiosum (MC)",
    "therapeutic_area": "Dermatology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2028-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Molluscum Contagiosum Epidemiology Forecast",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Molybdenum Cofactor Deficiency (MOCOD)",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Molybdenum Cofactor Deficiency Type A (MoCoD-A)",
    "therapeutic_area": "Genetic Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 2
  },
  {
    "indication_name": "Monkeypox",
    "therapeutic_area": "Infectious Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2025-2032",
    "total_reports": 2
  },
  {
    "indication_name": "Monkeypox - Competitive Landscape",
    "therapeutic_area": "Infectious Diseases",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Monoamine Oxidase B (MAO-B) Inhibitor",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Monoamine Oxidase Inhibitor (MAOIs)",
    "therapeutic_area": "Neurology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Monoamine Oxidase Type-B (MAO-B) Inhibitors Market Size, Target Population, Competitive Landscape & Market Forecast",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Monoclonal Antibody",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Monoclonal Gammopathy of Undetermined Significance",
    "therapeutic_area": "Hematological Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Monoclonal antibodies - Competitive landscape",
    "therapeutic_area": "Oncology",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Morcellators",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Morquio Syndrome",
    "therapeutic_area": "Genetic Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 2
  },
  {
    "indication_name": "Morquio Syndrome Mps IV",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Motor Neuron Disease",
    "therapeutic_area": "Neurology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Motor Neuron Disease Treatment",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Mouth & Throat Pain",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Mouth Neoplasms",
    "therapeutic_area": "Dental and Oral Health",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Mu Antagonist",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Mucinoses",
    "therapeutic_area": "Dermatology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Mucinous Cystic Neoplasm",
    "therapeutic_area": "Oncology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Mucinous Cystic Neoplasms (MCNs)",
    "therapeutic_area": "Oncology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Mucodyne - API Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Mucopolysaccharidosis III",
    "therapeutic_area": "Endocrinology and Metabolic Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 12
  },
  {
    "indication_name": "Mucopolysaccharidosis Type I \u2013 Pipeline Insight",
    "therapeutic_area": "Genetic Disorders",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Mucosa-Associated Lymphoid Tissue (MALT) Lymphoma",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2025-2032",
    "total_reports": 2
  },
  {
    "indication_name": "Mucosal Atomization Devices",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Mucosta - API Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Multaq - API Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Multi-Drug-Resistant (MDR) Neisseria Gonorrhoeae\\n",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "MultiStem Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Multidrug Resistant Acinetobacter Infections",
    "therapeutic_area": "Infectious Diseases",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Multidrug-resistant Gram-negative (MDRGN) Infection",
    "therapeutic_area": "Infectious Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Multifocal Motor Neuropathy",
    "therapeutic_area": "Neurology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Multiple Myeloma (MM)",
    "therapeutic_area": "Oncology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Multiple Myeloma Patient Pool Analysis",
    "therapeutic_area": "Immunological and Autoimmune Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Multiple Myeloma-Related Bone Disease",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Multiple Organ Dysfunction Syndrome",
    "therapeutic_area": "Neurology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2032-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Multiple Osteochondromas (MO)",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Multiple Sclerosis",
    "therapeutic_area": "Neurology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Multiple Sclerosis - Competitive landscape",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Multiple System Atrophy (MSA)",
    "therapeutic_area": "Neurology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Murine Double Minute 2 (MDM2) Inhibitor",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Muscarinic Acetylcholine Receptor (mAChR) Antagonist",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Muscarinic Acetylcholine Receptor M1 Antagonists",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 3
  },
  {
    "indication_name": "Muscarinic Agonist",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Muscarinic M1 Agonist",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Muscle Invasive Bladder cancer",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Muscle Relaxant Drugs",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Muscle Spasticity",
    "therapeutic_area": "Musculoskeletal",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2025-2032",
    "total_reports": 2
  },
  {
    "indication_name": "Muscle Spasticity Epidemiology Forecast",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Musculoskeletal Pain",
    "therapeutic_area": "Musculoskeletal",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 6
  },
  {
    "indication_name": "Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Myasthenia Gravis",
    "therapeutic_area": "Immunological and Autoimmune Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Myasthenia Gravis - Global API Manufacturers, Marketed and Phase III Drugs Landscape",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Myasthenia Gravis Patient Pool Analysis",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Myc Proto Oncogene Protein",
    "therapeutic_area": "Other Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Mycamine - API Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Mycosis Fungoides (MF)",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2028,
    "year_range": "2028",
    "total_reports": 1
  },
  {
    "indication_name": "Mycosis Fungoides - Global API Manufacturers, Marketed and Phase III Drugs Landscape",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Mydriasis",
    "therapeutic_area": "Ophthalmology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Myelin Regeneration in Multiple Sclerosis",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Myelodysplastic Syndrome",
    "therapeutic_area": "Hematological Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 5
  },
  {
    "indication_name": "Myelodysplastic Syndrome with Excess Blasts2",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Myelofibrosis (MF)",
    "therapeutic_area": "Hematological Disorders",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Myelofibrosis - Global API Manufacturers, Marketed and Phase III Drugs Landscape",
    "therapeutic_area": "Hematological Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Myelofibrosis Epidemiology Forecast",
    "therapeutic_area": "Hematological Disorders",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Myeloproliferative Disorder Treatment",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Myeloproliferative Neoplasms",
    "therapeutic_area": "Other Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Myfortic - API Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Myocardial Infarction",
    "therapeutic_area": "Cardiovascular Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 2
  },
  {
    "indication_name": "Myocardial Infarction Epidemiology Forecast",
    "therapeutic_area": "Cardiovascular Diseases",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Myocardial Infarction Patient Pool Analysis",
    "therapeutic_area": "Cardiovascular Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Myocardial Infarction Pipeline Insight",
    "therapeutic_area": "Cardiovascular Diseases",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Myocarditis",
    "therapeutic_area": "Cardiovascular Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Myofascial Pain Syndrome",
    "therapeutic_area": "Musculoskeletal",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Myofibroblasts",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Myopia",
    "therapeutic_area": "Ophthalmology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 5
  },
  {
    "indication_name": "Myopia Progression",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Myopia Progression Epidemiology Forecast",
    "therapeutic_area": "Ophthalmology",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Myopia Progression Pipeline Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Myopia Treatment Devices",
    "therapeutic_area": "Ophthalmology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Myopic Macular Degeneration (MMD) ",
    "therapeutic_area": "Ophthalmology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Myopic Macular Degeneration (MMD) \u2013 Epidemiology Forecast",
    "therapeutic_area": "Ophthalmology",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Myositis",
    "therapeutic_area": "Rare Diseases",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Myostatin Inhibitor",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Myotonic Dystrophy (DM)",
    "therapeutic_area": "Genetic Disorders",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Myotubular Myopathy",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "N-803 Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "NADPH Oxidase (NOX)-Replacement Therapies Market, Target Population, Competitive Landscape, and Market Forecast",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "NAMUSCLA Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "NBI-827104 Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "NBI-921352 Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "NCX-470",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "NE3107 Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "NETs Related Disease",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 2
  },
  {
    "indication_name": "NF-Kappa B Inhibitors \u2013 Pipeline Insights",
    "therapeutic_area": "Immunological and Autoimmune Disorders",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2022,
    "year_range": "2022",
    "total_reports": 1
  },
  {
    "indication_name": "NF-kappa B inhibitors Market, Target Population, Competitive Landscape, and Market Forecast",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "NGLY1 Deficiency",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 2
  },
  {
    "indication_name": "NK Cell Therapy",
    "therapeutic_area": "Hematological Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 2
  },
  {
    "indication_name": "NLRP3 Protein Inhibitors",
    "therapeutic_area": "Immunological and Autoimmune Disorders",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "NMDA (N-methyl-D-aspartate) Receptor Antagonist Market Size, Target Population, Competitive Landscape & Market Forecast",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "NMDA Receptor Antagonist",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "NN6535 Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "NNC0174-0833 Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "NPLATE Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 2
  },
  {
    "indication_name": "NR2E3 mutation-associated retinal degeneration",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2032-2034",
    "total_reports": 2
  },
  {
    "indication_name": "NR2E3 mutation-associated retinal degeneration and CEP290 mutation-associated retinal disease",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "NRG Fusion - Competitive landscape",
    "therapeutic_area": "Oncology",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "NS-065/NCNP-01 (Viltolarsen)",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "NTCD-M3 Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "NUCALA Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "NULIBRY Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "NYX-783",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Nail Diseases",
    "therapeutic_area": "Dermatology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Namenda - API Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "NanoFlu Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Nanomedicine",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Narcolepsy",
    "therapeutic_area": "Central Nervous System",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 4
  },
  {
    "indication_name": "Narcotic Overdose",
    "therapeutic_area": "Central Nervous System",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Narsoplimab Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Nasal Packing Devices",
    "therapeutic_area": "Otolaryngology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Nasal Polyposis",
    "therapeutic_area": "Otolaryngology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 5
  },
  {
    "indication_name": "Nasal Polyps",
    "therapeutic_area": "Otolaryngology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Nasal Splints",
    "therapeutic_area": "Otolaryngology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Nasolabial Fold",
    "therapeutic_area": "Dermatology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2032-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Nasopharyngeal Cancer",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Nasopharyngeal Cancer - Global API Manufacturers, Marketed and Phase III Drugs Landscape",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 2
  },
  {
    "indication_name": "Nasopharyngeal Carcinoma",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Nasopharyngeal Neoplasms",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Nasopharyngoscope",
    "therapeutic_area": "Otolaryngology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Natpara - API Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Natural Killer (NK)-Cell Lymphoma",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2025-2032",
    "total_reports": 2
  },
  {
    "indication_name": "Natural Killer Cell Therapies Competitive Landscape, Technology and Pipeline Analysis",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2021,
    "year_range": "2021",
    "total_reports": 1
  },
  {
    "indication_name": "Natural Killer Cells - Competitive Landscape, Pipeline and Market Analysis",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2017,
    "year_range": "2017",
    "total_reports": 1
  },
  {
    "indication_name": "Natural Killer T Cell Lymphoma",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Nausea and Vomiting Induced by Motion Sickness",
    "therapeutic_area": "Other Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Nausea and Vomiting Induced by Motion Sickness \u2013 Epidemiology Forecast",
    "therapeutic_area": "Other Diseases",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Near Field Communication (NFC) in Healthcare",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Nebivololo Mylan - API Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Nebulizers",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Necrobiosis Lipoidica (NL)",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2032-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Necrobiosis Lipoidica Diabeticorum (NLD)",
    "therapeutic_area": "Dermatology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Necrotizing Enterocolitis",
    "therapeutic_area": "Infectious Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Necrotizing Enterocolitis (NEC) \u2013 Epidemiology Forecast",
    "therapeutic_area": "Infectious Diseases",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Nedosiran Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Needle Free Injections",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Negative Pressure Wound Therapy Systems",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Neisseria Meningitides Meningitis",
    "therapeutic_area": "Infectious Diseases",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Nemolizumab Market Market Size",
    "therapeutic_area": "Dermatology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Neo Antigen T-Cell Therapy",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Neoantigen-based Personalized Cancer Therapeutic Vaccines ",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2025-2032",
    "total_reports": 2
  },
  {
    "indication_name": "Neoantigen-based Personalized Cancer therapeutic Vaccines Competitive Landscape and Market Forecast\u2014by",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Neonatal Fc Receptor Antagonists",
    "therapeutic_area": "Immunological and Autoimmune Disorders",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Neonatal Incubator",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Neonatal Phototherapy",
    "therapeutic_area": "Gastroenterology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Neonatal Respiratory Distress Syndrome",
    "therapeutic_area": "Respiratory Diseases",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Neovascular Age-related Macular Degeneration",
    "therapeutic_area": "Ophthalmology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Nephroblastoma",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2032-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Nephropathic Cystinosis",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Nephrosclerosis",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Nephrotic Syndrome",
    "therapeutic_area": "Genito Urinary System and Sex Hormones",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Nephrotic Syndrome (NS) Etiologies",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Nephrotic Syndrome Epidemiology Forecast",
    "therapeutic_area": "Dental and Oral Health",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Nerve Entrapment Syndrome",
    "therapeutic_area": "Neurology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2032-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Nerve Growth Factor",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Nerve Monitoring System - Global",
    "therapeutic_area": "Neurology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Nerve Repair and Regeneration",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Nerve Sheath Neoplasms",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Nesina - API Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Netherton Syndrome",
    "therapeutic_area": "Dermatology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2030-2034",
    "total_reports": 4
  },
  {
    "indication_name": "Netherton Syndrome Pipeline Insight",
    "therapeutic_area": "Genetic Disorders",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Neu-P11 Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Neuregulins (NRGs) Fusion \u2013 Market Size, Target Population, Competitive Landscape, and Market Forecast",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Neuroblastoma",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Neurodermatitis",
    "therapeutic_area": "Dermatology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2032-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Neuroendocrine Carcinoma",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2032-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Neuroendocrine Prostate Cancer",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Neuroendocrine Prostate Cancer Epidemiology Forecast",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Neuroendocrine Tumors (NETs)",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2027-2034",
    "total_reports": 4
  },
  {
    "indication_name": "Neuroendocrine Tumors Epidemiology Forecast",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Neuroendocrine Tumours",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Neuroendoscopy",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 2
  },
  {
    "indication_name": "Neurofibroma",
    "therapeutic_area": "Genetic Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Neurofibromatoses",
    "therapeutic_area": "Genetic Disorders",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Neurofibromatosis",
    "therapeutic_area": "Genetic Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Neurofibromatosis Type 1 (NF1)",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Neurofibromatosis Type 1-associated Plexiform Neurofibromas (NF1-PN)\u2013 Epidemiology",
    "therapeutic_area": "Dermatology",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Neurofibromatosis Type 2",
    "therapeutic_area": "Genetic Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Neurofibromatosis Type-2 ",
    "therapeutic_area": "Genetic Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Neurofibromatosis type 1-associated Plexiform Neurofibromas (NF1-PN) ",
    "therapeutic_area": "Genetic Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Neurofibrosarcoma",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Neurogenic Detrusor Overactivity",
    "therapeutic_area": "Genito Urinary System and Sex Hormones",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2032-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Neurokinin (NK) Receptor Antagonist",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Neurokinin 1 (NK1) Receptor Agonist",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Neuroleptic Malignant Syndrome",
    "therapeutic_area": "Other Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 2
  },
  {
    "indication_name": "Neurological Biomarkers",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Neurological Diagnostic and Monitoring Equipment",
    "therapeutic_area": "Neurology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Neurology Devices",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Neuromodulation Devices",
    "therapeutic_area": "Neurology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Neuromyelitis Optica",
    "therapeutic_area": "Neurology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Neuromyelitis Optica Spectrum Disorder (NMOSD)",
    "therapeutic_area": "Infectious Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Neuronal Ceroid-Lipofuscinoses (CLN1 disease)",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Neuronal Nitric Oxide Synthase (nNOS or Type I NOS) Inhibitor",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Neurontin - API Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Neuropathic Ocular Pain (NOP)",
    "therapeutic_area": "Ophthalmology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2030-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Neuropathic Ocular Pain (NOP)\u2014Epidemiology Forecast",
    "therapeutic_area": "Ophthalmology",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Neuropathic Pain",
    "therapeutic_area": "Central Nervous System",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Neuropathic Pruritus & Postburn Itch",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Neuroprosthetics",
    "therapeutic_area": "Neurology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Neuroprotection Devices",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Neurostimulation Devices",
    "therapeutic_area": "Neurology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Neurotrophic Keratitis",
    "therapeutic_area": "Ophthalmology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Neurotrophic Keratitis Epidemiology Forecast",
    "therapeutic_area": "Neurology",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Neurotrophic Keratitis Patient Pool Analysis",
    "therapeutic_area": "Ophthalmology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Neurotrophic Keratopathy",
    "therapeutic_area": "Immunological and Autoimmune Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 5
  },
  {
    "indication_name": "Neurovascular Catheters Devices",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Neurovascular Coiling Assist Devices",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Neurovascular Devices",
    "therapeutic_area": "Neurology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Neurovascular Embolization Devices",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Neurovascular Thrombectomy Devices/Neurothrombectomy Devices",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Neutropenia",
    "therapeutic_area": "Hematological Disorders",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Neutrophil Elastase Inhibitor",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Nevoid Basal Cell Carcinoma Syndrome (NBCCS)",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Newborn Jaundice",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Newborn Screening",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Nexavar (sorafenib)",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Nexavar - API Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Nexium-Mups - API Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Nexplanon - API Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Next Generation Complement Therapeutics",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Next Generation Immunotherapies",
    "therapeutic_area": "Other Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Next-Generation Sequencing",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Next-Generation Therapeutics for Bleeding disorders",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Niaspan LP - API Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Nicotine Addiction",
    "therapeutic_area": "Neurology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Nicotine Replacement Therapy",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Niemann Pick C Disease",
    "therapeutic_area": "Rare Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 4
  },
  {
    "indication_name": "Niemann-Pick Disease (Type A)",
    "therapeutic_area": "Genetic Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Niemann-Pick Disease Type C (NPC)",
    "therapeutic_area": "Genetic Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2027,
    "year_range": "2027",
    "total_reports": 1
  },
  {
    "indication_name": "Niemann-Pick Disease Type C (NPC)\u2013 Epidemiology Forecast",
    "therapeutic_area": "Genetic Disorders",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Niemann-Pick Type C Disease",
    "therapeutic_area": "Genetic Disorders",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Night Vision Disturbances (NVD)",
    "therapeutic_area": "Ophthalmology",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 2
  },
  {
    "indication_name": "Nipah Virus (NiV) Infection",
    "therapeutic_area": "Infectious Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Nipocalimab Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Nirsevimab Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Nitric Oxide Synthase Inhibitor",
    "therapeutic_area": "Neurology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "No Option Refractory Disabling Angina (NORDA)",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Nociceptin Receptor Agonists",
    "therapeutic_area": "Neurology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Nocturia",
    "therapeutic_area": "Genito Urinary System and Sex Hormones",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Nocturia - Global API Manufacturers, Marketed and Phase III Drugs Landscape",
    "therapeutic_area": "Genito Urinary System and Sex Hormones",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Nocturnal Enuresis",
    "therapeutic_area": "Genito Urinary System and Sex Hormones",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Non Alcoholic Fatty Liver Disease (NAFLD)",
    "therapeutic_area": "Gastroenterology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Non Alcoholic Fatty Liver Disease (NAFLD) - Global API Manufacturers, Marketed and Phase III Drugs Landscape",
    "therapeutic_area": "Gastroenterology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Non Muscle Invasive Bladder Cancer",
    "therapeutic_area": "Oncology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Non Selective COX Inhibitor",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Non-Alcoholic Fatty Liver Disease (NAFLD) Patient Pool Analysis",
    "therapeutic_area": "Endocrinology and Metabolic Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Non-Alcoholic Steatohepatitis (NASH) ",
    "therapeutic_area": "Gastroenterology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 4
  },
  {
    "indication_name": "Non-Cystic Fibrosis Bronchiectasis (NCFB)",
    "therapeutic_area": "Respiratory Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 5
  },
  {
    "indication_name": "Non-Hodgkin's Lymphoma (NHL)",
    "therapeutic_area": "Oncology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Non-Hodgkin's Lymphoma Epidemiology Forecast",
    "therapeutic_area": "Oncology",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Non-Muscle Invasive Bladder Cancer (NMIBC) Patient Pool Analysis",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Non-Opioid Strontium Chloride",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Non-Postoperative Acute Pain",
    "therapeutic_area": "Other Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Non-Radiographic Axial Spondyloarthritis (nr-AxSpA)",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Non-Receptor Tyrosine Kinase Inhibitor",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Non-ST Segment Elevation Acute Coronary Syndromes (NSTE ACSs)",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Non-Small Cell Lung Cancer (NSCLC)",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Non-Small Cell Lung Cancer - Global API Manufacturers, Marketed and Phase III Drugs Landscape",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Non-Small-Cell Lung Carcinoma (NSCLC) Epidemiology Forecast",
    "therapeutic_area": "Oncology",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Non-Steroidal Anti-Inflammatory Drugs",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Non-Structural Protein 5 Inhibitor",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Non-invasive Prenatal Testing",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Non-metastatic Prostate Cancer (nmPC)",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Non-muscle Invasive Bladder Cancer (NMIBC)",
    "therapeutic_area": "Oncology",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Non-small cell lung cancer (NSCLC) Patient Pool Analysis",
    "therapeutic_area": "Nutritional Disorders and Weight Loss",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Nonalcoholic Steatohepatitis (NASH) Patient Pool Analysis",
    "therapeutic_area": "Gastroenterology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Nonmelanoma Skin Cancer",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Nonsense Mutation Duchenne Muscular Dystrophy (nmDMD)",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Nontuberculous Mycobacterial (NTM) Infections",
    "therapeutic_area": "Infectious Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Noonan Syndrome",
    "therapeutic_area": "Genetic Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2032-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Noradrenaline Transporter (NAT or Norepinephrine Transporter or NET) Inhibitor",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Norovirus Infection",
    "therapeutic_area": "Infectious Diseases",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Northera - API Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Norursodeoxycholic acid Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Norvasc - API Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Norvir SEC - API Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Nosocomial Infections",
    "therapeutic_area": "Infectious Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Nosocomial Infections - Global API Manufacturers, Marketed and Phase III Drugs Landscape",
    "therapeutic_area": "Infectious Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Nosocomial Pneumonia",
    "therapeutic_area": "Infectious Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2025-2032",
    "total_reports": 2
  },
  {
    "indication_name": "Notch Receptor Antagonists",
    "therapeutic_area": "Oncology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Notch Signaling Pathway Inhibitor",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Novel Drug Delivery Devices",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Novothyrox - API Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Nrf2 Pathway Activators",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Nrg1 Fusion Cancer",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Nubeqa",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Nuclear Imaging Equipment",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Nuclear Magnetic Resonance (NMR) Spectrometer",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Nuclear Medicine/Radiopharmaceuticals",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Nucleic Acid Amplification Testing",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Nucleic Acid and Gene Therapies in Neuromuscular Disorders",
    "therapeutic_area": "Neurology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Nucleotide Analog Reverse Transcriptase Inhibitor (NtRTI)s",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "NurOwn (MSC-NTF Cells)",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Nutraceutical Ingredients",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2027,
    "year_range": "2027",
    "total_reports": 1
  },
  {
    "indication_name": "Nutricosmetics",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Nutrigenomics",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Nutritional Premixes",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2027,
    "year_range": "2027",
    "total_reports": 1
  },
  {
    "indication_name": "Nuvaring - API Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Nuvigil - API Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Nyxol (Phentolamine Mesylate) Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Nyxol + Pilocarpine Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "OCALIVA Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "OCE-205 Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "OCS-01 Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 2
  },
  {
    "indication_name": "OCS-02 Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 2
  },
  {
    "indication_name": "OFEV (nintedanib) Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "OHB-607 Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "OLUMIANT Market Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "OLUMIANT Market Size",
    "therapeutic_area": "Other Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "OMVOH Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "ON101 Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "ONC201 Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "ONCOS-102 Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "OPSUMIT Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "OPT-302 Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "OPZELURA Market Size",
    "therapeutic_area": "Dermatology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "ORENCIA Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 2
  },
  {
    "indication_name": "ORKAMBI Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "ORMD-0801 Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "OSE210 Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "OTEZLA Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "OX-40 Agonist",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "OX40 Ligand Inhibitors Market Size, Target Population, Competitive Landscape & Market Forecast",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "OXERVATE Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "OXLUMO Market Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "OZAWADE Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "OZEMPIC",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Obese Patients with Schizophrenia",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Obesity",
    "therapeutic_area": "Endocrinology and Metabolic Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Obesity Patient Pool Analysis",
    "therapeutic_area": "Musculoskeletal",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Obeticholic acid Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Obexelimab Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Obsessive Compulsive Disorder",
    "therapeutic_area": "Neurology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Obstretic Suction Cups",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Obstructive Hypertrophic Cardiomyopathy (HCM)",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Obstructive Sleep Apnea (OSA)",
    "therapeutic_area": "Sleep Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Obstructive Sleep Apnea Patient Pool Analysis",
    "therapeutic_area": "Respiratory Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Occlusion Devices",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Octreotide Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Ocular Drug Delivery System",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Ocular Graft versus host Disease",
    "therapeutic_area": "Immunological and Autoimmune Disorders",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Ocular GvHD",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Ocular Hypertension",
    "therapeutic_area": "Cardiovascular Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 5
  },
  {
    "indication_name": "Ocular Implants",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Ocular Inflammation and Pain",
    "therapeutic_area": "Ophthalmology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Ocular Melanoma",
    "therapeutic_area": "Ophthalmology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Ocular Melanoma \u2013 Epidemiology Forecast",
    "therapeutic_area": "Ophthalmology",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Ocular Motility Disturbance",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Ocular Neuropathic Pain/Corneal Neuropathic Pain",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Ocular Pain",
    "therapeutic_area": "Other Diseases",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Ofev - API Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Olaparib \u00b1 bevacizumab Market Size",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Olezarsen Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2034,
    "year_range": "2032-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Oligodendroglioma",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Oligometastatic Disease",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Oligometastatic Disease \u2013 Epidemiology Forecast",
    "therapeutic_area": "Oncology",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Oligonucleotide Synthesis",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Oligonucleotides - Competitive landscape",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Olokizumab",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Olpasiran Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Olysio - API Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Omburtamab Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Omega 3",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2027,
    "year_range": "2027",
    "total_reports": 1
  },
  {
    "indication_name": "Onchocerciasis",
    "therapeutic_area": "Infectious Diseases",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Oncocytoma",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Oncology Drugs",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Oncolytic Adenovirus",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Oncolytic Virus - Competitive Landscape",
    "therapeutic_area": "Oncology",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Oncolytic Virus Cancer Therapy",
    "therapeutic_area": "Oncology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2018-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Oncolytic Virus Cancer Therapy - Competitive landscape",
    "therapeutic_area": "Oncology",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Oncolytic Virus Therapies \u2013 Market Size, Target Population, Competitive Landscape, and Market Forecast",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Onglyza - API Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Onpattro",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Onvansertib + Abiraterone",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Onvansertib Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Onycholysis",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Onychomycosis",
    "therapeutic_area": "Infectious Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 6
  },
  {
    "indication_name": "OpRegen",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Opana ER - API Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Opdivo (nivolumab) + Yervoy (ipilimumab) Market Size",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Opdualag (nivolumab and relatlimab) Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2035,
    "year_range": "2035",
    "total_reports": 1
  },
  {
    "indication_name": "Open-Angle Glaucoma (OAG)",
    "therapeutic_area": "Ophthalmology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2030,
    "year_range": "2028-2030",
    "total_reports": 2
  },
  {
    "indication_name": "Open-Angle Glaucoma - Global API Manufacturers, Marketed and Phase III Drugs Landscape",
    "therapeutic_area": "Ophthalmology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Open-Angle Glaucoma Epidemiology Forecast",
    "therapeutic_area": "Ophthalmology",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Open-Angle Glaucoma Pipeline Insight",
    "therapeutic_area": "Ophthalmology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Operating Room Equipment",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Ophthalmic Devices",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Ophthalmic Drugs - Global",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2028,
    "year_range": "2028",
    "total_reports": 1
  },
  {
    "indication_name": "Ophthalmic Imaging Equipment",
    "therapeutic_area": "Ophthalmology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Ophthalmic Knives",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Ophthalmic Lasers",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Ophthalmic Perimeters",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Ophthalmic Surgical Devices",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Ophthalmic Ultrasound Devices",
    "therapeutic_area": "Ophthalmology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Ophthalmic Viscoelastic Devices",
    "therapeutic_area": "Ophthalmology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Ophthalmic femtosecond laser",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Ophthalmological Devices",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Ophthalmoplegia",
    "therapeutic_area": "Ophthalmology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Ophthalmoscopes",
    "therapeutic_area": "Ophthalmology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Opioid Dependence",
    "therapeutic_area": "Neurology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Opioid Kappa Receptor Agonists",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Opioid Kappa Receptor Agonists Market Size, Target Population, Competitive Landscape & Market Forecast",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Opioid Overdose",
    "therapeutic_area": "Neurology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Opioid Receptor Agonist",
    "therapeutic_area": "Neurology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Opioid Related Disorder",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Opioid Use Disorder (OUD)",
    "therapeutic_area": "Toxicology",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Opioid Withdrawal Syndrome",
    "therapeutic_area": "Toxicology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Opioid-Induced Constipation",
    "therapeutic_area": "Gastroenterology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Opioid-Induced Constipation - Global API Manufacturers, Marketed and Phase III Drugs Landscape",
    "therapeutic_area": "Gastroenterology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Opioid-Induced Respiratory Depression",
    "therapeutic_area": "Toxicology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Opioid-related Disorders",
    "therapeutic_area": "Neurology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2032-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Opium Addiction",
    "therapeutic_area": "Neurology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2032-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Opsumit - API Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Optic Atropy",
    "therapeutic_area": "Ophthalmology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Optic Nerve Diseases",
    "therapeutic_area": "Neurology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Optic Neuritis",
    "therapeutic_area": "Ophthalmology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Optic Neuritis - Global API Manufacturers, Marketed and Phase III Drugs Landscape",
    "therapeutic_area": "Ophthalmology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Optic Neuropathy",
    "therapeutic_area": "Ophthalmology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Optical Biometry Devices",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Optical Coherence Tomography (OCT) Devices",
    "therapeutic_area": "Ophthalmology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Optogenetics Actuators and Sensors",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Optruma - API Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Oral Care Products",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2027,
    "year_range": "2027",
    "total_reports": 1
  },
  {
    "indication_name": "Oral Dysplasia",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Oral Electrolyte Solutions",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2025-2032",
    "total_reports": 2
  },
  {
    "indication_name": "Oral Mucositis (OM)",
    "therapeutic_area": "Dental and Oral Health",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2028,
    "year_range": "2027-2028",
    "total_reports": 2
  },
  {
    "indication_name": "Oral Mucositis - Global API Manufacturers, Marketed and Phase III Drugs Landscape",
    "therapeutic_area": "Dental and Oral Health",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Orenitram Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Orexin Receptor (Hypocretin Receptor) Antagonist",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Orforglipron Sales Forecast, and Market Size Analysis",
    "therapeutic_area": "Other Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Organoids",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Orilissa (Elagolix)",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Ornithine Decarboxylase (ODC) Inhibitor",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Ornithine Transcarbamylase Deficiency (OTC Deficiency)",
    "therapeutic_area": "Genetic Disorders",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Oropharyngeal Cancer",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Oropharyngeal Cancer Epidemiology Forecast",
    "therapeutic_area": "Oncology",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Oropharyngeal Cancer Pipeline Insight",
    "therapeutic_area": "Oncology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Orphan Drugs",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Orthobiologics",
    "therapeutic_area": "Musculoskeletal",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Orthokeratology Lens",
    "therapeutic_area": "Ophthalmology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Orthopedic Bone Cement",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Orthopedic Braces and Support System",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Orthopedic Digit Implants",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Orthopedic Implants",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Orthopedic Power Devices",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Orthopedic Prosthesis Devices",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Orthopedic Screwdriver",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Orthopedic Software",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Orthopedic Splints",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Orthopedic Trauma Devices",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Orthostatic Hypotension",
    "therapeutic_area": "Other Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Orthotic Devices",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Orvepitant Maleate Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Osphena - API Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Osseointegration Implants",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Osteoarthritis",
    "therapeutic_area": "Central Nervous System",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 2
  },
  {
    "indication_name": "Osteoarthritis Patient Pool Analysis",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Osteoarthritis Pipeline Insight",
    "therapeutic_area": "Musculoskeletal",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Osteochondrodysplasia",
    "therapeutic_area": "Musculoskeletal",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 2
  },
  {
    "indication_name": "Osteochondromas",
    "therapeutic_area": "Non-Malignant Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 2
  },
  {
    "indication_name": "Osteogenesis Imperfecta (OI)",
    "therapeutic_area": "Genetic Disorders",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Osteomyelitis",
    "therapeutic_area": "Infectious Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Osteonecrosis",
    "therapeutic_area": "Other Diseases",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Osteoporosis",
    "therapeutic_area": "Endocrinology and Metabolic Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 4
  },
  {
    "indication_name": "Osteosarcoma",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Otenaproxesul Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Otezla - API Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Otilimab (GSK3196165)",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Otitis Media",
    "therapeutic_area": "Otolaryngology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Otitis Media - Global API Manufacturers, Marketed and Phase III Drugs Landscape",
    "therapeutic_area": "Otolaryngology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Otoacoustic Emissions Screening Systems",
    "therapeutic_area": "Otolaryngology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Otological Drill Burrs/Drill Surgical Power Tool",
    "therapeutic_area": "Otolaryngology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Otomycosis",
    "therapeutic_area": "Infectious Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Otoscope",
    "therapeutic_area": "Otolaryngology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Ovarian Cancer",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Ovarian Clear Cell Carcinoma",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 2
  },
  {
    "indication_name": "Ovarian Granulosa Cell Tumors",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Over the Counter (OTC) Drugs",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Over-the-Wire Micro-Guide Catheter",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Overactive Bladder (OAB)",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2032-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Overactive Bladder Syndrome",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Overactive Bladder Treatment",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Overactive Bowel Disease",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Overt Hepatic Encephalopathy",
    "therapeutic_area": "Gastroenterology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 5
  },
  {
    "indication_name": "Oxygen & Hyperbaric Oxygen Equipment",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Oxygen Conservers",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Oxygen Conserving Devices",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Oxygen Therapy Equipment",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Oxygen and Hyperbaric Oxygen Equipment",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Oxygenators",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "P2X7 Receptor Antagonist",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "P2Y12 Platelet ADP Receptor Antagonist",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "P38 Mitogen-Activated Protein (MAP) Kinase Inhibitors",
    "therapeutic_area": "Genetic Disorders",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "P53 Antigen Modulators",
    "therapeutic_area": "Oncology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "PADCEV Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "PADCEV and KEYTRUDA Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "PALFORZIA Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "PALOVAROTENE",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "PALYNZIQ (Pegvaliase-pqpz) Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "PARP Inhibitors",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 2
  },
  {
    "indication_name": "PBF-680 Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "PCSK9 Inhibitors",
    "therapeutic_area": "Genetic Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "PCSK9 Inhibitors (PCSK9i) disease",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "PCSK9 Inhibitors Epidemiology Forecast",
    "therapeutic_area": "Genetic Disorders",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "PCSK9 Inhibitors Pipeline Insight",
    "therapeutic_area": "Cardiovascular Diseases",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "PD-(L)1 Inhibitors",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "PD-1 Inhibitor",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "PD-1 Non-Small Cell Lung Cancer (PD-1+ NSCLC)",
    "therapeutic_area": "Oncology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "PD-1 Refractory Advanced Melanoma",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "PD-1 Resistant Head and Neck Cancer (HNC)",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2030-2034",
    "total_reports": 3
  },
  {
    "indication_name": "PD-1 and PD-L1",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "PD-1 and PD-L1 Inhibitors - Competitive Landscape, Pipeline and Market Analysis",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2017,
    "year_range": "2017",
    "total_reports": 1
  },
  {
    "indication_name": "PD-1 and PD-L1 Inhibitors Market Size, Target Population, Competitive Landscape & Market Forecast",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "PD-1 and PD-L1 Inhibitors- Competitive Landscape",
    "therapeutic_area": "Oncology",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "PD-L1 Metastatic Non-small Cell Lung Cancer",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "PDE 10 inhibitor",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 2
  },
  {
    "indication_name": "PDE Inhibitor",
    "therapeutic_area": "Cardiovascular Diseases",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "PDE3/4 inhibitor - Target Population, Competitive Landscape, and Market Forecast",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 2
  },
  {
    "indication_name": "PDP-716 Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "PEComa",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "PEGCETACOPLAN (APL-2)",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "PEMAZYRE Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "PENNSAID Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "PENTHROX Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "PERSERIS Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "PET-MRI Systems",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "PEXA-VEC Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "PF-06425090 Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "PF-06650833 Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "PF-06651600 Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "PF-06823859 Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "PF-06882961 Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "PF-06939926",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "PF-07055480 Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "PF-07923568 Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "PH10 Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "PH94B Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "PI3K Inhibitor",
    "therapeutic_area": "Oncology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "PI3K/mTOR Pathway Inhibitor",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "PIQRAY Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "PK101 Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "PLN-74809 Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "POMC Deficiency Obesity",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "POSIMIR Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "POTELIGEO Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 2
  },
  {
    "indication_name": "PPAR-Beta / Delta Agonist",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "PPMX-T003 Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "PRA-023 Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "PRAX-114 Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "PRAX562 Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "PRMT5 Protein Inhibitors",
    "therapeutic_area": "Oncology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "PRN-1008 Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "PROLASTIN Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "PROMACTA Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 2
  },
  {
    "indication_name": "PROTAC Market Size, Target Population, Competitive Landscape & Market Forecast",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "PRV-031 Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "PRX-102 (Pegunigalsidase alfa)",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "PSMA-Targeted Therapy Market Size, Target Population, Competitive Landscape & Market Forecast",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "PT010 Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "PTCL-NOS",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "PTI-428",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "PTI-801",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "PTI-808",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "PULMOZYME Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "PVSRIPO Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Pacemakers",
    "therapeutic_area": "Cardiovascular Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Pacemakers Pipeline Insight and Competitive Landscape",
    "therapeutic_area": "Cardiovascular Diseases",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2023,
    "year_range": "2023",
    "total_reports": 1
  },
  {
    "indication_name": "Pachyonychia Congenita",
    "therapeutic_area": "Dermatology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2032-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Paclitaxel trevatide (ANG1005) Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Paget's Disease",
    "therapeutic_area": "Musculoskeletal",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Pain Management Devices",
    "therapeutic_area": "Neurology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Palivizumab Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Palmar Fibromatosis",
    "therapeutic_area": "Other Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 2
  },
  {
    "indication_name": "Palmar Hyperhidrosis (US)",
    "therapeutic_area": "Other Diseases",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Palmoplantar Keratoderma (PPK)",
    "therapeutic_area": "Dermatology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Palmoplantar Pustulosis",
    "therapeutic_area": "Dermatology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Paltusotine Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Pamrevlumab Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 3
  },
  {
    "indication_name": "Pancreatic Adenocarcinoma",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Pancreatic Cancer",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Pancreatic Cancer - Competitive Landscape",
    "therapeutic_area": "Oncology",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Pancreatic Cancer Patient Pool Analysis",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Pancreatic Ductal Adenocarcinoma",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2025-2032",
    "total_reports": 2
  },
  {
    "indication_name": "Pancreatic Ductal Carcinoma",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Pancreatic Endocrine Tumor",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Pancreatic Neuroendocrine Tumors (PNET)",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2028,
    "year_range": "2028",
    "total_reports": 1
  },
  {
    "indication_name": "Pancreatitis",
    "therapeutic_area": "Gastroenterology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Panic Disorder",
    "therapeutic_area": "Other Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Panuveitis",
    "therapeutic_area": "Ophthalmology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Papillary Thyroid Cancer",
    "therapeutic_area": "Oncology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Papilloma",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Papulopustular Rosacea",
    "therapeutic_area": "Dermatology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Paraganglioma",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 2
  },
  {
    "indication_name": "Parainfluenza Virus Infection",
    "therapeutic_area": "Infectious Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 4
  },
  {
    "indication_name": "Paranasal Sinus Cancer",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Parathyroid Hormone Receptor Agonist",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Parenteral Nutrition",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Pariet - API Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Parkinson's Disease",
    "therapeutic_area": "Neurology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 6
  },
  {
    "indication_name": "Parkinson's Disease Levodopa-Induced Dyskinesia",
    "therapeutic_area": "Neurology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Parkinson's Disease Psychosis",
    "therapeutic_area": "Neurology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Parkinson's Disease Related Dementia",
    "therapeutic_area": "Neurology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 2
  },
  {
    "indication_name": "Parkinson's Disease Treatment Resistant Epilepsy",
    "therapeutic_area": "Neurology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Parkinson's disease Patient Pool Analysis",
    "therapeutic_area": "Neurology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Parkinson\u2019s disease",
    "therapeutic_area": "Neurology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Parkinson\u2019s disease Levodopa-induced dyskinesia (PD-LID) \u2013 Epidemiology Forecast",
    "therapeutic_area": "Neurology",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Paroxysmal Hemoglobinuria",
    "therapeutic_area": "Hematological Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Paroxysmal Nocturnal Hemoglobinuria",
    "therapeutic_area": "Hematological Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 5
  },
  {
    "indication_name": "Paroxysmal Nocturnal Hemoglobinuria - Global API Manufacturers, Marketed and Phase III Drugs Landscape",
    "therapeutic_area": "Hematological Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Paroxysmal Supraventricular Tachycardia",
    "therapeutic_area": "Cardiovascular Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Parry-Romberg Syndrome (PRS)",
    "therapeutic_area": "Rare Diseases",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Pars Planitis",
    "therapeutic_area": "Ophthalmology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2032-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Partial Epilepsy",
    "therapeutic_area": "Neurology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Partial Knee Arthroplasty",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Partial Onset seizures",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Partial Paralysis",
    "therapeutic_area": "Neurology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Partial Paralysis and Muscle Weakness",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Partial Seizure",
    "therapeutic_area": "Neurology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Partial Seizure - Global API Manufacturers, Marketed and Phase III Drugs Landscape",
    "therapeutic_area": "Neurology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Patent Foramen Ovale (PFO) Closure Devices",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Patient Engagement Solutions",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Patient Flow Management Solutions",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Patient Lateral Transfer",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Patient Lifting Equipment",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Patient Monitoring Devices",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Patient-controlled Analgesic Pumps",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Paucity of Interlobular Bile Ducts",
    "therapeutic_area": "Gastroenterology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Peak Flow Meters",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Peanut Allergy",
    "therapeutic_area": "Immunological and Autoimmune Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2028-2034",
    "total_reports": 6
  },
  {
    "indication_name": "Peanut Allergy (PA)\u2014Epidemiology Forecast to",
    "therapeutic_area": "Immunological and Autoimmune Disorders",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Peanut Allergy - Global API Manufacturers, Marketed and Phase III Drugs Landscape",
    "therapeutic_area": "Immunological and Autoimmune Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Peanut Allergy Pipeline Insight",
    "therapeutic_area": "Immunological and Autoimmune Disorders",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Pearson Syndrome",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Pediatric Brain Cancer",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Pediatric Brain Tumors",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Pediatric Central Nervous System Tumors",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Pediatric Drugs",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Pediatric Growth Hormone Deficiency",
    "therapeutic_area": "Endocrinology and Metabolic Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Pediatric Neuroblastoma",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Pediatric Neurology Devices",
    "therapeutic_area": "Neurology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Pediatric Obesity",
    "therapeutic_area": "Pediatrics",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Pediatric Relapsed-Refractory Neuroblastoma",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Pedicle Screw System",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Pegargiminase Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Pegcetacoplan (APL-2) Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Pegfilgrastim \u2013 Biosimilar Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2024,
    "year_range": "2024",
    "total_reports": 1
  },
  {
    "indication_name": "Pegozafermin (BIO89-100) Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Pelacarsen Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Pelizaeus-Merzbacher Disease",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Pelvic Cancer induced Hemorrhagic Cystitis",
    "therapeutic_area": "Genito Urinary System and Sex Hormones",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Pelvic Floor Disorders Treatment Devices",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Pelvic Floor Stimulation Devices",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Pelvic Inflammatory Disease",
    "therapeutic_area": "Womens Health",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Pelvic Organ Prolapse",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Pemphigus Vulgaris (PV)",
    "therapeutic_area": "Dermatology",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Penicillin-Binding Proteins",
    "therapeutic_area": "Other Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Penicillin-Binding Proteins (PBPs) Inhibitor",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Penile Cancer",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Penile Implants",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Pentasa Enema - API Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Peptic Ulcer Hemorrhage",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Peptic Ulcer Hemorrhage Epidemiology Forecast",
    "therapeutic_area": "Gastroenterology",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Peptic Ulcers",
    "therapeutic_area": "Gastroenterology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Peptide Drug Conjugates",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Peptide Synthesis",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Peptide Therapeutics",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Percutaneous Arterial Closure Device",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Percutaneous Mechanical Circulatory Support Devices",
    "therapeutic_area": "Cardiovascular Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Percutaneous Nephrolithotomy System",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Perennial Allergic Rhinitis",
    "therapeutic_area": "Otolaryngology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Pericarditis",
    "therapeutic_area": "Cardiovascular Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2025-2032",
    "total_reports": 2
  },
  {
    "indication_name": "Periodontal Disease",
    "therapeutic_area": "Dental and Oral Health",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Periodontal Inflammation",
    "therapeutic_area": "Dental and Oral Health",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Peripheral Aneurysms",
    "therapeutic_area": "Cardiovascular Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Peripheral Arterial Disease (PAD)/ Pulmonary Vascular Disease (PVD)",
    "therapeutic_area": "Cardiovascular Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 2
  },
  {
    "indication_name": "Peripheral Arterial Disease (PAD)/ Pulmonary Vascular Disease (PVD) - Global API Manufacturers, Marketed and Phase III Drugs Landscape",
    "therapeutic_area": "Cardiovascular Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Peripheral Arterial Disease Pipeline Insight",
    "therapeutic_area": "Cardiovascular Diseases",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Peripheral Artery Disease (PAD)",
    "therapeutic_area": "Cardiovascular Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2032-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Peripheral Artery Disease (PAD) Treatment",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Peripheral Artery Disease and Stenosis Treatment Devices",
    "therapeutic_area": "Cardiovascular Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Peripheral Embolic Protection Devices",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Peripheral Nerve Injuries",
    "therapeutic_area": "Neurology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Peripheral Nerve Repair Devices",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Peripheral Nerve Stimulators",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Peripheral Nerve Stimulators (PNS)\u2013Pipeline Insight and Competitive Landscape",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2023,
    "year_range": "2023",
    "total_reports": 1
  },
  {
    "indication_name": "Peripheral Neuritis",
    "therapeutic_area": "Neurology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2032-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Peripheral Neuropathic Pain",
    "therapeutic_area": "Neurology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Peripheral Neuropathic Pain - Global API Manufacturers, Marketed and Phase III Drugs Landscape",
    "therapeutic_area": "Neurology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Peripheral SpA",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Peripheral T cell Lymphoma",
    "therapeutic_area": "Oncology",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Peripheral T-Cell Lymphoma (PTCL) Patient Pool Analysis",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Peripheral T-Cell Lymphomas (PTCL)",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2027,
    "year_range": "2025-2027",
    "total_reports": 2
  },
  {
    "indication_name": "Peripheral T-Cell Lymphomas (PTCL) - Global API Manufacturers, Marketed and Phase III Drugs Landscape",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Peripheral Vascular Clot Management Interventions",
    "therapeutic_area": "Cardiovascular Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Peripheral Vascular Devices",
    "therapeutic_area": "Cardiovascular Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Peripheral Vascular Interventions",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2032-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Peripheral arterial disease (PAD) Patient Pool Analysis",
    "therapeutic_area": "Neurology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Peripherally Inserted Central Catheter (PICC) Devices",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Peritoneal Cancer",
    "therapeutic_area": "Oncology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Peritoneal Carcinomatosis (PC)",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Peritoneal Dialysis Equipment",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Peritoneal Dialysis Equipment\u2013Pipeline Insight and Competitive Landscape",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2023,
    "year_range": "2023",
    "total_reports": 1
  },
  {
    "indication_name": "Perivascular Epithelioid Cell Tumor",
    "therapeutic_area": "Other Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Peroxisome Proliferator-Activated Receptor (PPAR) Agonist",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Persistant Angina Pain",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Persistent Corneal Edema ",
    "therapeutic_area": "Ophthalmology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Persistent Corneal Epithelial Defect",
    "therapeutic_area": "Ophthalmology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Persistent Depressive Disorder",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Persistent Epithelial Defects (PEDs)",
    "therapeutic_area": "Ophthalmology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2032-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Persistent Epithelial Defects Pipeline Insight",
    "therapeutic_area": "Ophthalmology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Persistent Pulmonary Hypertension of the Newborn",
    "therapeutic_area": "Respiratory Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Personal Care Contract Manufacturing",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Personal Care Ingredients",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2027,
    "year_range": "2027",
    "total_reports": 1
  },
  {
    "indication_name": "Personal Emergency Response Systems (PERS)",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Pertussis",
    "therapeutic_area": "Infectious Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 5
  },
  {
    "indication_name": "Pet Care",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Pet Food Ingredients",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2028,
    "year_range": "2028",
    "total_reports": 1
  },
  {
    "indication_name": "Phaeochromocytoma",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2025-2032",
    "total_reports": 3
  },
  {
    "indication_name": "Phage Therapies - Competitive landscape",
    "therapeutic_area": "Infectious Diseases",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Pharma 4.0",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Pharmaceutical Cartridges",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Pharmaceutical Contract Manufacturing",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Pharmaceutical Contract Packaging",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Pharmaceutical Excipients",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Pharmaceutical Filtration",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Pharmaceuticals",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Pharmacogenomics",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Pharmacovigilance and Drug Safety Software",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Pharmacy Automation Devices",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2028,
    "year_range": "2028",
    "total_reports": 1
  },
  {
    "indication_name": "Pharyngitis",
    "therapeutic_area": "Otolaryngology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Pharyngoscopes",
    "therapeutic_area": "Otolaryngology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Phenylketonuria (PKU)",
    "therapeutic_area": "Endocrinology and Metabolic Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2030-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Phenylketonuria (PKU) - Global API Manufacturers, Marketed and Phase III Drugs Landscape",
    "therapeutic_area": "Endocrinology and Metabolic Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Pheochromocytoma Epidemiology Forecast",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Pheochromocytomas and Paragangliomas (PCPG)",
    "therapeutic_area": "Rare Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Phoropters",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Phosphatidylinositol 3 Kinase Delta Inhibitors",
    "therapeutic_area": "Oncology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Phosphodiesterase-4 (PDE4) Inhibitor Market Size, Target Population, Competitive Landscape & Market Forecast",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Phosphoglucomutase (PGM 1) Deficiency",
    "therapeutic_area": "Immunological and Autoimmune Disorders",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Phosphoglucomutase 1 Deficiency",
    "therapeutic_area": "Endocrinology and Metabolic Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2028-2032",
    "total_reports": 2
  },
  {
    "indication_name": "Phosphoinositide 3-Kinase Beta (PI3K Beta) Inhibitor",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Phosphoinositide 3-Kinase Delta (PI3K Delta) Inhibitor",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Phosphoinositide 3-kinase inhibitors (PI3K) Market Size, Target Population, Competitive Landscape, and Market Forecast",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Phosphor Screen Scanners",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Phosphoramidite",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Photodynamic Therapies in Oncology Target Population, Competitive Landscape, and Market Forecast",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Phototherapies for Psoriasis",
    "therapeutic_area": "Dermatology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Phototherapy Devices",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Physiotherapy Equipment",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Pigment Epithelial Detachment",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Pigmentation Disorder",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Pim Kinase Inhibitor",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Pituitary ACTH Hypersecretion (Cushing's Disease)",
    "therapeutic_area": "Endocrinology and Metabolic Disorders",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Pituitary Stalk Interruption Syndrome (PSIS)",
    "therapeutic_area": "Endocrinology and Metabolic Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Placenta Growth Factor Inhibitors",
    "therapeutic_area": "Ophthalmology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Plague",
    "therapeutic_area": "Infectious Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Plant Extracts",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2027,
    "year_range": "2027",
    "total_reports": 1
  },
  {
    "indication_name": "Plantar Fasciitis",
    "therapeutic_area": "Immunological and Autoimmune Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2025-2032",
    "total_reports": 2
  },
  {
    "indication_name": "Plaque Modification Devices",
    "therapeutic_area": "Other Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Plaque Psoriasis",
    "therapeutic_area": "Immunological and Autoimmune Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Plaquenil \u2013 Drug Insights",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2020,
    "year_range": "2020",
    "total_reports": 1
  },
  {
    "indication_name": "Plasma Cell Leukemia",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2032-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Plasma Protease C1-inhibitor",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Plasma Protein Therapeutics",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Plasmacytoma",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2025-2032",
    "total_reports": 2
  },
  {
    "indication_name": "Plasmacytoma Epidemiology Forecast",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Plasmid DNA Manufacturing",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Plasmin Inhibitor",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Plasminogen Activator Inhibitor",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Plasminogen Activator Inhibitor-1 (PAI-1)",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Plasminogen Activators",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Plasmodium Vivax Malaria",
    "therapeutic_area": "Other Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Platelet Aggregation Devices",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Platelet Derived Growth Factor Inhibitor",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Platelet Rich Plasma (PRP)",
    "therapeutic_area": "Other Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2028,
    "year_range": "2028",
    "total_reports": 1
  },
  {
    "indication_name": "Platinum Resistant Ovarian Cancer (PROC)",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Platinum-Resistant Relapsed Ovarian Cancer",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 2
  },
  {
    "indication_name": "Platinum-based Chemotherapy and Nephrotoxicity",
    "therapeutic_area": "Toxicology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Platinum-based Chemotherapy and Nephrotoxicity Epidemiology Forecast",
    "therapeutic_area": "Toxicology",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Plavix - API Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Pletal - API Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Pleural Diseases",
    "therapeutic_area": "Respiratory Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Pleural Effusion",
    "therapeutic_area": "Respiratory Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Pleural Effusion Treatment Devices",
    "therapeutic_area": "Respiratory Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Plexiform Neurofibroma",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Plozasiran Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Pneumococcal Disease",
    "therapeutic_area": "Infectious Diseases",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Pneumococcal Infections",
    "therapeutic_area": "Infectious Diseases",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Pneumoconiosis",
    "therapeutic_area": "Respiratory Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2032-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Pneumonia",
    "therapeutic_area": "Infectious Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2032-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Pneumonia, Pneumococcal",
    "therapeutic_area": "Infectious Diseases",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Pneumothorax Treatment Devices",
    "therapeutic_area": "Respiratory Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Point of Care Diagnostics",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Point of Care Glucose Testing",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Poliomyelitis",
    "therapeutic_area": "Infectious Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Pollen Allergy",
    "therapeutic_area": "Immunological and Autoimmune Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Polo-Like Kinase 1 (PLK1 ) Inhibitor",
    "therapeutic_area": "Oncology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Polo-Like Kinase Inhibitor",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Poly (ADP-Ribose) Polymerase 1 (PARP) Inhibitor",
    "therapeutic_area": "Oncology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Poly(ADP-ribose) Polymerase Inhibitors",
    "therapeutic_area": "Oncology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Polyarticular Juvenile Idiopathic Arthritis",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Polycystic Kidney Disease (PKD)",
    "therapeutic_area": "Genito Urinary System and Sex Hormones",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2028,
    "year_range": "2028",
    "total_reports": 1
  },
  {
    "indication_name": "Polycystic Kidney Disease - Global API Manufacturers, Marketed and Phase III Drugs Landscape",
    "therapeutic_area": "Genito Urinary System and Sex Hormones",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Polycystic Ovarian Syndrome",
    "therapeutic_area": "Womens Health",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Polycystic Ovarian Syndrome Epidemiology Forecast",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Polycystic Ovary Syndrome",
    "therapeutic_area": "Womens Health",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Polycythemia",
    "therapeutic_area": "Hematological Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Polycythemia - Global API Manufacturers, Marketed and Phase III Drugs Landscape",
    "therapeutic_area": "Hematological Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Polycythemia Vera",
    "therapeutic_area": "Hematological Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 4
  },
  {
    "indication_name": "Polycythemia Vera Patient Pool Analysis",
    "therapeutic_area": "Hematological Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Polymerase Chain Reaction",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Polymyalgia Rheumatica",
    "therapeutic_area": "Other Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 5
  },
  {
    "indication_name": "Polymyositis",
    "therapeutic_area": "Hematological Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 5
  },
  {
    "indication_name": "Polypoidal Choroidal Vasculopathy (PCV)",
    "therapeutic_area": "Ophthalmology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Polysomnography Device",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Pomalyst - API Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Pompe Disease",
    "therapeutic_area": "Endocrinology and Metabolic Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 4
  },
  {
    "indication_name": "Pompe Disease - Global API Manufacturers, Marketed and Phase III Drugs Landscape",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Pork Tapeworm Infection",
    "therapeutic_area": "Infectious Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Porphyria",
    "therapeutic_area": "Genetic Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Porphyria - Global API Manufacturers, Marketed and Phase III Drugs Landscape",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Portable Ultrasound Bladder Scanner",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Portable Ultrasound Devices",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Portable X-Ray Devices",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Portal Hypertension",
    "therapeutic_area": "Genetic Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2025-2032",
    "total_reports": 2
  },
  {
    "indication_name": "Positive Air Pressure Devices",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Positive Airway Pressure Device",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Positron Emission Tomography",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Post Menopausal Osteoporosis",
    "therapeutic_area": "Endocrinology and Metabolic Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Post Menopausal Osteoporosis - Global API Manufacturers, Marketed and Phase III Drugs Landscape",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Post Operative Pain Management",
    "therapeutic_area": "Musculoskeletal",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Post Surgical Pain",
    "therapeutic_area": "Other Diseases",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Post operative pain management Epidemiology Forecast",
    "therapeutic_area": "Other Diseases",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Post-Bariatric Hypoglycemia",
    "therapeutic_area": "Endocrinology and Metabolic Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 2
  },
  {
    "indication_name": "Post-Cardiac Arrest Syndrome (PCAS)",
    "therapeutic_area": "Cardiovascular Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 4
  },
  {
    "indication_name": "Post-Operative Cataract Surgery Inflammation",
    "therapeutic_area": "Other Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Post-Operative Nausea & Vomiting",
    "therapeutic_area": "Other Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2032-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Post-Polycythemia Vera Myelofibrosis",
    "therapeutic_area": "Hematological Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Post-Surgical infection",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Post-Surgical pain",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Post-Transplant Lymphoproliferative Disorder",
    "therapeutic_area": "Immunological and Autoimmune Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Post-Traumatic Stress Disorder (PTSD)",
    "therapeutic_area": "Neurology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Post-Traumatic Stress Disorder (PTSD) - Global API Manufacturers, Marketed and Phase III Drugs Landscape",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Post-transplant Lymphoproliferative Disease",
    "therapeutic_area": "Immunological and Autoimmune Disorders",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Postherpetic Neuralgia",
    "therapeutic_area": "Central Nervous System",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Postherpetic Neuralgia - Global API Manufacturers, Marketed and Phase III Drugs Landscape",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Postmenopausal Vaginal Atrophy",
    "therapeutic_area": "Womens Health",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Postmyocardial Infarction Syndrome",
    "therapeutic_area": "Cardiovascular Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 2
  },
  {
    "indication_name": "Postoperative Acute Pain",
    "therapeutic_area": "Other Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Postoperative Gastrointestinal Dysfunction",
    "therapeutic_area": "Gastroenterology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Postoperative Ileus",
    "therapeutic_area": "Gastroenterology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Postoperative Nausea & Vomiting (PONV)",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Postoperative Nausea and Vomiting (PONV)",
    "therapeutic_area": "Other Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Postoperative Pain",
    "therapeutic_area": "Neurology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 4
  },
  {
    "indication_name": "Postoperative Pain Epidemiology Forecast",
    "therapeutic_area": "Neurology",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Postoperative Pain Management Pipeline Insight",
    "therapeutic_area": "Musculoskeletal",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Postpartum Depression",
    "therapeutic_area": "Womens Health",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 5
  },
  {
    "indication_name": "Postpartum Hemorrhage",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Potassium Channel Openers",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Pouchitis",
    "therapeutic_area": "Immunological and Autoimmune Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2032-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Pouchitis - Global API Manufacturers, Marketed and Phase III Drugs Landscape",
    "therapeutic_area": "Genito Urinary System and Sex Hormones",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 4
  },
  {
    "indication_name": "Povetacicept Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Povorcitinib (INCB054707) Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Powered Surgical Instrument",
    "therapeutic_area": "Otolaryngology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Pozelimab Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Prader-Willi Syndrome",
    "therapeutic_area": "Genetic Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 4
  },
  {
    "indication_name": "Pre-Eclampsia",
    "therapeutic_area": "Rare Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Prebiotics Ingredients",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2028,
    "year_range": "2028",
    "total_reports": 1
  },
  {
    "indication_name": "Precocious Puberty",
    "therapeutic_area": "Endocrinology and Metabolic Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Prediabetes",
    "therapeutic_area": "Endocrinology and Metabolic Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Preeclampsia Diagnostics",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Preeclampsia \u2013 Epidemiology Forecast",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Prefilled Syringes",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Premarin - API Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Premature Ejaculation",
    "therapeutic_area": "Male Health",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Premature Ejaculation - Global API Manufacturers, Marketed and Phase III Drugs Landscape",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Premature Labor (Tocolysis)",
    "therapeutic_area": "Womens Health",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Premature Labor (Tocolysis) - Global API Manufacturers, Marketed and Phase III Drugs Landscape",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Premenstrual Dysphoric Disorder (PMDD)",
    "therapeutic_area": "Womens Health",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "PresbiDrops (CSF-1) Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Presbyopia",
    "therapeutic_area": "Ophthalmology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 7
  },
  {
    "indication_name": "Presbyopia Patient Pool Analysis",
    "therapeutic_area": "Ophthalmology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Pressure Relief Devices - Global",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Pressure Ulcers",
    "therapeutic_area": "Dermatology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Prevymis (letermovir)",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Prezista - API Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Pridopidine Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 2
  },
  {
    "indication_name": "Prilosec - API Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Primary Axillary Hyperhidrosis",
    "therapeutic_area": "Rare Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2025-2032",
    "total_reports": 2
  },
  {
    "indication_name": "Primary Biliary Cholangitis (PBC)",
    "therapeutic_area": "Gastroenterology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Primary Biliary Cirrhosis",
    "therapeutic_area": "Gastroenterology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Primary Biliary Cirrhosis - Global API Manufacturers, Marketed and Phase III Drugs Landscape",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Primary Ciliary Dyskinesia (PCD)",
    "therapeutic_area": "Neurology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Primary Gastric Lymphoma",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2032-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Primary Hyperoxaluria",
    "therapeutic_area": "Endocrinology and Metabolic Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 5
  },
  {
    "indication_name": "Primary Immune Deficiency (PID)",
    "therapeutic_area": "Genetic Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Primary Immune Deficiency (PID) - Global API Manufacturers, Marketed and Phase III Drugs Landscape",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Primary Mediastinal Large B-Cell Lymphoma",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Primary Mitochondrial Myopathies (PMM)",
    "therapeutic_area": "Genetic Disorders",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Primary Myelofibrosis",
    "therapeutic_area": "Hematological Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Primary Open Angle Glaucoma (POAG)",
    "therapeutic_area": "Ophthalmology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Primary Progressive Aphasia",
    "therapeutic_area": "Neurology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Primary Progressive Multiple Sclerosis (PPMS)",
    "therapeutic_area": "Central Nervous System",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Primary Sclerosing Cholangitis (PSC)",
    "therapeutic_area": "Gastroenterology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2032-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Primary Sclerosing Cholangitis (PSC) Patient Pool Analysis",
    "therapeutic_area": "Endocrinology and Metabolic Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "PrimeC Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Primordial Dwarfism",
    "therapeutic_area": "Genetic Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2032-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Primordial Dwarfism/ Dwarfism",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Prinzmetal Angina",
    "therapeutic_area": "Cardiovascular Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Pristiq - API Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Pro-Opiomelanocortin (POMC) Deficiency Obesity & Leptin Receptor (LEPR) Deficiency Obesity",
    "therapeutic_area": "Endocrinology and Metabolic Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Probiotics",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Proemend - API Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Progeria",
    "therapeutic_area": "Genetic Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 2
  },
  {
    "indication_name": "Progesterone Receptor (PR) Antagonist",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Progesterone Receptor Agonist",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Prograf - API Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Programmed death-ligand 1 (PD-L1) Non-small Cell Lung Cancer (NSCLC)",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Progressive Familial Intrahepatic Cholestasis (PFIC)",
    "therapeutic_area": "Genetic Disorders",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Progressive Fibrosing Interstitial Lung Disease (pfild)",
    "therapeutic_area": "Respiratory Diseases",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Progressive Fibrosing Interstitial Lung Disease Patient Pool Analysis",
    "therapeutic_area": "Respiratory Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Progressive Keratoconus",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Progressive Multifocal Leukoencephalopathy",
    "therapeutic_area": "Neurology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Progressive Pulmonary Fibrosis (PPF)",
    "therapeutic_area": "Respiratory Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 2
  },
  {
    "indication_name": "Progressive Supranuclear Palsy Epidemiology Forecast",
    "therapeutic_area": "Neurology",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Progressive Supranuclear Palsy Pipeline Insight",
    "therapeutic_area": "Neurology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Progressive supranuclear palsy (PSP)",
    "therapeutic_area": "Neurology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2030-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Prolactin Receptor Antagonist",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Proliferative Diabetic Retinopathy",
    "therapeutic_area": "Ophthalmology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Proliferative Vitreoretinopathy",
    "therapeutic_area": "Ophthalmology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2025-2032",
    "total_reports": 2
  },
  {
    "indication_name": "Propecia - API Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Propionic Acidemia",
    "therapeutic_area": "Genetic Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Proscar - API Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Prostaglandin Antagonist",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Prostate Cancer",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2030-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Prostate Cancer - Competitive landscape",
    "therapeutic_area": "Oncology",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Prostate Cancer Diagnostics",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Prostate Cancer Epidemiology Forecast",
    "therapeutic_area": "Oncology",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Prostate Cancer Pipeline Insight",
    "therapeutic_area": "Oncology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Prosthetic Heart Valves",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Prosthetic Joint Infections",
    "therapeutic_area": "Infectious Diseases",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Prosthetic joint infection (PJI)",
    "therapeutic_area": "Neurology",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Prosthetic joint infection (PJI)\u2013 Epidemiology Forecast",
    "therapeutic_area": "Infectious Diseases",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Proteasome Inhibitors",
    "therapeutic_area": "Oncology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Protein 50S Ribosomal Subunit Inhibitors",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Protein Chip",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Protein Degraders",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Protein Engineering",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Protein Expression",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Protein Kinase C (PKC) Inhibitor",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Protein Labelling",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Protein Supplements",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Protein Tyrosine Phosphatase Non Receptor Type 11 Antagonists",
    "therapeutic_area": "Oncology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Protein-Tyrosine Phosphatase (PTP) Inhibitor",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Protein-Tyrosine Phosphatase 1B (PTP1B) Inhibitor",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Protein-Tyrosine-Phosphatase Inhibitors",
    "therapeutic_area": "Oncology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Proteomics",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Proteus Syndrome",
    "therapeutic_area": "Neurology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Proto Oncogene Protein c-akt Inhibitors",
    "therapeutic_area": "Oncology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Proto Oncogene Protein c-myc Inhibitors",
    "therapeutic_area": "Oncology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Proto Oncogene Proteins C PIM 1 Inhibitors",
    "therapeutic_area": "Oncology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Proto-Oncogene Protein c mdm2 Inhibitors - Pipeline Isnight",
    "therapeutic_area": "Oncology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2022,
    "year_range": "2022",
    "total_reports": 1
  },
  {
    "indication_name": "Proto-Oncogene Protein c-bcl-2 Inhibitors",
    "therapeutic_area": "Oncology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Protopic - API Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Prurigo Nodularis",
    "therapeutic_area": "Dermatology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 5
  },
  {
    "indication_name": "Pruritis",
    "therapeutic_area": "Dermatology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2025-2032",
    "total_reports": 2
  },
  {
    "indication_name": "Pruritus",
    "therapeutic_area": "Dermatology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Pseudomonal Infections",
    "therapeutic_area": "Infectious Diseases",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Pseudomonas Aeruginosa Infection",
    "therapeutic_area": "Infectious Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2025-2032",
    "total_reports": 2
  },
  {
    "indication_name": "Pseudomonas Aeruginosa-Induced Lung Injury",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Pseudoxanthoma Elasticum",
    "therapeutic_area": "Dermatology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Psilocybin Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Psoriasis",
    "therapeutic_area": "Immunological and Autoimmune Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 6
  },
  {
    "indication_name": "Psoriasis Patient Pool Analysis",
    "therapeutic_area": "Respiratory Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Psoriasis Treatment",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Psoriasis Vulgaris",
    "therapeutic_area": "Dermatology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Psoriasis Vulgaris Epidemiology Forecast",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Psoriasis Vulgaris Pipeline Insight",
    "therapeutic_area": "Dermatology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Psoriatic Arthritis",
    "therapeutic_area": "Immunological and Autoimmune Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 5
  },
  {
    "indication_name": "Psoriatic Arthritis - Global API Manufacturers, Marketed and Phase III Drugs Landscape",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Psychosis",
    "therapeutic_area": "Central Nervous System",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 2
  },
  {
    "indication_name": "Psychosis in Parkinson\u2019s and Alzheimer\u2019s Disease",
    "therapeutic_area": "Neurology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Psychosis in Parkinson\u2019s and Alzheimer\u2019s disease \u2013 Epidemiology Forecast",
    "therapeutic_area": "Neurology",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Ptosis",
    "therapeutic_area": "Neurology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2032-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Pulmicort Turbuhaler - API Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Pulmonary Arterial Hypertension (PAH)",
    "therapeutic_area": "Cardiovascular Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2027-2032",
    "total_reports": 5
  },
  {
    "indication_name": "Pulmonary Arterial Hypertension - Global API Manufacturers, Marketed and Phase III Drugs Landscape",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Pulmonary Drugs - Global",
    "therapeutic_area": "Respiratory Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2028,
    "year_range": "2028",
    "total_reports": 1
  },
  {
    "indication_name": "Pulmonary Embolism",
    "therapeutic_area": "Cardiovascular Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 4
  },
  {
    "indication_name": "Pulmonary Embolism - Global API Manufacturers, Marketed and Phase III Drugs Landscape",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Pulmonary Emphysema",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Pulmonary Fibrosis",
    "therapeutic_area": "Respiratory Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Pulmonary Hypertension",
    "therapeutic_area": "Cardiovascular Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Pulmonary Hypertension associated with Interstitial Lung Disease (PH-ILD)",
    "therapeutic_area": "Cardiovascular Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Pulmonary Sarcoidosis",
    "therapeutic_area": "Respiratory Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Pulmonary alveolar proteinosis",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Pulmonary arterial hypertension (PAH) Patient Pool Analysis",
    "therapeutic_area": "Rare Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Pulmonology Devices",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Pulse Electromagnetic Field Therapy",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Pulse Oximeters",
    "therapeutic_area": "Respiratory Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Pulsed Electromagnetic Field Therapy Devices",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Pulsed Lavage Systems Devices",
    "therapeutic_area": "Infectious Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Punctate Epitheliopathy",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Pupillometer",
    "therapeutic_area": "Ophthalmology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Purinergic Receptor (Purinoceptor) Antagonist",
    "therapeutic_area": "Cardiovascular Diseases",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Purinoceptor P2Y12 Antagonists",
    "therapeutic_area": "Cardiovascular Diseases",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Pyelonephritis",
    "therapeutic_area": "Infectious Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Pyelonephritis - Global API Manufacturers, Marketed and Phase III Drugs Landscape",
    "therapeutic_area": "Ophthalmology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 2
  },
  {
    "indication_name": "Pyoderma Gangrenosum (PG)",
    "therapeutic_area": "Immunological and Autoimmune Disorders",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Pyruvate Kinase Deficiency (PKD) ",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "QSYMIA (Phentermine\u2013 topiramate)",
    "therapeutic_area": "Endocrinology and Metabolic Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "QULIPTA Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Quadrivalent VLP vaccine Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Qvarspray - API Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "RAGE Inhibitor",
    "therapeutic_area": "Neurology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "REACT Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "REBYOTA Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "REGN4461 Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "REL-1017",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "REL-1017 Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "RELUGOLIX (TAK-385)",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "REM Poisioning",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 2
  },
  {
    "indication_name": "REM Sleep Behavior Disorder",
    "therapeutic_area": "Sleep Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 2
  },
  {
    "indication_name": "REMICADE (Infliximab) Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "REPLAGAL",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "RET (Ret Proto-Oncogene) protein Inhibitor",
    "therapeutic_area": "Oncology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "RET Fusion Market Size, Target Population, Competitive Landscape & Market Forecast",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "REX-001 Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "REYVOW Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "REZAFUNGIN",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "RG6139 (RO7247669) Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2035,
    "year_range": "2035",
    "total_reports": 1
  },
  {
    "indication_name": "RG7774 Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "RGX-121",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "RGX-314 Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "RHB -104 Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "RINVOQ (Upadacitinib) Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "RIPK1 Inhibitor",
    "therapeutic_area": "Oncology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "RITUXAN Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 2
  },
  {
    "indication_name": "RL-007 Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "RNA Interference Pipeline Insight",
    "therapeutic_area": "Hematological Disorders",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "RNA Interference Therapy-Competitive landscape",
    "therapeutic_area": "Oncology",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "RNA- Competitive Landscape",
    "therapeutic_area": "Oncology",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "RNA-Dependent RNA Polymerase (RdRP or RNA Replicase) Inhibitor",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "RNS60 Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "RO7171009 (RG6147)",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "ROCKLATAN Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "RON (Recepteur d'origine Nantais) Inhibitor",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "ROR Inhibitors \u2013 Target Population, Competitive Landscape, and Market Forecast",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "ROS1 Protein Inhibitors",
    "therapeutic_area": "Oncology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "ROZLYTREK Market Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "RP-L102 Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "RP1 Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "RRx-001 Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "RSLV-132 Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "RSVpreF Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "RT 100",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "RT234 Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "RTX Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 2
  },
  {
    "indication_name": "RTX-GRT7039 Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 2
  },
  {
    "indication_name": "RYZODEG Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Rabeximod Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Rabies Immunoglobulins",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Rabies Infection",
    "therapeutic_area": "Infectious Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Rabies Virus",
    "therapeutic_area": "Infectious Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Radial Artery Compression Devices",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Radiation Dermatitis",
    "therapeutic_area": "Dermatology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2030-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Radiation Dermatitis Epidemiology Forecast",
    "therapeutic_area": "Dermatology",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Radiation Dermatitis Pipeline Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Radiation Retinopathy",
    "therapeutic_area": "Ophthalmology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2032-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Radiation Toxicity",
    "therapeutic_area": "Toxicology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Radiation induced-Oral Mucositis (RIOM) in Head and neck Cancer (HNC)",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 4
  },
  {
    "indication_name": "Radiation-Induced Esophagitis",
    "therapeutic_area": "Immunological and Autoimmune Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Radicava - API Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Radiodermatitis",
    "therapeutic_area": "Dermatology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Radiodermatitis Epidemiology Forecast",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Radiodermatitis Pipeline Insight",
    "therapeutic_area": "Dermatology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Radiofrequency Ablation Devices",
    "therapeutic_area": "Cardiovascular Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Radioimmunoassay (RIA)",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Radioligand Therapies Market Size, Target Population, Competitive Landscape & Market Forecast",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Radiologic Cancer Therapy",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Radiotherapy Induced Oral Mucositis",
    "therapeutic_area": "Dental and Oral Health",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Radiotherapy or Radiation Oncology Devices",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Ragweed Pollen Hypersensitivity",
    "therapeutic_area": "Immunological and Autoimmune Disorders",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Ralinepag Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Ranexa - API Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Ranibizumab Biosimilars Insight",
    "therapeutic_area": "Ophthalmology",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2024,
    "year_range": "2024",
    "total_reports": 1
  },
  {
    "indication_name": "Rapamune - API Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Rapid Diagnostic Kits",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Rapivab - API Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Rare NRG1 Fusion",
    "therapeutic_area": "Other Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2030-2034",
    "total_reports": 4
  },
  {
    "indication_name": "Raynauds Disease",
    "therapeutic_area": "Cardiovascular Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Raynauds Disease - Global API Manufacturers, Marketed and Phase III Drugs Landscape",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "ReNu Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 3
  },
  {
    "indication_name": "Reactive Airway Disease",
    "therapeutic_area": "Respiratory Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2032-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Reactive Arthritis",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Real-World Evidence Solution",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Receptor-interacting Protein Kinase 1 (RIPK1) Inhibitors \u2013 Target Population, Competitive Landscape, and Market Forecast",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Recessive Dystrophic Epidermolysis (RDEB)",
    "therapeutic_area": "Immunological and Autoimmune Disorders",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Recessive Dystrophic Epidermolysis Bullosa",
    "therapeutic_area": "Genetic Disorders",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Recurrent Anaplastic Astrocytomas",
    "therapeutic_area": "Neurology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Recurrent Clostridioides Difficile Infection (rCDI)",
    "therapeutic_area": "Infectious Diseases",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Recurrent Glioblastoma",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2032-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Recurrent Glioblastoma \\n",
    "therapeutic_area": "Oncology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Recurrent Head And Neck Cancer Squamous Cell Carcinoma",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Recurrent Head And Neck Cancer Squamous Cell Carcinoma - Global API Manufacturers, Marketed and Phase III Drugs Landscape",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Recurrent Herpes Labialis",
    "therapeutic_area": "Infectious Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Recurrent Malignant Glioma",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Recurrent Pericarditis",
    "therapeutic_area": "Cardiovascular Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 5
  },
  {
    "indication_name": "Recurrent Respiratory Papillomatosis (RRP) ",
    "therapeutic_area": "Respiratory Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Recurrent blood clots (Thrombophilia)",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Recurrent or Metastatic HER2-Overexpressing Solid Tumors",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Recurrent or Metastatic Head and Neck cancer",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Recurrent or Metastatic Nasopharyngeal Carcinoma",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Refractive Errors",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Refractive Surgery Devices",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Refractory Angina",
    "therapeutic_area": "Cardiovascular Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Refractory Epilepsy",
    "therapeutic_area": "Neurology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Refractory Metastatic Melanoma",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 2
  },
  {
    "indication_name": "Refractory Metastatic Melanoma Pipeline Insight",
    "therapeutic_area": "Dermatology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Refractory Multiple Myeloma",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Refractory Status Epilepticus (RSE)",
    "therapeutic_area": "Central Nervous System",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 2
  },
  {
    "indication_name": "Regorafenib Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Regulatory Affairs Outsourcing",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Regulatory T cells (Tregs) Market Size, Target Population, Competitive Landscape & Market Forecast",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Rehabilitation Equipment",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Relapsed B-Cell Small Lymphocytic Lymphoma",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Relapsed Chronic Lymphocytic Leukemia (CLL)",
    "therapeutic_area": "Oncology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Relapsed Chronic Lymphocytic Leukemia (CLL) - Global API Manufacturers, Marketed and Phase III Drugs Landscape",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Relapsed and Refractory CD5-Expressing T Cell Lymphomas",
    "therapeutic_area": "Oncology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Relapsed or Refractory Mycosis Fungoides",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2032-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Relapsed or Refractory Mycosis Fungoides (MF) and Sezary Syndrome (SS)",
    "therapeutic_area": "Oncology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Relapsed or Refractory Myelodysplastic Syndrome",
    "therapeutic_area": "Hematological Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2025-2032",
    "total_reports": 2
  },
  {
    "indication_name": "Relapsed/Refractory Acute Myeloid Leukemia (R/R AML)",
    "therapeutic_area": "Oncology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Relapsed/Refractory Epstein Barr Virus",
    "therapeutic_area": "Infectious Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Relapsed/Refractory Epstein Barr Virus infection associated disorders",
    "therapeutic_area": "Infectious Diseases",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Relapsed/Refractory Multiple Myeloma (RRMM)",
    "therapeutic_area": "Hematological Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Relapsing Multiple Sclerosis (RMS)",
    "therapeutic_area": "Central Nervous System",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Relapsing Multiple Sclerosis (RMS) - Global API Manufacturers, Marketed and Phase III Drugs Landscape",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Relapsing Refractory Multiple Myeloma",
    "therapeutic_area": "Hematological Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 4
  },
  {
    "indication_name": "Relapsing-Remitting Multiple Sclerosis",
    "therapeutic_area": "Neurology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Relapsing-Remitting Multiple Sclerosis Pipeline Insight",
    "therapeutic_area": "Neurology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Reldesemtiv Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Relpax - API Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Remodulin - API Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Remote Healthcare",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Remternetug Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Renal Anemia",
    "therapeutic_area": "Hematological Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Renal Anemia - Global API Manufacturers, Marketed and Phase III Drugs Landscape",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Renal Autologous Cell Therapy Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Renal Cancer",
    "therapeutic_area": "Oncology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Renal Cell Carcinoma",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Renal Denervation Devices",
    "therapeutic_area": "Cardiovascular Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Renal Fanconi Syndrome",
    "therapeutic_area": "Genito Urinary System and Sex Hormones",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Renal Impairment",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Renal Insufficiency",
    "therapeutic_area": "Endocrinology and Metabolic Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2032-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Renal Transplant Therapeutics",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Renal Tubular Acidosis",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Renal Vasculitis",
    "therapeutic_area": "Cardiovascular Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2032-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Renin Inhibitor",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Requip - API Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Resiniferatoxin Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Resistant Hypertension",
    "therapeutic_area": "Hematological Disorders",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Resmetirom Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Resminostat Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Resorbable Vascular Scaffolds",
    "therapeutic_area": "Cardiovascular Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Respiratory Disease Testing",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Respiratory Distress Syndrome",
    "therapeutic_area": "Respiratory Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2032-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Respiratory Drugs",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Respiratory Gas Monitors",
    "therapeutic_area": "Respiratory Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Respiratory Inhalers",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Respiratory Monitoring Devices",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Respiratory Syncytial Virus (RSV)",
    "therapeutic_area": "Infectious Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2032-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Respiratory Syncytial Virus Pipeline Insight",
    "therapeutic_area": "Infectious Diseases",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Respiratory syncytial virus (RSV) Patient Pool Analysis",
    "therapeutic_area": "Musculoskeletal",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Respiratory syncytial virus Epidemiology Forecast",
    "therapeutic_area": "Infectious Diseases",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Restex - API Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Restless Legs Syndrome",
    "therapeutic_area": "Other Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 6
  },
  {
    "indication_name": "Restless Legs Syndrome - Global API Manufacturers, Marketed and Phase III Drugs Landscape",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Restrictive Cardiomyopathy (RCM)",
    "therapeutic_area": "Cardiovascular Diseases",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Retinal Detachment",
    "therapeutic_area": "Ophthalmology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Retinal Detachment Disorder",
    "therapeutic_area": "Ophthalmology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Retinal Edema",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Retinal Neovascularization(NV)",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Retinal Ultrasound Systems",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Retinal Vein Occlusion",
    "therapeutic_area": "Ophthalmology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 5
  },
  {
    "indication_name": "Retinal Vein Occlusion - Global API Manufacturers, Marketed and Phase III Drugs Landscape",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Retinitis Pigmentosa (Retinitis)",
    "therapeutic_area": "Ophthalmology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Retinitis Pigmentosa Patient Pool Analysis",
    "therapeutic_area": "Ophthalmology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Retinoblastoma",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Retinoic Acid Receptors (RARs) Agonist",
    "therapeutic_area": "Oncology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Retinoic acid receptor-\u03b3 (RAR-\u03b3) agonist - Target Population, Competitive Landscape, and Market Forecast",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Retinopathy Of Prematurity",
    "therapeutic_area": "Ophthalmology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Retinopathy of Prematurity \u2013 Epidemiology Forecast",
    "therapeutic_area": "Ophthalmology",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Rett Syndrome",
    "therapeutic_area": "Rare Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Revatio - API Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Reversal of Mydriasis (RM)",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Reversible Anticholinesterases",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Revlimid - API Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Rexulti and Zoloft Combination",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Reyataz - API Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Rezaltas - API Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Rhabdomyosarcoma",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Rheumatic Heart Disease",
    "therapeutic_area": "Cardiovascular Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Rheumatoid Arthritis (RA)",
    "therapeutic_area": "Immunological and Autoimmune Disorders",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Rheumatoid Arthritis (RA) Patient Pool Analysis",
    "therapeutic_area": "Endocrinology and Metabolic Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Rhinitis",
    "therapeutic_area": "Immunological and Autoimmune Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Rhino-Conjunctivitis",
    "therapeutic_area": "Ophthalmology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Rhinolaryngoscope Devices",
    "therapeutic_area": "Otolaryngology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Rhinometry Systems",
    "therapeutic_area": "Otolaryngology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Rhinoscope Devices",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Rhinosinusitis",
    "therapeutic_area": "Ophthalmology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2025-2032",
    "total_reports": 2
  },
  {
    "indication_name": "Rhinosinusitis - Global API Manufacturers, Marketed and Phase III Drugs Landscape",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 2
  },
  {
    "indication_name": "Rhinosinusitis Epidemiology Forecast",
    "therapeutic_area": "Otolaryngology",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Rhinovirus Infection",
    "therapeutic_area": "Otolaryngology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Rho Kinase (Rho-Associated Coiled-Coil Forming Protein Kinase or ROCK) Inhibitor",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Rhopressa (netarsudil ophthalmic solution)",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Ribonucleotide Reductase Inhibitors",
    "therapeutic_area": "Neurology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Richters Syndrome",
    "therapeutic_area": "Immunological and Autoimmune Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Ridinilazole Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Rilzabrutinib Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2034,
    "year_range": "2032-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Ringworm",
    "therapeutic_area": "Dermatology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Risuteganib Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Ritlecitinib Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Rituximab - Biosimilars Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2024,
    "year_range": "2024",
    "total_reports": 1
  },
  {
    "indication_name": "Rituximab Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Rivastigmine Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Robotic Process Automation (RPA) in Healthcare",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Rocephin - API Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Rodatristat ethyl Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Rosacea",
    "therapeutic_area": "Dermatology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 4
  },
  {
    "indication_name": "Rosacea - Global API Manufacturers, Marketed and Phase III Drugs Landscape",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Rosai-Dorfman Disease",
    "therapeutic_area": "Hematological Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Rotator Cuff Injuries",
    "therapeutic_area": "Other Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Rotavirus Infections",
    "therapeutic_area": "Infectious Diseases",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Roxadustat Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Rubella",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Runcaciguat Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Rusfertide Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Ruzurgi (amifampridine)",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "S-600918 Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "SAB-176 Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "SAGE-217 Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 2
  },
  {
    "indication_name": "SAGE-718 Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "SAPHNELO Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2034,
    "year_range": "2032-2034",
    "total_reports": 2
  },
  {
    "indication_name": "SAXENDA (Liraglutide)",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "SB-525",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "SB-913",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "SB206 Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "SBP-101 Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "SC efgartigimod Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "SCN2A Developmental and Epileptic Encephalopathy",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "SCN2A Developmental and Epileptic Encephalopathy (SCN2A",
    "therapeutic_area": "Neurology",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "SDN-037 Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "SEFA-1024 Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "SER-109 Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "SFX-01 Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "SHR0302 Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "SIMPONI Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 3
  },
  {
    "indication_name": "SKYRIZI (Risankizumab) Market Size",
    "therapeutic_area": "Other Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "SLAMF7 Inhibitors Market Size, Target Population, Competitive Landscape & Market Forecast",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "SLS-005 Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "SM04690 Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 2
  },
  {
    "indication_name": "SMAD4/DPC4 Market Size, Target Population, Competitive Landscape & Market Forecast",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "SMARCA Degrader Market, Target Population, Competitive Landscape, and Market",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "SMYRAF Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "SOLIRIS Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 3
  },
  {
    "indication_name": "SOM3355 Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "SPK 3006",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "SPK-8011",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "SPRAVATO Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 2
  },
  {
    "indication_name": "SRC Family Kinases (SFK) Inhibitor",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "SRP-9001",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "SScILD",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2032-2034",
    "total_reports": 2
  },
  {
    "indication_name": "ST-920",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "STAT Inhibitors",
    "therapeutic_area": "Other Diseases",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "STELARA (Ustekinumab)",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "STELARA Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 2
  },
  {
    "indication_name": "STK-001 Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "STRATAGRAFT Market Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "STS Devices",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "SUNOSI Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "SURF-201 Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "SVT-15473 Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "SYMDEKO Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "SYNAGIS Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "SYNB1618",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Sacral Nerve Stimulation Devices",
    "therapeutic_area": "Neurology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 2
  },
  {
    "indication_name": "Salivary Gland Infection",
    "therapeutic_area": "Gastroenterology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Sandhoff Disease",
    "therapeutic_area": "Endocrinology and Metabolic Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2025-2032",
    "total_reports": 2
  },
  {
    "indication_name": "Sandostatine - API Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Sanfilippo Syndrome",
    "therapeutic_area": "Genetic Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Sanfilippo Syndrome Type A (MPS IIIA)",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Sapablursen Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Sarcoidosis",
    "therapeutic_area": "Immunological and Autoimmune Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 5
  },
  {
    "indication_name": "Sarcoidosis - Global API Manufacturers, Marketed and Phase III Drugs Landscape",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Sarconeos Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Sarcopenia",
    "therapeutic_area": "Musculoskeletal",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 2
  },
  {
    "indication_name": "Sarcopenia Pipeline Insight",
    "therapeutic_area": "Musculoskeletal",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Saroglitazar Mg Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Scabies",
    "therapeutic_area": "Dermatology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2032-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Scars",
    "therapeutic_area": "Dermatology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Scedosporiosis",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Scedosporium Infection",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Schistosomiasis",
    "therapeutic_area": "Infectious Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Schizoaffective Disorder",
    "therapeutic_area": "Central Nervous System",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Schizophrenia",
    "therapeutic_area": "Neurology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 5
  },
  {
    "indication_name": "Schnitzler syndrome",
    "therapeutic_area": "Rare Diseases",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Sciatic Pain",
    "therapeutic_area": "Infectious Diseases",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Sciatica",
    "therapeutic_area": "Central Nervous System",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 4
  },
  {
    "indication_name": "Scleritis",
    "therapeutic_area": "Ophthalmology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Scleroderma",
    "therapeutic_area": "Dermatology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2025-2032",
    "total_reports": 2
  },
  {
    "indication_name": "Sclerostin Inhibitor",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Scoliosis",
    "therapeutic_area": "Other Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Seasonal Allergic Rhinitis",
    "therapeutic_area": "Respiratory Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Seasonal Allergic Rhinitis - Global API Manufacturers, Marketed and Phase III Drugs Landscape",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Seasonal Influenza",
    "therapeutic_area": "Infectious Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 2
  },
  {
    "indication_name": "Sebohrrea",
    "therapeutic_area": "Dermatology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Seborrhea",
    "therapeutic_area": "Dermatology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2032-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Seborrheic Eczema",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Seborrhoeic Dermatitis",
    "therapeutic_area": "Dermatology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Secondary Hyperparathyroidism",
    "therapeutic_area": "Endocrinology and Metabolic Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Secondary Hyperparathyroidism - Global API Manufacturers, Marketed and Phase III Drugs Landscape",
    "therapeutic_area": "Endocrinology and Metabolic Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Secondary Myelofibrosis",
    "therapeutic_area": "Hematological Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Secondary Progressive Multiple Sclerosis (SPMS)",
    "therapeutic_area": "Central Nervous System",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Secondary Progressive Multiple Sclerosis (SPMS) - Global API Manufacturers, Marketed and Phase III Drugs Landscape",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Secretase Inhibitor",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Sedation",
    "therapeutic_area": "Central Nervous System",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Sedation - Global API Manufacturers, Marketed and Phase III Drugs Landscape",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Seizures",
    "therapeutic_area": "Central Nervous System",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Seizures - Global API Manufacturers, Marketed and Phase III Drugs Landscape",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Seladelpar Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Selatogrel Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Selectin Inhibitor",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Selective COX-2 Inhibitor",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Selective Estrogen Receptor Degraders Pipeline Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Selective Inhibitor of the CXCR4 Chemokine Receptor Market Size, Target Population, Competitive Landscape & Market Forecast",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Selgantolimod (GS-9688)",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Selzentry - API Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Semaglutide Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Semaglutide oral Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Semicarbazide Sensitive Amine Oxidase (SSAO) Inhibitor",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Sensipar - API Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Sensorineural Hearing Loss",
    "therapeutic_area": "Neurology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2025-2032",
    "total_reports": 2
  },
  {
    "indication_name": "Sensory Neuropathy",
    "therapeutic_area": "Central Nervous System",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Sepetaprost",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Sepsis",
    "therapeutic_area": "Infectious Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2030-2034",
    "total_reports": 4
  },
  {
    "indication_name": "Sepsis Diagnostics",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Sepsis Epidemiology Forecast",
    "therapeutic_area": "Infectious Diseases",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Sepsis Pipeline Insight",
    "therapeutic_area": "Infectious Diseases",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Septic Shock",
    "therapeutic_area": "Infectious Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Seroquel - API Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Serotonin 1B Receptor Agonists",
    "therapeutic_area": "Neurology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Serotonin 3 Receptor Antagonists",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Serotonin Reuptake Inhibitor (SRI)",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Serotonin Transporter Inhibitor",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Seroxat - API Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Setanaxib Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Severe Acne Vulgaris",
    "therapeutic_area": "Dermatology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Severe Acne Vulgaris or Severe Recalcitrant Nodular Acne",
    "therapeutic_area": "Dermatology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection",
    "therapeutic_area": "Respiratory Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Severe Asthma",
    "therapeutic_area": "Respiratory Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Severe Atopic Dermatitis ",
    "therapeutic_area": "Dermatology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Severe Dry Eye",
    "therapeutic_area": "Ophthalmology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2032-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Severe Hypertriglyceridemia (SHTG)",
    "therapeutic_area": "Endocrinology and Metabolic Disorders",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Severe Hypoglycemia",
    "therapeutic_area": "Endocrinology and Metabolic Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Severe Keratitis",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Severe Psoriasis",
    "therapeutic_area": "Immunological and Autoimmune Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Severe Toxicities in Lymphoma",
    "therapeutic_area": "Other Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2032-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Sevikar - API Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Seviteronel",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Sexually Transmitted Diseases Diagnostics",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Sezary Syndrome (SS)",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2028-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Shigella Infections",
    "therapeutic_area": "Infectious Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Shigellosis",
    "therapeutic_area": "Infectious Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2025-2032",
    "total_reports": 2
  },
  {
    "indication_name": "Shingles",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Shingles Epidemiology Forecast",
    "therapeutic_area": "Infectious Diseases",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Shingles Pipeline Insight",
    "therapeutic_area": "Infectious Diseases",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Shingrix",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Short Bowel Syndrome",
    "therapeutic_area": "Gastroenterology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 5
  },
  {
    "indication_name": "Short Bowel Syndrome (SBS) Patient Pool Analysis",
    "therapeutic_area": "Gastroenterology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Short Bowel Syndrome - Global API Manufacturers, Marketed and Phase III Drugs Landscape",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Short-Acting Insulin",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Shoulder Replacement Devices - Global",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Sialidosis",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Sialorrhea",
    "therapeutic_area": "Neurology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Sibutramine/Topiramate Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Sick Sinus Syndrome",
    "therapeutic_area": "Cardiovascular Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2032-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Sickle Cell Disease (SCD)",
    "therapeutic_area": "Genetic Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2028,
    "year_range": "2028",
    "total_reports": 1
  },
  {
    "indication_name": "Sickle Cell Disease - Competitive landscape",
    "therapeutic_area": "Hematological Disorders",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Sickle Cell Disease - Global API Manufacturers, Marketed and Phase III Drugs Landscape",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Siderosis",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Sigma Receptor Agonist",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Sigma-1 Receptor Agonists",
    "therapeutic_area": "Neurology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Sigmoidoscopes",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Sildenafil Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Simufilam Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Singapore Healthcare Outlook Report",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Single Ventricle Heart Disease",
    "therapeutic_area": "Cardiovascular Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Single-use Bioreactors",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Singulair Paediatric - API Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Sinus Dilation Devices",
    "therapeutic_area": "Otolaryngology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Sinuscope",
    "therapeutic_area": "Otolaryngology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Sinusitis",
    "therapeutic_area": "Otolaryngology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Sipralexoro - API Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Sjogren's Syndrome",
    "therapeutic_area": "Immunological and Autoimmune Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2028-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Sjogren\u2019s syndrome",
    "therapeutic_area": "Immunological and Autoimmune Disorders",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Skelaxin - API Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Skin And Skin Structure Infections (SSSI) Caused By Bacteria",
    "therapeutic_area": "Dermatology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Skin Burns",
    "therapeutic_area": "Dermatology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 4
  },
  {
    "indication_name": "Skin Care Products",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Skin Care Supplements",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Skin Grafting Devices",
    "therapeutic_area": "Dermatology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Skin Neoplasms",
    "therapeutic_area": "Dermatology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "SkinTE Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Skincare",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Skull Clamps",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Sleep Aid",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Sleep Apnea",
    "therapeutic_area": "Sleep Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Sleep Apnea - Global API Manufacturers, Marketed and Phase III Drugs Landscape",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Sleep Apnea Devices",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Sleep Apnea Diagnostic Devices",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Sleep Apnea Implants",
    "therapeutic_area": "Neurology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Sleep Apnoea Syndrome",
    "therapeutic_area": "Sleep Disorders",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Sleep Tech Devices",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Slit Lamps",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Sly Syndrome",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Small Cell Lung Cancer",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Small Fiber Neuropathy",
    "therapeutic_area": "Neurology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2025-2032",
    "total_reports": 2
  },
  {
    "indication_name": "Small Lymphocytic Lymphoma",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Smallpox",
    "therapeutic_area": "Infectious Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Smallpox - Global API Manufacturers, Marketed and Phase III Drugs Landscape",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Smart Inhalers",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Smart Insulin Pens",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Smart Medical Devices",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Smart Pills",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Smith-Lemli-Opitz Syndrome",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Smoke Evacuation Devices",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Smoking Cessation",
    "therapeutic_area": "Other Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Smoking Cessation and Nicotine Addiction \u2013 Epidemiology Forecast",
    "therapeutic_area": "Neurology",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Smoking Cessation and Nicotine Deaddiction",
    "therapeutic_area": "Neurology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Social Anxiety Disorder (SAD)",
    "therapeutic_area": "Other Diseases",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Sodium Channel Blockers",
    "therapeutic_area": "Neurology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Sodium Dependent Glucose Transporter 1 (SGLT1) Inhibitor",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Sodium-glucose Co-transporter 2 (SGLT2) and 1 (SGLT1) Inhibitors Market Size, Target Population, Competitive Landscape & Market Forecast",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Sodium-glucose co-transporter-2 (SGLT2) inhibitors Target Population, Competitive Landscape, and Market Forecast",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Soft Drinks Concentrate",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Soft Tissue Defect",
    "therapeutic_area": "Other Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2032-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Soft Tissue Neoplasms",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Soft Tissue Sarcoma",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Soft Tissue Sarcoma - Global API Manufacturers, Marketed and Phase III Drugs Landscape",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Soft Tissue Sarcoma with Lung Metastases",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Soft Tisue Sarcoma (STS) with lung metastases",
    "therapeutic_area": "Oncology",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Solid Tumors With Pre-specified MDM2 Amplification Levels",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Somatostatin Receptor Agonist",
    "therapeutic_area": "Endocrinology and Metabolic Disorders",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Somatostatinoma",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Somatotropin - Biosimilar Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2024,
    "year_range": "2024",
    "total_reports": 1
  },
  {
    "indication_name": "Somatotropin Deficiency",
    "therapeutic_area": "Rare Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2025-2032",
    "total_reports": 2
  },
  {
    "indication_name": "Sonelokimab Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Sotatercept Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Soticlestat Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Sovaldi - API Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Spain Healthcare Outlook Report",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Sparsentan Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Spasmodic-Torticollis",
    "therapeutic_area": "Neurology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Spastic Cerebral Palsy",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Spasticity",
    "therapeutic_area": "Neurology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 4
  },
  {
    "indication_name": "Spasticity - Global API Manufacturers, Marketed and Phase III Drugs Landscape",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Speciality Food Ingredients",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2027,
    "year_range": "2027",
    "total_reports": 1
  },
  {
    "indication_name": "Specialty Medical Chairs",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Specialty PACS",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Sphingosine 1 Phosphate Receptor (S1PR) Modulators Market Size, Target Population, Competitive Landscape & Market Forecast",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Sphingosine 1 Phosphate Receptor Modulators",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Sphingosine 1-Phosphate (S1P) Inhibitor",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Sphingosine 1-Phosphate (S1P) Receptor Agonist",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Spina Bifida In-Utero",
    "therapeutic_area": "Other Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Spinal Cord Injury (SCI)",
    "therapeutic_area": "Neurology",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Spinal Cord Stimulators",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Spinal Decompression/Traction Devices",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Spinal Fusion",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Spinal Fusion Devices",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Spinal Implants",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Spinal Muscular Atrophy (SMA)",
    "therapeutic_area": "Central Nervous System",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 4
  },
  {
    "indication_name": "Spinal Muscular Atrophy (SMA) - Global API Manufacturers, Marketed and Phase III Drugs Landscape",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Spinal Non-Fusion Devices",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Spinal Osteosynthesis Units",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Spinal Stenosis",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Spinal Stenosis Devices",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Spinal Surgery Devices",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Spinal Trauma Devices",
    "therapeutic_area": "Central Nervous System",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2030-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Spine Augmentation Systems",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Spine Pain",
    "therapeutic_area": "Musculoskeletal",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Spinocerebellar Ataxia (SCA)",
    "therapeutic_area": "Neurology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2028-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Spinocerebellar Ataxias",
    "therapeutic_area": "Genetic Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Spinraza (nusinersen)",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Spirometers",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Spleen Tyrosine Kinase (SYK) Inhibitors",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Splendil - API Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Spondylolisthesis",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Sporadic Inclusion Body Myositis (sIBM)",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Sport Nutrition",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2028,
    "year_range": "2028",
    "total_reports": 1
  },
  {
    "indication_name": "Sprifermin Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 2
  },
  {
    "indication_name": "Sprycel - API Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Squalene Epoxidase Inhibitor",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Squamous Cell Carcinoma",
    "therapeutic_area": "Oncology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Squamous Cell Carcinoma of the Lung",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Stable Angina",
    "therapeutic_area": "Cardiovascular Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Staphylococcal Infections",
    "therapeutic_area": "Infectious Diseases",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Staphylococcus Aureus Bacteremic Pneumonia",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Staphylococcus Aureus Infection",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Staphylococcus aureus Bacteremia",
    "therapeutic_area": "Infectious Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Stargardt Disease (STGD)",
    "therapeutic_area": "Genetic Disorders",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Status Epilepticus",
    "therapeutic_area": "Central Nervous System",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Stem Cell",
    "therapeutic_area": "Other Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Stem Cell Mobilization",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Stents",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Stereotactic Surgery Devices",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Sternal Closure Devices",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Sternal Closure Systems",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Sternal Wound Infection",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Steroid Refactory Acute Graft-Versus-Host Disease (GVHD)",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Steroid Refractory Acute Graft-Versus-Host Disease (SR-aGvHD) ",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Sterol 14 Alpha-Demethylase Inhibitor",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Stethoscope",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Still's Disease",
    "therapeutic_area": "Genetic Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2025-2032",
    "total_reports": 2
  },
  {
    "indication_name": "Stilnox - API Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Stomatitis",
    "therapeutic_area": "Other Diseases",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Strattera - API Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Stress Urinary Incontinence",
    "therapeutic_area": "Genito Urinary System and Sex Hormones",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Stress Urinary Incontinence Devices",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Stress urinary incontinence Patient Pool Analysis",
    "therapeutic_area": "Rare Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Structural Heart Devices",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Sturge-weber Syndrome (SWS)",
    "therapeutic_area": "Neurology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2032-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Stuttering",
    "therapeutic_area": "Other Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 2
  },
  {
    "indication_name": "Subarachnoid Hemorrhage",
    "therapeutic_area": "Neurology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Subdermal Contraceptive Implants",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Substance (Drug) Abuse",
    "therapeutic_area": "Central Nervous System",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Substance Use Disorder",
    "therapeutic_area": "Toxicology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 2
  },
  {
    "indication_name": "Substance Use Disorder Pipeline Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Sudden Sensorineural hearing loss (SSNHL)",
    "therapeutic_area": "Otolaryngology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 4
  },
  {
    "indication_name": "Sulopenem Etzadroxil/Probenecid Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Sulphonamides",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Superficial Punctate Keratitis",
    "therapeutic_area": "Ophthalmology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2032-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Superoxide Dismutase (SOD) Inhibitor",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Supraventricular Tachycardia",
    "therapeutic_area": "Cardiovascular Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2032-2034",
    "total_reports": 2
  },
  {
    "indication_name": "SurVaxM Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Surepost - API Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Surface Disinfectant",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Surgery Incisional Infections",
    "therapeutic_area": "Other Diseases",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Surgery and Radiation Therapy in Brain Cancer",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Surgical Bleeding",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Surgical Camera",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Surgical Drainage Devices",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Surgical Dressing",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Surgical Energy Generators",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Surgical Equipments",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Surgical Lasers",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Surgical Loupes",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Surgical Mask & Respirator",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Surgical Microscopes",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Surgical Navigation Systems",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Surgical Pliers",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Surgical Retractors",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Surgical Robotic System",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Surgical Sealant Tissue Patch",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Surgical Sealant and Adhesives",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Surgical Simulation",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Surgical Site Infections (SSI)",
    "therapeutic_area": "Infectious Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 6
  },
  {
    "indication_name": "Surgical Snares",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Surgical Staplers",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Surgical Stapling Devices",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Surgical Sutures",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Surgical Wound Infections",
    "therapeutic_area": "Central Nervous System",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Sustiva - API Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Sutent (sunitinib malate)",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Sutent - API Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Symptomatic Partial-thickness Rotator Cuff Tears",
    "therapeutic_area": "Other Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Synchronous Endometrial and Ovarian Cancer (SEOC)",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2032-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Syncope",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Syndromic and Monogenic Obesity ",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Synoptophore",
    "therapeutic_area": "Ophthalmology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Synovial Sarcoma (SS)",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2028-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Synovial Sarcoma Epidemiology Forecast",
    "therapeutic_area": "Other Diseases",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Synovial Sarcoma Pipeline Insight",
    "therapeutic_area": "Oncology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Syphilis",
    "therapeutic_area": "Infectious Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Syringes and Needles",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Systemic Amyloidosis",
    "therapeutic_area": "Rare Diseases",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Systemic Inflammatory Response Syndrome",
    "therapeutic_area": "Immunological and Autoimmune Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Systemic Juvenile Idiopathic Arthritis (SJIA)",
    "therapeutic_area": "Musculoskeletal",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Systemic Juvenile Idiopathic Arthritis (SJIA) - Global API Manufacturers, Marketed and Phase III Drugs Landscape",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Systemic Lupus Erythematosus (SLE)",
    "therapeutic_area": "Immunological and Autoimmune Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2028,
    "year_range": "2025-2028",
    "total_reports": 2
  },
  {
    "indication_name": "Systemic Lupus Erythematosus - Global API Manufacturers, Marketed and Phase III Drugs Landscape",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Systemic Lupus Erythematosus Epidemiology Forecast",
    "therapeutic_area": "Immunological and Autoimmune Disorders",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Systemic Mastocytosis",
    "therapeutic_area": "Gastroenterology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Systemic Mastocytosis - Global API Manufacturers, Marketed and Phase III Drugs Landscape",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Systemic Scleroderma",
    "therapeutic_area": "Immunological and Autoimmune Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Systemic Sclerosis",
    "therapeutic_area": "Dermatology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Systemic Sclerosis (SS) in Interstitial Lung Disease (ILD)",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Systemic Sclerosis associated Interstitial Lung Disease (SSc-ILD)",
    "therapeutic_area": "Immunological and Autoimmune Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 5
  },
  {
    "indication_name": "T Cell Inhibitor",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "T Cell Lymphoma",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "T Cell Therapy",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "T Type Calcium Channel Antagonists",
    "therapeutic_area": "Neurology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "T-Cell Acute Lymphoblastic Leukemia",
    "therapeutic_area": "Oncology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "T-Cell Blood Cancer",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "T-Cell Leukemia",
    "therapeutic_area": "Dermatology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "T-Cell Lymphoma",
    "therapeutic_area": "Oncology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "T-Cell Prolymphocytic Leukemia (T-PLL)",
    "therapeutic_area": "Oncology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "T-cell Malignancies",
    "therapeutic_area": "Oncology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 2
  },
  {
    "indication_name": "T-cell Receptor Therapy",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "T-cell Surface Glycoprotein CD4 \u2013 Pipeline Insights",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2024,
    "year_range": "2024",
    "total_reports": 1
  },
  {
    "indication_name": "TADEKINIG ALFA",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "TAFINLAR + MEKINIST Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "TAK-672 Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "TAK-755 Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "TALTZ Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "TARPEYO Market Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "TAVALISSE Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 2
  },
  {
    "indication_name": "TAVNEOS (Avacopan) Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "TC-002",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "TC-210 Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "TCR Therapy",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2025-2032",
    "total_reports": 2
  },
  {
    "indication_name": "TEMODAR Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "TEPEZZA Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "TERN-501 Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "TGF-Beta Inhibitor",
    "therapeutic_area": "Hematological Disorders",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "TGF-Beta-1 Inhibitor",
    "therapeutic_area": "Oncology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "TGF-Beta-2 Inhibitor",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "THR-\u03b2 Agonist - Target Population, Competitive Landscape, and Market Forecast",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "TIBSOVO Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "TIE-2 Receptor Agonists",
    "therapeutic_area": "Cardiovascular Diseases",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "TIGIT Inhibitors",
    "therapeutic_area": "Oncology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "TIGIT Inhibitors - Competitive Landscape",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "TIGLUTIK",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "TIL Therapy",
    "therapeutic_area": "Oncology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "TIM-3 Antagonist",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "TIM-3 Inhibitor",
    "therapeutic_area": "Oncology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "TIM-3-Next Generation Immunotherapy - Competitive Landscape and Market Forecast",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2035,
    "year_range": "2035",
    "total_reports": 2
  },
  {
    "indication_name": "TL1A Binder Market Size, Target Population, Competitive Landscape & Market Forecast",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "TLC599 Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 4
  },
  {
    "indication_name": "TLR 7/8 Agonist \u2013 Target Population, Competitive Landscape, and Market Forecast",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "TLR-9 Modulator Pipeline Insight",
    "therapeutic_area": "Oncology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "TLR2 Modulator Market Size, Target Population, Competitive Landscape & Market Forecast",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "TNX-102 SL Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "TNX-1300 Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "TOCILIZUMAB",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "TOCTINO Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "TOUJEO Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "TR-987 Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "TRACLEER Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "TRAIL Receptor 1 & Receptor 2 Agonist",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "TRAIL Receptor 2 Agonists",
    "therapeutic_area": "Oncology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "TREAKISYM",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "TREMFYA Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 4
  },
  {
    "indication_name": "TRESIBA Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "TRIKAFTA Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "TRK Fusion Cancer",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "TRK1-Transforming Tyrosine Kinase (Trk-A or High Affinity Nerve Growth Factor Receptor) Antagonist",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "TRODELVY (Sacituzumab govitecan) Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "TROP-2 Inhibitors Market Size, Target Population, Competitive Landscape & Market Forecast",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 3
  },
  {
    "indication_name": "TROP2 ADCs in NSCLC Market Size, Target Population, Competitive Landscape & Market Forecast",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2040,
    "year_range": "2040",
    "total_reports": 1
  },
  {
    "indication_name": "TRPV1 Receptor Antagonists",
    "therapeutic_area": "Ophthalmology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "TRS01 Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 2
  },
  {
    "indication_name": "TRUSELTIQ Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "TRYVIO/JERAYGO Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "TT-00420 Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "TTAX01 Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "TTP399 Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "TYK2 Kinase Inhibitors",
    "therapeutic_area": "Immunological and Autoimmune Disorders",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "TYSABRI (Natalizumab)",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "TYVASO Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 3
  },
  {
    "indication_name": "Tadalafil Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Tafinlar - API Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Tagrisso",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Takepron - API Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Takotsubo Syndrome",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Talimogene Laherparepvec",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Talion - API Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Tamiflu - API Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Tarceva - API Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Tardive Dyskinesia",
    "therapeutic_area": "Neurology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Tardive Dyskinesia Epidemiology Forecast",
    "therapeutic_area": "Neurology",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Tardive Dyskinesia Pipeline Insight",
    "therapeutic_area": "Neurology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Tasigna - API Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Tasurgratinib Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Tau Inhibitors",
    "therapeutic_area": "Neurology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Tay-Sachs Disease",
    "therapeutic_area": "Genetic Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Teeth Whitening",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Telehealth",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Telemedicine Service",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Teleradiology",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Telomerase Inhibitor",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Temferon Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Temporomandibular Disorders",
    "therapeutic_area": "Dental and Oral Health",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2032-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Tendinopathy",
    "therapeutic_area": "Musculoskeletal",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 2
  },
  {
    "indication_name": "Tendinopathy Epidemiology Forecast",
    "therapeutic_area": "Musculoskeletal",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Tendinopathy Pipeline Insight",
    "therapeutic_area": "Other Diseases",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Tendonitis",
    "therapeutic_area": "Musculoskeletal",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2030-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Tendonitis Epidemiology Forecast",
    "therapeutic_area": "Musculoskeletal",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Tendonitis Pipeline Insight",
    "therapeutic_area": "Musculoskeletal",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Tenofovir alafenamide",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Tenofovir disoproxil",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Tenosynovial Giant Cell Tumors (TSGCTs)",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 4
  },
  {
    "indication_name": "Tenosynovitis",
    "therapeutic_area": "Other Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 2
  },
  {
    "indication_name": "Tepmetko",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Teriparatide\u2013 Biosimilar Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2024,
    "year_range": "2024",
    "total_reports": 1
  },
  {
    "indication_name": "Testicular Cancer",
    "therapeutic_area": "Male Health",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Testicular Cancer Epidemiology Forecast",
    "therapeutic_area": "Oncology",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Testicular Cancer Pipeline Insight",
    "therapeutic_area": "Oncology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Testicular Neoplasm",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Tetanus",
    "therapeutic_area": "Infectious Diseases",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Tetrahydrofolate Dehydrogenase Inhibitor",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Tezepelumab Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Thalassemia",
    "therapeutic_area": "Hematological Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Therapeutic Respiratory Devices",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Therapy Resistant Psychiatric Disorders",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Thoracic Aortic Stent Grafts\u2013Pipeline Insight and Competitive Landscape",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2023,
    "year_range": "2023",
    "total_reports": 1
  },
  {
    "indication_name": "Thoracic Drainage Devices",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Throat Cancer",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2032-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Thrombectomy Devices",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Thrombocytopenia",
    "therapeutic_area": "Hematological Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 6
  },
  {
    "indication_name": "Thrombocytopenia - Global API Manufacturers, Marketed and Phase III Drugs Landscape",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Thrombotic Microangiopathy (TMA)",
    "therapeutic_area": "Rare Diseases",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Thrombotic Microangiopathy Epidemiology Forecast",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Thrombotic Thrombocytopenic Purpura (TTP)",
    "therapeutic_area": "Hematological Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2030-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Thrombotic Thrombocytopenic Purpura - Global API Manufacturers, Marketed and Phase III Drugs Landscape",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Thymic Carcinoma",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Thymic Stromal Lymphopoietin Inhibitors (TSLP inhibitors) \u2013 Target Population, Competitive Landscape, and Market Forecast",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Thymidine Kinase 2 Deficiency (TK2D)",
    "therapeutic_area": "Other Diseases",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Thymidine Phosphorylase Inhibitors Market Size, Target Population, Competitive Landscape & Market Forecast",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Thymidylate Synthase Inhibitors",
    "therapeutic_area": "Oncology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Thymoma",
    "therapeutic_area": "Oncology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Thymus Cancer",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Thyroid Cancer",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Thyroid Cancer - Global API Manufacturers, Marketed and Phase III Drugs Landscape",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Thyroid Eye Disease (TED)",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2032-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Thyroid Gland Disorder Treatment",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Thyroid Hormone Receptor Agonists",
    "therapeutic_area": "Endocrinology and Metabolic Disorders",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Tibial Bearings",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Tick Borne Encephalitis",
    "therapeutic_area": "Infectious Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2032-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Tie-2 Receptor Inhibitor",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Tie-2 modulators",
    "therapeutic_area": "Oncology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Tildacerfont Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Tildrakizumab Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Tinea Pedis",
    "therapeutic_area": "Infectious Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Tinea Unguium",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Tinnitus",
    "therapeutic_area": "Otolaryngology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Tinnitus Medical Devices",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Tip Location Devices",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Tirzepatide",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Tislelizumab Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Tissue Banking",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Tissue Engineering",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Tissue Factor Pathway Inhibitors (TFPI) Market Size, Target Population, Competitive Landscape & Market Forecast",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Tissue Heart Valves",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Tofersen Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Tolebrutinib Sales Forecast, and Market Size Analysis",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Toll- Like Receptor Agonist",
    "therapeutic_area": "Oncology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Toll-Like Receptor 3 (TLR-3) Agonist",
    "therapeutic_area": "Infectious Diseases",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Toll-Like Receptor 4 (TLR-4) Agonist",
    "therapeutic_area": "Oncology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Toll-Like Receptor 8 Agonist",
    "therapeutic_area": "Oncology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Toll-Like Receptor Modulators",
    "therapeutic_area": "Oncology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Tongue Cancer",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Tonic clonic Seizure",
    "therapeutic_area": "Musculoskeletal",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2032-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Tonometers",
    "therapeutic_area": "Ophthalmology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Tonsillitis",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Topical Skin Infection Treatment",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Topoisomerase Inhibitor",
    "therapeutic_area": "Oncology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Total Ankle Replacement",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Total Artificial Heart",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Total Knee Arthroplasty",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Total Wrist Prosthesis",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Tourette Syndrome",
    "therapeutic_area": "Neurology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Tourette Syndrome - Global API Manufacturers, Marketed and Phase III Drugs Landscape",
    "therapeutic_area": "Neurology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Toxicology Drug Screening",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Tracheostomy Products",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Tradipitant Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Tralokinumab Market Market Size",
    "therapeutic_area": "Dermatology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Transcatheter Aortic Valve Replacement/Implantation",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Transcatheter Embolization And Occlusion Devices - Global",
    "therapeutic_area": "Neurology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Transcatheter Heart Valve Replacement Devices",
    "therapeutic_area": "Cardiovascular Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Transcatheter Mitral Valve Repair Devices",
    "therapeutic_area": "Cardiovascular Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Transcatheter Treatment",
    "therapeutic_area": "Cardiovascular Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Transcranial Alternating Current Stimulation (tACS)",
    "therapeutic_area": "Neurology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Transcranial Doppler",
    "therapeutic_area": "Neurology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Transcranial Magnetic Stimulator",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Transdermal Drug Delivery Devices",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Transforming Growth Factor (TGF) Inhibitor",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Transforming Growth Factor Beta (TGFb) Inhibitor",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Transfusion-dependent Thalassaemia",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Transient Ischemic Attack",
    "therapeutic_area": "Neurology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Transient Receptor Potential Cation Channel, Subfamily A, Member 1 (TRPA1) Antagonist",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 2
  },
  {
    "indication_name": "Transient Receptor Potential Vanilloid 1 (TRPV-1) Receptor (Capsaicin Receptor or Vanilloid Receptor 1) Antagonist",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 2
  },
  {
    "indication_name": "Transitional Cell Carcinoma",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Transmucosal Drug Delivery Devices",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Transmucosal Drugs",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Transradial Access Products",
    "therapeutic_area": "Cardiovascular Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Transthyretin Amyloid Cardiomyopathy (ATTR-CM)",
    "therapeutic_area": "Rare Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2025-2032",
    "total_reports": 2
  },
  {
    "indication_name": "Transthyretin Amyloidosis (ATTR)",
    "therapeutic_area": "Rare Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2027-2032",
    "total_reports": 2
  },
  {
    "indication_name": "Transverse Myelitis",
    "therapeutic_area": "Neurology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Trastuzumab - Biosimilars Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2024,
    "year_range": "2024",
    "total_reports": 1
  },
  {
    "indication_name": "Trauma Fixation Devices",
    "therapeutic_area": "Neurology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Traumatic Brain Injury Assessment Devices",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Traumatic Brain Injury(TBI)",
    "therapeutic_area": "Womens Health",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Traveler's Diarrhea",
    "therapeutic_area": "Gastroenterology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 4
  },
  {
    "indication_name": "Traveler's Diarrhea - Global API Manufacturers, Marketed and Phase III Drugs Landscape",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Treatment Resistant Depression",
    "therapeutic_area": "Neurology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2025-2032",
    "total_reports": 2
  },
  {
    "indication_name": "Treatment-Resistant Depression (TRD)",
    "therapeutic_area": "Neurology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2028,
    "year_range": "2028",
    "total_reports": 1
  },
  {
    "indication_name": "Treatment-Resistant Hypertension",
    "therapeutic_area": "Cardiovascular Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Treatment-resistant Hypertension (RHTN)\u2014Epidemiology Forecast",
    "therapeutic_area": "Cardiovascular Diseases",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Treg Cell-Based Therapies",
    "therapeutic_area": "Other Diseases",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Treprostinil palmitil Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Treprostinil sodium Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Trichomoniasis (US)",
    "therapeutic_area": "Infectious Diseases",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Trichotillomania (TTM)",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Trigeminal Neuralgia (TN)",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Triple Negative Breast Cancer (TNBC)",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 4
  },
  {
    "indication_name": "Triple Negative Breast Cancer Epidemiology Forecast",
    "therapeutic_area": "Oncology",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Triple Negative Breast Neoplasms",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Triple Negative Cancer",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Triple X Syndrome",
    "therapeutic_area": "Genetic Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Triple-refractory Multiple Myeloma",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "TrkC Receptor Antagonists",
    "therapeutic_area": "Hematological Disorders",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Trocars and Access Devices",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Tropical Spastic Paraparesis",
    "therapeutic_area": "Neurology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Tuberculosis",
    "therapeutic_area": "Infectious Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2025-2032",
    "total_reports": 2
  },
  {
    "indication_name": "Tuberculosis Diagnostics",
    "therapeutic_area": "Infectious Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Tuberculous Meningitis",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Tuberous Sclerosis",
    "therapeutic_area": "Infectious Diseases",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Tuberous Sclerosis Complex (TSC)",
    "therapeutic_area": "Genetic Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2027,
    "year_range": "2027",
    "total_reports": 1
  },
  {
    "indication_name": "Tukysa (tucatinib) \u00b1 Herceptin (trastuzumab) Market Size",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Tularaemia",
    "therapeutic_area": "Gastroenterology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Tumor Ablation",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Tumor Necrosis Factor (TNF)-alpha Inhibitor Market Size, Target Population, Competitive Landscape & Market Forecast",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Tumor Necrosis Factor Alpha (TNF-a) Agonist",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Tumor-Infiltrating Lymphocyte (TIL) Therapies Market, Target Population, Competitive Landscape, and Market",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Tumor-Infiltrating Lymphocytes",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Tumour Necrosis Factor Ligand Superfamily Member 15 Inhibitor Market Size, Target Population, Competitive Landscape & Market Forecast",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Turner Syndrome",
    "therapeutic_area": "Endocrinology and Metabolic Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2025-2032",
    "total_reports": 2
  },
  {
    "indication_name": "Tympanostomy Tubes",
    "therapeutic_area": "Otolaryngology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Type 1 Diabetes",
    "therapeutic_area": "Endocrinology and Metabolic Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Type 1 Fibroblast Growth Factor Receptor Antagonists",
    "therapeutic_area": "Oncology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 2
  },
  {
    "indication_name": "Type 1 Lysophosphatidic Acid Receptor (LPA1) Inhibitor",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Type 2 Diabetes",
    "therapeutic_area": "Endocrinology and Metabolic Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Type 4 Cyclic Nucleotide Phosphodiesterase Inhibitors",
    "therapeutic_area": "Respiratory Diseases",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Type II DNA Topoisomerase inhibitors",
    "therapeutic_area": "Infectious Diseases",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Typhoid Fever",
    "therapeutic_area": "Infectious Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Tyrosine Kinase Inhibitors (TKIs) Market Size, Target Population, Competitive Landscape & Market Forecast",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 2
  },
  {
    "indication_name": "Tyrosine kinase 2 (TYK2) Inhibitors \u2013 Target Population, Competitive Landscape, and Market Forecast",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "UB-221",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "UBRELVY Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "UDCA Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "UK Healthcare Outlook Report",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 2
  },
  {
    "indication_name": "ULTOMIRIS Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 4
  },
  {
    "indication_name": "UPLIZNA Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "UX701 Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Ubiquitin Specific Proteases (USP) Inhibitor",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Ubiquitin conjugating enzyme Inhibitor",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Ulcer Haemorrhage",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Ulcerated Necrobiosis Lipoidica (UNL)",
    "therapeutic_area": "Dermatology",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Ulcerative Colitis (UC)",
    "therapeutic_area": "Gastroenterology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Ulcerative Colitis Patient Pool Analysis",
    "therapeutic_area": "Infectious Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Ulcerative Proctitis",
    "therapeutic_area": "Gastroenterology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Ultra-Large Volume Wearable Injectors",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Ultrasonic Aspirator",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Ultrasound Devices",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Uncomplicated Urinary Tract Infections",
    "therapeutic_area": "Genito Urinary System and Sex Hormones",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 5
  },
  {
    "indication_name": "Uncomplicated Urinary Tract Infections Patient Pool Analysis",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Uncontrolled Bleeding",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Underactive Bladder (UAB)",
    "therapeutic_area": "Endocrinology and Metabolic Disorders",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Undifferentiated Pleomorphic Sarcoma (UPS)",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Uniflox - API Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Unisia (Amlodipine + Candesartan) - API Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "United States FemTech",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "United States Respiratory Disease Testing",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "United States Sexually Transmitted Diseases (STD) Diagnostics",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "United States Urinary Tract Infection Testing",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Unresectable Melanoma",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Unstable Angina",
    "therapeutic_area": "Cardiovascular Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Untreated Metastatic or Unresectable Melanoma",
    "therapeutic_area": "Oncology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Upadacitinib",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Upper Limb Hypertonia",
    "therapeutic_area": "Central Nervous System",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2032-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Upper Tract Urothelial Cancer",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Urea Cycle Disorders",
    "therapeutic_area": "Other Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Urea Cycle Disorders Epidemiology Forecast",
    "therapeutic_area": "Endocrinology and Metabolic Disorders",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Urea Cycle Disorders Pipeline Insight",
    "therapeutic_area": "Endocrinology and Metabolic Disorders",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Uremic Pruritus (UP)",
    "therapeutic_area": "Dermatology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Uremic Pruritus and Associated Dry Skin",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Ureteroscope",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Urethral Stricture Treatment Devices",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Urinalysis",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Urinary Catheters",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Urinary Catheters Pipeline Insight and Competitive Landscape",
    "therapeutic_area": "Genito Urinary System and Sex Hormones",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2023,
    "year_range": "2023",
    "total_reports": 1
  },
  {
    "indication_name": "Urinary Drainage Bags",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Urinary Flow Meter Devices",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Urinary Incontinence",
    "therapeutic_area": "Genito Urinary System and Sex Hormones",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Urinary Incontinence - Global API Manufacturers, Marketed and Phase III Drugs Landscape",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Urinary Incontinence Devices",
    "therapeutic_area": "Other Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Urinary Incontinence Including Neurogenic Bladder",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Urinary Retention",
    "therapeutic_area": "Genito Urinary System and Sex Hormones",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Urinary Stents/Ureteral Stents",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Urinary Tract Infection Testing Devices",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Urinary Tract Infections",
    "therapeutic_area": "Infectious Diseases",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Urinary Tract Obstruction Treatment Devices",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Urine Output Monitoring Systems",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Urodynamic Devices",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Urolithiasis",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Urolithiasis Management Devices",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Urology Catheters",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Urology Devices",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Urology Lasers",
    "therapeutic_area": "Genito Urinary System and Sex Hormones",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Urology Ultrasound Devices",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Urolosin - API Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Uromune (MV140) Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Urothelial Carcinoma",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 4
  },
  {
    "indication_name": "Urothelial Carcinoma Patient Pool Analysis",
    "therapeutic_area": "Respiratory Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Urticaria",
    "therapeutic_area": "Dermatology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Urticaria Or Hives",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Usher Syndrome",
    "therapeutic_area": "Genetic Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Usher Syndrome Type 2",
    "therapeutic_area": "Genetic Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2032-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Usher Syndrome Type 2 \\n",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Uterine Fibroids & Endometriosis",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Uterine Fibroids Treatment Devices",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Uterine Leiomyoma (Uterine Fibroids)",
    "therapeutic_area": "Non-Malignant Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Uterine Leiomyoma (Uterine Fibroids) - Global API Manufacturers, Marketed and Phase III Drugs Landscape",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Uterine Leiomyosarcoma",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2025-2032",
    "total_reports": 2
  },
  {
    "indication_name": "Uterine Manipulators",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Uterine Sarcoma",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Uterine Serous Carcinoma",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 2
  },
  {
    "indication_name": "Uterine fibroids",
    "therapeutic_area": "Womens Health",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Uveal Melanoma",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Uveal Neoplasms",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Uveitic Glaucoma",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Uveitis",
    "therapeutic_area": "Ophthalmology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 4
  },
  {
    "indication_name": "Uveitis Patient Pool Analysis",
    "therapeutic_area": "Ophthalmology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "VABYSMO Market Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "VAC-18193 Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "VAL-083 Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "VAXELIS Market Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "VAY736 Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 2
  },
  {
    "indication_name": "VB 111 (VBL Therapeutics)",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "VBI-1901 Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "VBP-245 Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "VCAM-1 (vascular cell adhesion molecule-1) gene expression inhibitor",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "VCF Treatment Devices",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "VE303 Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "VE416 Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "VEBICORVIR (ABI-H0731)",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "VEGFR Inhibitor-induced Hand-Foot Skin Reaction",
    "therapeutic_area": "Dermatology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "VELETRI Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "VELSIPITY Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "VEMLIDY Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "VERZENIO Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "VIB4920 Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "VIR-2218 + VIR- 3434 Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "VITRAKVI Market Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "VK2809 Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "VLX-1005 Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "VOTUBIA Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "VP-102 Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 2
  },
  {
    "indication_name": "VP01 Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 2
  },
  {
    "indication_name": "VRAYLAR",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "VRAYLAR (MDD) Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "VRDN-001 Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "VT-1011 Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "VTX-801 Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "VUITY Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "VVZ-149 Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "VX 121",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "VX-147 Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "VX-561",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "VX15 (pepinemab) Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "VXA-A1.1 Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "VYEPTI Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 2
  },
  {
    "indication_name": "Vaccine",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Vaccine Adjuvants",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Vaccine Contract Manufacturing",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Vaginal Pessary",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Vaginal Rejuvenation Systems",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Vaginal Slings",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Vaginal Specula/Vaginal Speculum",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Vaginal and Vulval Inflammatory Diseases",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Vaginitis",
    "therapeutic_area": "Dermatology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Vagus Nerve Stimulator (VNS) - Global",
    "therapeutic_area": "Neurology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Valley Fever",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Valrox (Valoctocogene Roxaparvovec)",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Vamorolone",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Vancomycin Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Vancomycin Resistant Enterococcal Infections",
    "therapeutic_area": "Infectious Diseases",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Vancomycin-Resistant Enterococcus Faecium Infections",
    "therapeutic_area": "Infectious Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Vancomycin-Resistant Enterococcus Faecium Infections - Global API Manufacturers, Marketed and Phase III Drugs Landscape",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Varicella Zoster (HHV-3) Infections",
    "therapeutic_area": "Infectious Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Varicella Zoster (HHV-3) Infections - Global API Manufacturers, Marketed and Phase III Drugs Landscape",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Varicose Ulcer",
    "therapeutic_area": "Dermatology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Varicose Vein Treatment Devices",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Varicose Veins",
    "therapeutic_area": "Cardiovascular Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Varicose Veins - Global API Manufacturers, Marketed and Phase III Drugs Landscape",
    "therapeutic_area": "Cardiovascular Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Vasculan Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Vascular Access Device",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Vascular Adhesion Protein 1 (VAP-1) Inhibitor",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Vascular Anomalies",
    "therapeutic_area": "Other Diseases",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Vascular Calcification",
    "therapeutic_area": "Cardiovascular Diseases",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Vascular Closure Devices",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Vascular Dementia",
    "therapeutic_area": "Neurology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Vascular Dementia Patient Pool Analysis",
    "therapeutic_area": "Neurology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Vascular Ehlers-Danlos Syndrome (vEDS)",
    "therapeutic_area": "Genetic Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size, Target Population, Competitive Landscape & Market Forecast",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Vascular Endothelial Growth Factor A (VEGF-A) Inhibitor",
    "therapeutic_area": "Ophthalmology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Vascular Endothelial Growth Factor Inhibitor",
    "therapeutic_area": "Ophthalmology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Vascular Endothelial Growth Factor Receptor 3 Antagonists",
    "therapeutic_area": "Oncology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 2
  },
  {
    "indication_name": "Vascular Grafts",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Vascular Grafts Pipeline Insight and Competitive Landscape",
    "therapeutic_area": "Cardiovascular Diseases",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2023,
    "year_range": "2023",
    "total_reports": 1
  },
  {
    "indication_name": "Vascular Imaging Devices",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Vascular Malformations",
    "therapeutic_area": "Cardiovascular Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Vascular Patches",
    "therapeutic_area": "Cardiovascular Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Vascular Stents",
    "therapeutic_area": "Cardiovascular Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Vasculitis",
    "therapeutic_area": "Cardiovascular Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Vaso-Occlusive Crisis",
    "therapeutic_area": "Hematological Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Vaso-Occlusive Crisis Associated With Sickle Cell Disease",
    "therapeutic_area": "Genetic Disorders",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Vasomotor Symptoms",
    "therapeutic_area": "Endocrinology and Metabolic Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Vasomotor Symptoms of Menopause",
    "therapeutic_area": "Womens Health",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Vasomotor symptoms (Hot flashes/Night sweats)\u2013 Epidemiology Forecast",
    "therapeutic_area": "Endocrinology and Metabolic Disorders",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Vasopressin Receptor Antagonist",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Vasopressin V1 Receptor (V1R) Antagonist",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Vasopressin V2 Receptor (V2R) Antagonist",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 2
  },
  {
    "indication_name": "Vein Illumination Devices",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Velcade - API Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Velmetia - API Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Venglustat",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Venoferrum - API Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Venous Leg Ulcers",
    "therapeutic_area": "Other Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Venous Stenosis",
    "therapeutic_area": "Other Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2032-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Venous Thromboembolism",
    "therapeutic_area": "Cardiovascular Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Venous Thromboembolism - Global API Manufacturers, Marketed and Phase III Drugs Landscape",
    "therapeutic_area": "Cardiovascular Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Venous Thromboembolism Treatment Devices",
    "therapeutic_area": "Cardiovascular Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Venous Ulcer",
    "therapeutic_area": "Dermatology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Ventilator Associated Pneumonia (VAP)",
    "therapeutic_area": "Respiratory Diseases",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Ventilators",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Ventorlin Expectorant - API Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Ventral Hernia",
    "therapeutic_area": "Other Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2032-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Ventricular Assist Devices (VAD)",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Ventricular Dysfunction",
    "therapeutic_area": "Cardiovascular Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Ventricular Fibrillation",
    "therapeutic_area": "Cardiovascular Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2032-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Ventricular Hypertrophy",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Ventricular Tachycardia (V-tach or VT)",
    "therapeutic_area": "Cardiovascular Diseases",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Veramyst - API Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Verdiperstat Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Vernal Keratoconjunctivitis",
    "therapeutic_area": "Ophthalmology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 4
  },
  {
    "indication_name": "Vertebral Body Replacement (VBR) Systems",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Vertebral Compression Fractures (VCF) Treatment Devices",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Vertigo",
    "therapeutic_area": "Otolaryngology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor Market Size, Target Population, Competitive Landscape & Market Forecast",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Vestibular Schwannoma",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Vestibular Testing Systems",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Veterinary Diagnostic Imaging",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Veterinary Vaccines",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Vfend - API Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Vidaza - API Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Vimpat - API Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Viral Conjunctivitis",
    "therapeutic_area": "Gastroenterology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Viral Core Protein Inhibitors",
    "therapeutic_area": "Infectious Diseases",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Viral RNA Polymerase Inhibitor",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Viral Vector Manufacturing",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Viralym-M Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Viread - API Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Visceral Pain associated with GI disorders",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Vision Screeners",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Visual Cycle Modulation (VCM)",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Vital Sign Monitoring Devices",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Vitamin A Deficiency",
    "therapeutic_area": "Nutritional Disorders and Weight Loss",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Vitamin D Receptor (VDR or Calcitriol Receptor) Agonist",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Vitiligo",
    "therapeutic_area": "Dermatology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 5
  },
  {
    "indication_name": "Vitrectomy Devices",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Vitreomacular Traction Syndrome",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Vitreoretinal Surgery Devices",
    "therapeutic_area": "Ophthalmology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Vivacor - API Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Vivanza - API Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Vixarelimab Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Voice Prosthesis Devices",
    "therapeutic_area": "Otolaryngology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Volibris - API Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Volixibat Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Voltage-Dependent Calcium Channel Blockers",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Voltage-Dependent T-Type Calcium Channel Blockers",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Voltage-Gated Sodium Channel Blockers",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Von Hippel-Lindau (VHL) Disease",
    "therapeutic_area": "Genetic Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2030-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Von Willebrand Disease (VWD)",
    "therapeutic_area": "Genetic Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2030,
    "year_range": "2027-2030",
    "total_reports": 3
  },
  {
    "indication_name": "Von Willebrand\u2019s Disease",
    "therapeutic_area": "Genetic Disorders",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Vonvendi [von Willebrand factor (recombinant)] (US)/VEYVONDI [vonicog alfa, a recombinant human von Willebrand factor (rVWF)] (EU)",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Votrient - API Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Votubia - API Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Vulvar Cancer",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Vulvar Cancer Pipeline Insight",
    "therapeutic_area": "Oncology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Vulvar Squamous Cell Carcinoma",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2032-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Vulvodynia",
    "therapeutic_area": "Womens Health",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2032-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Vulvovaginal Candidiasis",
    "therapeutic_area": "Infectious Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Vutrisiran",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2032-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Vyndaqel",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Vyvanse - API Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Vyzulta (latanoprostene bunod ophthalmic solution)",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "WAS - Competitive Landscape and",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2018,
    "year_range": "2018",
    "total_reports": 1
  },
  {
    "indication_name": "WAYLIVRA Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 2
  },
  {
    "indication_name": "WEE1 Protein Inhibitors",
    "therapeutic_area": "Oncology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "WEGOVY (Semaglutide)",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "WEGOVY Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 3
  },
  {
    "indication_name": "WHIM Syndrome",
    "therapeutic_area": "Rare Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "WRN Inhibitors Market- Target Population, Competitive Landscape, and Market Metadata",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2040,
    "year_range": "2040",
    "total_reports": 1
  },
  {
    "indication_name": "Waldenstrom Macroglobulinemia - Global API Manufacturers, Marketed and Phase III Drugs Landscape",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Waldenstrom's Macroglobulinaemia",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 6
  },
  {
    "indication_name": "Walking Assist Devices",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Walking Impairment in Multiple Sclerosis",
    "therapeutic_area": "Neurology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Warm Autoimmune Hemolytic Anemia (WAIHA) \u2013 Pipeline Insights",
    "therapeutic_area": "Immunological and Autoimmune Disorders",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2022,
    "year_range": "2022",
    "total_reports": 1
  },
  {
    "indication_name": "Warm Autoimmune Hemolytic Anemia (wAIHA )",
    "therapeutic_area": "Hematological Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2028-2034",
    "total_reports": 5
  },
  {
    "indication_name": "Warts",
    "therapeutic_area": "Dermatology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Wasting Syndrome",
    "therapeutic_area": "Nutritional Disorders and Weight Loss",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2032-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Wavefront Aberrometer",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Wearable Injectors",
    "therapeutic_area": "Cardiovascular Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Wearable Medical Devices",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Wegener Vasculitis",
    "therapeutic_area": "Cardiovascular Diseases",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Wegener's Granulomatosis with Polyangiitis",
    "therapeutic_area": "Rare Diseases",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Wegener's Granulomatosis/Granulomatosis with Polyangiitis",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Weight Loss/Weight Management (Obesity)",
    "therapeutic_area": "Endocrinology and Metabolic Disorders",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Welchol - API Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "West Nile",
    "therapeutic_area": "Infectious Diseases",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "West Nile Encephalitis",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "West Syndrome",
    "therapeutic_area": "Neurology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Wet Age-Related Macular Degeneration (Wet AMD)",
    "therapeutic_area": "Ophthalmology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Wet Macular Degeneration",
    "therapeutic_area": "Ophthalmology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 4
  },
  {
    "indication_name": "Wet Macular Degeneration - Global API Manufacturers, Marketed and Phase III Drugs Landscape",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Wheelchair",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Wheelchair\u2013Pipeline Insight and Competitive Landscape",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2023,
    "year_range": "2023",
    "total_reports": 1
  },
  {
    "indication_name": "Whey Protein",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2027,
    "year_range": "2027",
    "total_reports": 1
  },
  {
    "indication_name": "Whiplash Injury",
    "therapeutic_area": "Musculoskeletal",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2030-2032",
    "total_reports": 2
  },
  {
    "indication_name": "Whooping cough/Pertussis",
    "therapeutic_area": "Infectious Diseases",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Wide Neck Bifurcation Intracranial Aneurysms",
    "therapeutic_area": "Other Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2032-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Wilms Tumor",
    "therapeutic_area": "Hematological Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Wilson Disease",
    "therapeutic_area": "Genetic Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 4
  },
  {
    "indication_name": "Wipes",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Wireless Brain Sensors",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Wiskott-Aldrich Syndrome",
    "therapeutic_area": "Immunological and Autoimmune Disorders",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Wnt Signaling Pathway Inhibitor",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Wolman Disease",
    "therapeutic_area": "Rare Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  },
  {
    "indication_name": "Women\u2019s Health",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Wound Closure Devices",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Wound Closure Devices\u2013Pipeline Insight and Competitive Landscape",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2023,
    "year_range": "2023",
    "total_reports": 1
  },
  {
    "indication_name": "Wound Debridement Devices",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Wound Healing Devices",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Wound Irrigation Systems",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Wrinkles",
    "therapeutic_area": "Dermatology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "X Linked Hypophosphatemia",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "X-Linked Adrenoleukodystrophy Pipeline Insight",
    "therapeutic_area": "Genetic Disorders",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "X-Linked Myotubular Myopathy (XLMTM)",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 2
  },
  {
    "indication_name": "X-Linked Retinitis Pigmentosa (XLRP)",
    "therapeutic_area": "Ophthalmology",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 2
  },
  {
    "indication_name": "X-Linked Retinoschisis",
    "therapeutic_area": "Ophthalmology",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "X-Ray Detector",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "X-Ray Devices",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "X0002 Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 2
  },
  {
    "indication_name": "XARACOLL Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "XARELTO Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "XELJANZ Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 3
  },
  {
    "indication_name": "XELPROS Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "XEN496 Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "XENICAL (Orlistat)",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "XIPERE Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "XOLAIR Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 2
  },
  {
    "indication_name": "XOLAIR Marketed Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "XP-3924 Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "XPOVIO Market Size",
    "therapeutic_area": "Oncology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Xadago (safinamide)",
    "therapeutic_area": "Neurology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Xanax - API Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Xanthine Oxidase Inhibitor",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Xarelto - API Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Xelevia - API Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Xeloda - API Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Xenazine - API Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Xeristar - API Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Xeroquel LP - API Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Xerosis",
    "therapeutic_area": "Oncology",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Xerostomia",
    "therapeutic_area": "Dental and Oral Health",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Xifaxan (rifaximin)",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Xiidra Market Size",
    "therapeutic_area": "Ophthalmology",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Xlinked Severe Combined Immunodeficiency (SCID)",
    "therapeutic_area": "Genetic Disorders",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 2
  },
  {
    "indication_name": "Xlinked hypophosphatemia (XLH)",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Xopenex - API Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Xtandi",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Xtandi - API Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Xyrem - API Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Xyzall - API Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "YSELTY (LINZAGOLIX; OBE2109)",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "YUTIQ Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Yellow Fever",
    "therapeutic_area": "Infectious Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Yescarta",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Yondelis - API Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "ZANAFLEX Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "ZEJULA Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "ZEMAIRA Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "ZEPOSIA (Ozanimod) Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "ZILOSUL Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 4
  },
  {
    "indication_name": "ZIMURA",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "ZINPLAVA Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "ZONTIVITY Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "ZULRESSO Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "ZYNRELEF Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Zactos - API Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Zaldiar - API Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Zamicastat Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Zanidatamab Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Zeclar - API Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Zeffix - API Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Zelboraf - API Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Zelitrex - API Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Zemplar - API Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Zenhale - API Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Zenocutuzumab Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 2
  },
  {
    "indication_name": "Zerbaxa - API Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Zibotentan + Dapagliflozin Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Zienam - API Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Zient - API Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Zika Virus",
    "therapeutic_area": "Infectious Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Zika Virus Infection",
    "therapeutic_area": "Infectious Diseases",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Ziltivekimab Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Zintrepid - API Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Zispin - API Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Zocor - API Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Zolgensma (onasemnogene abeparvovec-xioi)",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Zollinger Ellison Syndrome",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "Zoloft - API Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Zoltec - API Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Zometa Concentrate - API Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Zortress - API Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Zosyn - API Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Zunsemetinib (ATI-450) Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Zurcal - API Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Zygomatic and Pterygoid Implant",
    "therapeutic_area": "Dental and Oral Health",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "Zynteglo",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Zyprexa - API Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "Zytiga",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "Zytiga - API Insight",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "bRESCAP Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "cFMS Kinase Inhibitor",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "eHealth - Global",
    "therapeutic_area": "Other Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "ePharmacy",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "hepatits B virus Infection",
    "therapeutic_area": "Infectious Diseases",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2032-2034",
    "total_reports": 2
  },
  {
    "indication_name": "interleukin Agonist",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "mGlu 2/3 Agonist",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "mGlu 2/3/5 Antagonist",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "mGlu5 Antagonist",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "mRNA Synthesis and Manufacturing",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "mRNA Vaccine and Therapeutics",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2028,
    "year_range": "2028",
    "total_reports": 1
  },
  {
    "indication_name": "mRNA-1010 Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "mRNA-1345 Market Size",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2032,
    "year_range": "2032",
    "total_reports": 1
  },
  {
    "indication_name": "mTORC-1 Inhibitor",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "mTORC-2 Inhibitor",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "mTORC1 Protein Inhibitors",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "p70S6 Kinase (p70S6K or 70-kDa Ribosomal Protein S6 Kinase) Inhibitor",
    "therapeutic_area": "Other",
    "has_market_insight": "N",
    "has_drug_insight": "Y",
    "has_epidem_insight": "N",
    "most_recent_year": 2025,
    "year_range": "2025",
    "total_reports": 1
  },
  {
    "indication_name": "relapsed/refractory (R/R) Epstein-Barr virus (EBV)",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "Y",
    "has_epidem_insight": "Y",
    "most_recent_year": 2034,
    "year_range": "2025-2034",
    "total_reports": 3
  },
  {
    "indication_name": "scAAV9.CB.CLN6",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2030,
    "year_range": "2030",
    "total_reports": 1
  },
  {
    "indication_name": "\u03b2-Site Amyloid Precursor Protein Cleaving Enzyme 1 (BACE1) Inhibitors Market Size, Target Population, Competitive Landscape & Market Forecast",
    "therapeutic_area": "Other",
    "has_market_insight": "Y",
    "has_drug_insight": "N",
    "has_epidem_insight": "N",
    "most_recent_year": 2034,
    "year_range": "2034",
    "total_reports": 1
  }
]